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ABSTRACT 
The main portion of this thesis describes two distinct applications of guanidinium 
sulfation crystallization: use of a flat guanidinium chloride for enantiomeric identification 
and a chiral guanidinium bromide for diastereomeric resolution. Additionally, the 
follwing two chapters includes the modification of naturally occurring materials for 
pollution remediation and the synthesis of biodegradable polyesters for biomedical 
imaging.   
The importance of chirality can be found in a variety of fields including 
pharmaceuticals, fragrances, food additives, agrochemicals, and forensics. Most 
biologically active organic compounds such as amino acids and carbohydrates exhibit 
chirality, resulting in a high degree of stereoselectivity in processes that are mediated by 
biological systems. Since these metabolic and regulatory processes are sensitive to 
stereochemistry, often enantiomers of drugs will differ in terms of their behavior and 
activity in the body. This same problem arises in the aforementioned fields, where one of 
the enantiomers of the racemic mixture is active and the other enantiomer can either be 
inactive or even exhibit detrimental effects. Nonetheless, chiral products are often still 
marketed as racemic mixtures due to the difficulty in separation and production costs 
associated with accessing a single, active enantiomer.  
The first chapter of this thesis reviews the significance of chirality and provides 
several examples of the importance of a single enantiomer in various fields. The second 
chapter details the current field of absolute stereochemical determination and the 
development of our guanidinium sulfation crystallization methodology for enantiomeric 
ii 
iii 
identification. Extension of this methodology for the diastereomeric resolution of racemic 
mixtures is covered in the third chapter along with other complimentary techniques for 
the separation of enantiomers. 
Hazardous chemicals can escape to the environment through a number of natural 
and/or anthropogenic events. This environmental pollution is known to cause adverse 
health effects toward the public and non-targeted ecological species. The fourth chapter 
of this thesis details two common pollutants (volatile organic compounds and pesticides) 
and our efforts toward the remediation of each. 
The use of imaging agents and techniques are essential in the understanding of 
complex biological processes in situ and in real time. Polymeric materials have become 
increasingly popular for contrast imaging agents due to their inherent biodegradable and 
biocompatible profile. The fifth chapter of this thesis describes the synthesis, 
characterization, and X-ray evaluation of several iodoarene-containing polyesters.  
In the final chapter, a variety of acentric guanidinium sulfate salts are presented 
and discussed. These serendipitous structures all crystallized in the highly desired non-
centrosymmetric space group while containing a strong network of hydrogen bonding.  
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CHAPTER ONE 
GENERAL ASPECTS OF CHIRALITY IN ORGANIC CHEMISTRY 
1.1! CHIRALITY 
Chirality was first discovered in 1848 by Louis Pasteur when he observed two 
forms of sodium ammonium tartrate crystals under a microscope – right-handed and left-
handed crystals.1-2 The two isomers formed from a spontaneous resolution of the racemic 
mixture when crystallized at 27°C (Scheme 1.1).   
Centuries later, we now know that chirality plays a critical role in the majority of 
disciplines in organic chemistry. Chirality is a property of an object which is non-
superimposable with its mirror image. There are four types of chirality elements that exist 
including point chirality (i.e. the canonical “asymmetric center”, axial chirality, helical 
chirality, or planar chirality (Figure 1.1). If a molecule contains one of these elements, 
then the molecule and its mirror image are considered to be chiral.  The most common 
form of chirality is an asymmetic or stereogenic center in which a carbon atom bears four 
different substituents. Other atoms such as sulfur, phosphorus, and nitrogen can also form 


























Scheme 1.1. Spontaneous resolution of sodium ammonium tartrate.
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sites in the tetrahedron. Chiral planes, axes, or helices occur in molecules that lack a 
chiral center, but contain a structural fragment that has restricted rotation forcing 
enantiomers to have a differ spatial arrangement of atoms in the molecule with respect to 
the chiral plan, axis, or helix. Some common examples of inherent chirality include 
allenes (chiral axis), helicenes (chiral helix), and metallocenes (chiral plane). 
 
In the context of small organic compounds containing asymmetric centers, the two non-
superimposable mirror image forms are called enantiomers. Chiral molecules can rotate 
the plane of polarized light and two enantiomers of such compounds can be classified as 
levorotary (L-isomer) or dextrorotary (D-isomer) depending on whether they rotate plane-
polarized light in a left (–) or right (+) handed manner, respectively. An equimolar 
mixture of enantiomers is called a racemic mixture (D,L) and exhibits no optical activity.   
Thus, enantiomers will have the same chemical formula, same chemical and physical 
properties, while differing in the spatial arrangement of the atoms and the optical activity 
of a pure sample. The spatial arrangement of substituents can be used to easily 
distinguish each enantiomer following the Cahn-Ingold-Prelog convention (R or S).  
Substituents are ranked in order of priority based on atomic number and positioning. If 
























the 4th priority group away from the viewer, the configuration of the stereocenter is 
designated as R (rectus or right).  If the analysis results in tracking the top priority group 
to the third priority group in a counter clockwise direction, the stereocenter is assigned 
the  S (sinister or left) designation.1-5  
 
1.2! APPLICATIONS OF CHIRALITY  
 
Stereochemistry is a branch of chemistry that deals with chiral compounds and the 
spatial arrangement of atoms or groups in molecules. Drugs, agrochemicals, fragrances, 
and food additives all represent classes of compounds that contain a high degree of 
stereochemistry.  Chirality is also an inherent property of many small, biologically 
relevant organic compounds such as amino acids and carbohydrates. All of the amino 
acids, except glycine, possess a chiral carbon in the α-position relative to the carboxyl 
group, and the configuration of this chiral carbon is nearly always S when comprised in a 
peptide or protein. Similarly, sugars have at least one chiral carbon and for most naturally 
occurring sugars the configuration at the carbon furthest from the aldehyde or ketone 
functionality is D. In turn, there is a high degree of stereoselectivity in processes that are 
mediated by biological systems. Since these metabolic and regulatory processes are 
sensitive to stereochemistry, the majority (55%) of drugs being sold on the market today 
are chiral compounds.6 Agrochemicals or pesticides encompass several different classes 
of compounds including herbicides, insecticides, fungicides, disinfectants, or any other 
substance that can prevent, destroy, or control pests.7-8 Approximately 30% of the active 
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ingredients in currently registered pesticides contain asymmetric centers.8 This 
percentage is expected to increase as more complex compounds continue to be introduced 
and explored in the field. Nature, itself, is almost exclusively chiral and provides 
numerous examples that demonstrate the significance of a chiral center.  
 
1.3! IMPORTANCE OF A SINGLE ENANTIOMER 
 
The art of enantioseparation and stereochemical determination is a major 
scientific and economic interest.  As mentioned previously, chiral compounds exist in 
racemic mixtures where there are equal amounts of each enantiomers. In the multiple 
fields where chirality plays a critical role, the use of a single enantiomer is often 
preferred. This is due to the general phenomena where one of the enantiomers of the 
racemic mixture often has a higher activity for the desired function. The opposite 
enantiomer can either be less active, inactive, or even exhibit detrimental effects. Thus, 
the use of a single, active enantiomer often provides a more predictable, effective, and 
economical agent compared to the racemic mixture. The impact of this phenomena can be 
found in fields of stereochemistry because typically enantiomers only exhibit this 
difference in activity when in the presence of a chiral environment (i.e. our bodies, plants, 
animals, etc.). Despite the importance of a single enantiomer, chiral products are often 
still marketed as racemic mixtures due to difficulty in separation and production cost of 
the single enantiomer. The separation of enantiomers is challenging due to the fact that 
enantiomers possess many identical physical properties such as boiling point and 
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solubility, preventing simple methods (distillation and recrystallization) from being used. 
Additionally, the stereoselective synthesis of chiral compounds can be very taxing and 
expensive.  
 There are numerous examples that highlight the significance of the spatial 
arrangement about a stereogenic center in chiral compounds. A number of terpene natural 
products including carvone and limonene have drastically different odors and uses due to 
their enantiomeric identity. The (+)- or (S)-enantiomer of carvone is the major flavor 
component of caraway seeds (rye bread) while the (−)- or (R)-enantiomer is responsible 
for the smell of spearmint oil. The (+)- or (R)-enantiomer of limonene is found in the 
peels of fruits and has a citrus smell, while the (−)- or (S)-enantiomer has a piney, wood 
smell and is found in the cones of the Pinaceae family.  
 
 The use of a single enantiomer in chiral pesticides is a field that has a great room 
for growth and improvement. While 30% of active ingredients in registered pesticides are 
chiral, only an estimated 7% of chiral pesticides are sold as a pure isomer.8 For example, 
the three chiral pesticides shown in Figure 1.3 are all used as racemic mixtures. It is 
known that chiral pesticides can behave stereoselectively, where only one isomer is 










Figure 1.2. Examples of chiral terpene natural products: carvone and limonene.
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on non-target species. Nevertheless, the difference in performance of chiral pesticides 
enantiomers are rarely investigated due to the expenses involved in the production and/or 
purification process. 
 
Chirality in pharmaceuticals is of the highest importance due to biological 
processes, such as enzymatic reactions and messenger-receptor interactions being 
sensitive to stereochemistry.9-12 The literature provides many examples where 
stereoisomers of drugs differ in terms of their behavior and activity in the body (Figure 
1.4). A popular example is thalidomide where the (R)-enantiomer is effective against 
morning sickness for pregnant women but the (S)-enantiomer is teratogenic.13 The (S,S)-
enantiomer of ethambutol is used to treat tuberculosis, but the (R,R)-enantiomer causes 
blindness.14 (S)-Napoxen is a common medicine used for arthritis pain, but the opposite 
enantiomer causes liver poison with no analgesic effect.14 Furthermore, the L-isomer of 
all β-blockers are more potent in blocking β-adrenoceptors than their D-isomer antidote.14 
This leads to the fact that roughly 44% of the drugs that are sold on the pharmaceutical 
market are sold as a single enantiomer.6 However, there are still drugs that are 
administered as a racemic mixture that would be more effective when administered as a 































Figure 1.3. Examples of chiral pesticides sold as racemates. Asterisks indicate chiral centers.
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This abundance of chirality and its consequences makes for the preparation and 
identification of enantiopure compounds to be very important and practical issues. While 
significant work has been done in the community to address these critical issues, there are 
still challenges and opportunities for improvement. The next two chapters of this thesis 
will cover in depth the current strategies in place to assign the absolute configuration of 
enantiopure compounds and separate racemic mixtures. Additionally, our efforts in 
absolute stereochemical determination and diastereomeric resolution via guanidinium 
sulfate crystallization will be described.  The high utility of chiral organic compounds 
including drugs, agrochemicals, food additives, and fragrances, undoubtedly makes the 
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ABSOLUTE STEREOCHEMICAL IDENTIFICATION 
 OF SMALL ORGANIC COMPOUNDS 
 
  
2.1  GENERAL REMARKS 
 
 
The identity of the absolute stereochemistry of small organic compounds is a vital 
piece of information for many synthetic, pharmaceutical, and biological applications. As 
described in chapter one, enantiomers of chiral compounds can have drastically different 
activity when in the presence of a chiral reagent or environment. Thus, knowing exactly 
which enantiomer has been generated or isolated is highly important. For example, often 
the total synthesis of natural products include the use of stereoselective reactions. After 
isolation of the chiral intermediate or product, it is necessary to confirm the enantiomeric 
identity before publishing in the literature. Additionally, assigning the absolute 
stereochemistry is an essential step in the process of isolating and reporting a natural 
product from its original source.1 In pharmaceuticals, the enantiomeric identity of a given 
drug can have a profound effect on its pharmacokinetic and pharmacodynamics 
properties.2-3 Therefore, knowledge of the stereochemical configuration of chiral drugs is 
imperative and must be obtained with absolute certainty.  
While the identity of the absolute stereochemistry is a fundamental piece of 
information for a number of different applications, it still remains a daunting challenge. 
This is in contrast to the rather simple task of measuring the enantiomeric excess (ee) or 
enantiomeric ratio (e.r.) of a scalemic sample.4 Common resolution techniques, such as 
chiral stationary phase high performance liquid chromatography (HPLC) and chiral 
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stationary phase gas chromatography (GC) allow for the evaluation of the enantiopurity 
(ee or e.r,) of a sample to be completed with relative ease. However, even when it can be 
demonstrated that a compound is enantiomerically well resolved, determining which 
enantiomer has been generated or isolated is often very difficult.  
 
2.2   METHODS OF ENANTIOMERIC IDENTIFICATION 
 
The importance and abundance of chirality has led to the development of a wide 
range of techniques for the assignment of absolute stereochemistry.5-45 The most common 
techniques used today in the literature can be divided into four classes: chiroptical 
spectroscopy,5-22 kinetic analyses of stereoselective reactions,23-30 nuclear magnetic 
resonance (NMR) spectroscopy,31-36 and X-ray crystallography.37-47 Each technique will 
be described herein along with a comparative analysis of the advantages and 
disadvantages of each class.     
Chiroptical spectroscopy  refers to techniques that investigate the interaction of 
electromagnetic radiation with chiral substances including circular dichroism (CD), 
optical rotatory dispersion (ORD), vibrational Raman optical activity (VROA), and 
circular polarization of luminescence (CPL). Advances in CD by Nakanishi,5 Harada,5 
Berova,6 and Stephens,7  among others has made it a promising tool for the determination 
of the absolute configuration of target molecules. CD probes the difference in absorption 
of right-handed and left-handed circulary polarized light. This inherent sensitivity to 
chirality has made CD one of most popular strategies to identify stereocenters. CD as an 
12
analytical technique has multiple different derivatives including electronic circular 
dichroism (ECD),5-7 vibrational circular dichroism (VCD),8-10 and exciton coupled 
circular dichroism (ECCD).11-22 ECD, where CD is coupled with electronic transitions, 
examines chiral substrates containing electronic chromophores capable of absorbing 
visible light. If the chiral molecule lacks an electronic chromophore, CD can be coupled 
with vibrational transitions (VCD) or Raman scattering (VROA). Thus, ECD and VCD 
are the chiroptical counter part of ultraviolet-visible (UV-Vis) spectroscopy and infrared 
(IR) spectroscopy, respectively. Perhaps the most utilized CD technique is ECCD, which 




























Scheme 2.1. Complexation of target (S)-cyclohexylethylamine (II-1) with 
3,3’-bisporphyrin-substituted 2,2’-biphenol tweezer (II-2).
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workers have developed a series of metalated bis-porphyrin tweezers that are capable of 
binding chiral substrates.11-22 For example, they synthesized 3,3’-bisporphyrin-substituted 
2,2’-biphenol tweezer (II-2) was complexed with a variety of alkyl and aryl amines in 
hexane at a 1:20 host:guest ratio.19 In Scheme 2.1, one can see the complexation of the 
target enantiopure compound, (S)-cyclohexylethyl amine (II-1) with (II-2). Based off 
steric arguments, either the (M)- or (P)-helicity form of the complex will be favored. The 
induced helicity of the substrate-tweezer complex is measured using ECCD, which then 








" = 3,3’-bisporphyrin-substituted 2,2’-biphenol tweezer






















Figure 2.1. Proposed model for assigning the absolute stereochemistry of chiral 
amines. Complexation of (S)-cyclohexylethylamine (II-1) with II-2 is illustrated 
with both (M)- and (P)-helecity.
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For the substrate (II-1)-tweezer (II-2) complex, the (P)-(S) complex leads to the 
positioning of the CH3 group in the most sterically encumbered region compared to (M)-
(S) complex which places the smallest group (H) in the same comparable location (Figure 
2.1). Thus, the more energetically favorable complex is (P)-(S) and the experimental 
result yields a strong negative ECCD spectrum that corroborates the predicted 
assignment.19  A variety of chiral organic compounds including carboxylic acids,11-15 1,2-
diols, 1,2-diamines, 1,2-aminoalcohols,16 epoxy alcohols,17 1,n-glycols,18 amines,19-20 
cyanohydrins,21 and sulfoxides22 have been successfully identified using this method. 
Despite the wide range of chiral substrates tolerated under this elegant approach, the 
strategy has several disadvantages. The first being that the strategy requires the non-
trivial synthesis of the porphyrin tweezers and each different functional group requires its 
own set of tweezers for analysis. Additionally, the approach involves the use of 
specialized analytical instrumentation (circular dichroism) which may not be universally 
available. Overall, the major disadvantage of all chiroptical spectroscopy techniques is 
that they cannot directly assign the absolute configuration of chiral molecules. 
Theoretical models and mnemonics must be used to predict the chiroptical properties of 
the target molecule followed by comparative analysis of the experimental and predicted 
chiroptical spectra to then infer the absolute stereochemistry.  A significant data set of 
known examples must be analyzed to provide a sufficiently robust predictive, emperical 
model.   
Another common strategy for absolute stereochemical determination is the 
competing enantioselective conversion (CEC) method developed Rychnovsky and co-
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workers.23-30 In this technique, both enantiomers of a suitable kinetic resolution agent are 
reacted with the target enantiopure compound. The conversion of this reaction is 
measured, and the faster reacting substrate-reagent pair is then determined via NMR, 
TLC, or GC analysis. The absolute stereochemical assignment is deduced by comparing 
the kinetic resolution results to an empirical mnemonic. For chiral secondary alcohols, 
they employ the two enantiomers of Birman’s homobenzotetramisole (HBTM) acylation 
catalyst as the kinetic resolving agent. In the example showed in Scheme 2.2, the 
enantiopure alcohol (II-3) was acylated in the presence of propionic anhydride, 
diisopropylethylamine (DIPEA), and either 5 mol% of (S)-HBTM or 5 mol% of (R)-
HBTM catalyst.23   The reaction is conducted in deuterated chloroform allowing for the  
 
conversion to be monitored directly by NMR spectroscopy. The conversion, x, is then 
plotted as 1/(1–x) versus time to determine a rate constant for each catalyst enantiomer. 
Based on the kinetic resolution results and the developed empirical mnemonic (Figure 
2.2), the (R)-HBTM catalyst was the faster-reacting catalyst and the configuration of the 























Scheme 2.2. Acylation of enantiopure alcohol (II-3) with propionic anhydride and 
either 5 mol% of (S)-HBTM or 5 mol% of (R)-HBTM catalyst. The conversion was 
monitored by NMR spectroscopy.
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substituent on left and the large (Lg)  group on the right. Once doing so, the (S)-HBTM 
catalyst will prefer the enantiomer where the alcohol is in the back, whereas the (R)-
HBTM catalyst will prefer the enantiomer where the alcohol is in the front (Figure 2.2). 
Although this method has successfully identified amines,23-25 oxazolidinones, lactams,26 
and chiral alcohols27-30; the major drawback is that each class of substrates requires its 
own suitable catalyst or reagent capable of kinetic resolution.    
 
Another popular method for chiral identification is the Mosher ester analysis or 
the use of other chiral derivatizing agents (CDAs) in order to assign the absolute 
stereochemistry via NMR spectroscopy.31-36 Methods that utilize NMR spectroscopy 
require a transformation of the target enantiopure compound to two different species 
which can be differentiated by their NMR spectra. The differences in chemical shifts (∆δ) 
of the two species (diastereomers, conformers, atropisomers) along with model substrates 











Figure 2.2. Birman’s transition state model predicts the fast-reacting alcohol structure with 
the (S)-HBTM catalyst (left) where Ar= aryl group and Alk= alkyl group. The more general 
predictive mnemonic (right) that places the small group on the left and the large group on 
the right of a generic secondary alcohol. The alcohol preferred by the (S)-HBTM catalyst is 











Birman Model Predictive Mnemonic
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that can afford the required transformation have been on-going since the introduction of 
Mosher’s acid in the 1970s. Mosher’s acid (II-6), α-methoxy-α-trifluoromethyl-
phenylacetic acid (MTPA), has been shown to successfully identify secondary alcohols 
(Scheme 2.3) and primary amines.31 The Mosher ester analysis (Scheme 2.3) relies on the  
 
fact that protons in the diastereomeric MTPA esters (II-7a, II-7b) will display different 
arrays of chemical shits in their 1H NMR spectra due to the shielding effect of the phenyl 
group (Figure 2.3).31 Again, analysis of the differences in chemical shifts of the two 
esters can be used to reliably deduce the absolution configuration of the stereogenic  
















































Figure 2.3. Common representations of the conformations 
used for the analysis of each of the diastereomeric MTPA 
esters (II-7a, II-7b). The shielding effect from the phenyl 
group is indicated by the gray arrows.
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more recently reported agents being 2-(2-trifluromethyl)-1H-benzo[d]-imidazol-1-
yl)benzoic acid (TBBA).36 TBBA also has the ability to transform chiral secondary  
 
alcohols and primary amines while showing much higher differences in chemical shifts 
than the conventional Mosher’s acid.36 The general conformational model can be seen in 
Scheme 2.4, where the differences in chemical shifts of the two TBBA ester conformers 













9-AMAA MPA BPG TBBA
Figure 2.4. Commonly employed CDA agents. 9-anthrylmethoxy-acetic acid (9-AMAA), 






















Scheme 2.4. General conformational model for chiral primary 
amines and secondary alcohols depicting the (P)-TBBA 
ester/amide and (M)-TBBA  ester/amide.
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One significant disadvantage of NMR-based methods is the need for enantiomerically 
pure CDA agents that can afford the transformation of the target analyte. Another 
disadvantage of using NMR spectroscopy is the requirement that typically the functional 
group undergoing derivatization must be on or proximal to the asymmetric center of 
interest.  
 X-ray crystallography is commonly viewed as the most reliable and definite 
method to assign the absolute configuration of chiral molecules.37 However, the 
generation of single crystals suitable for X-ray analysis can be very challenging, 
especially when considering small organic compounds. Historically, this challenge has 
been overcome through the formation of derivatives that are crystalline37-44 or recently, 
employing host-guest chemistry using crystalline sponges45 or frameworks.46 Once the 
single crystal is obtained, the phenomenon of anomalous dispersion has become a useful 
tool for the unambiguous assignment of absolute configuration. Anomalous dispersion 
causes the intensity of inverted diffraction spots to be slightly different in non-
centrosymmetric crystal structures.  This is most apparent when at least one atom heavier 
than silicon (Z >14) is present.  Thus, modern diffractometers with sensitive detection 
and advanced software can now be used to routinely assign absolute stereochemistry with 
complete reliability.  
Several different derivatization protocols have been developed that afford a 
transformation of a chiral substrate into a crystalline derivative which can be analyzed via 
X-ray crystallography. Holstein and co-workers modified liquid chiral molecules 
(alcohols and amines) with a ferrocene derivatization protocol which generated single 
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crystals suitable for a X-ray diffraction experiment.42 The protocol uses ferrocene 
carboxylic acid (II-8) and oxalyl chloride to generate ferrocenoyl chloride (II-9). 
Ferrocenoyl chloride can then react with the liquid alcohol (II-10) or amine (II-11) to 
form a typically solid ferrocenoyl ester (II-12) or amide (II-13), respectively (Scheme   
2.5).  
 
Rychnvosky and co-workers have recently reported the osmylation of liquid 
alkenes to form crystalline osmate esters.44 The protocol utilizes osmium tetroxide and 
tetramethylethylenediamine (TMEDA) under cryogenic conditions to form stable 
crystalline adducts with alkenes. For example, they were able to use their protocol to 






















Scheme 2.5. General ferrocene derivatization where RXH represents target chiral 
molecule. Ferrocenoyl chloride (II-9) is generated in situ and reacts with chiral alcohol 
















Scheme 2.6. Formation of crystalline osmate ester (II-15) 
from liquid alkene (II-14) via Osmium tetroxide and TMEDA.
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the total synthesis of (−)-illisimonin A (Scheme 2.6). The major disadvantage of these 
approaches is the need for column chromatography purification after the derivatization.  
Additionally, once the pure solid is obtained, vapor phase recrystallization was required 
to produce the single crystal needed for the X-ray diffraction experiment and subsequent 
stereochemical determination.    
Chiral crystalline sponges are an emerging X-ray technique that can determine the 
absolute configurations of chiral compounds without the need of sample crystallization. 
Fujita and co-workers have been able to synthesize a chiral crystalline sponge consisting 
of zinc iodide, 2,4,6-tris-(4-pyridyl)-1,3,5-triazine (tpt), and an embedded chiral  
 
reference (G*) (Scheme 2.7).45 The synthesis involves layer diffusion of a methanol 

















Scheme 2.7. Synthesis of the chiral crystalline sponge (II-18) with 
embedded chiral reference (II-17). The resulting crystal can be employed 
for the subsequent stereochemical determination of a chiral analyte.
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reference (II-17). This results in yellow needle-like crystals (II-18) which are then 
soaked in a cyclohexane solution that contains the chiral compound of interest. After 
slow evaporation of the solution at 50 °C over two days, the target analyte is absorbed 
into the crystal lattice of the sponge. The resulting single crystal can be used in a X-ray 
diffraction experiment and the absolute configuration of target chiral compound can then 
be determined based on the embedded chiral reference. While this is a very elegant 
approach and provides several advantages, it does require the concomitant observation of 
both chiral molecules (the analyte and reference) in the crystal structure.  
The identification of the absolute stereochemistry of small organic compounds is 
indeed a rich area of research which has lead to a range of strategies to solve this 
daunting problem. While the methods described above are pioneering examples, they are 
not without significant drawbacks. In addition, some of the techniques are relatively 
complex and experimentally difficult or laborious. In chapter two of this thesis, we 
describe an innovative approach using the facile formation of guanidinium sulfate single 
crystals for the direct determination of the absolute and relative stereochemistry of 
enantiopure alcohols or other simple nucleophiles, via X-ray crystallography.7   
 
2.3  ORIGINAL INSPIRATION  
 
The original inspiration behind our approach was work done by Michael D. Ward 
and co-workers from New York University.48-54 His group was utilizing a guanidinium 
sulfonate network as a strategy for crystal engineering and material design. During these 
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studies, they were the first to observe that guanidinium salts of organosulfonates (i.e 
RSO3–) readily form high quality single crystals over a wide range of structural types 
because of the extensive hydrogen bonding between the sulfonate and guanidinium 
moieties.48-54 The highly flexible network allowed Ward’s group to synthesize hundreds 
of different compounds with a particular focus on the development of non-linear optical 
materials. We adapted this approach to related organosulfates (i.e ROSO3–) and exploited 
this favorable hydrogen bonding network for the crystallization and identification of 
substrates that otherwise would prove to be recalcitrant. 47 In our work, we find that the 
hydrogen bonding network in the related guanidinium sulfate salts readily form the same 
patterns as in the Ward compounds, leading to straight forward growth of high quality, 
well-formed crystals.  
 
2.4 OPTIMIZATION OF GUANIDINIUM SULFATION 
CRYSTALLIZATION: STRATEGY FOR ENANTIOMERIC 
IDENTIFICATION  
 
The first step of our approach47 toward the absolute stereochemical determination 
R1 R2
Sulfation
X = Suitable Functional






































Scheme 2.8. General protocol for enantiomeric identification via guanidinium sulfation crystallization. Two situations are displayed: 
derivatization site on chiral center of interest (top) and derivatization site is adjacent or else where on chiral compound (bottom). X= suitable 
functional group to sulfate.
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of organic substrates (Scheme 2.8) is the sulfation of an appropriate nucelophilic group 
on the chiral substrate of interest. Initially, we targeted alcohols as they represent a large 
percentage of significant chiral compounds and they are known to undergo facile 
sulfation. The optimization of the sulfation of 1-phenylethanol, the model substrate of 











Scheme 2.9. Sulfation of 1-phenylethanol via sulfur trioxide pyridine. Conversion 
measured by NMR spectroscopy. Ratio of integrated product quartet (HB)  to the 
integrated starting material quartet (HA).
OH
HA
Figure 2.5. 1H NMR of 1-phenylethanol. Peak of interest is quartet at 4.7 ppm 
which corresponds to hydrogen attached to the carbon chiral center (HA).
25
In the proton NMR of 1-phenyethanol (Figure 2.5), the peak of interest is the quartet at 
4.7 ppm; this quartet corresponds to the proton attached to the asymmetric sp3 carbon.  
After successful sulfation, this quartet shifted downfield to a higher chemical shift, due to 
the enhanced electronegativity of the sulfate moiety. Thus, the methine proton undergoes 
a deshielded shift to 5.2 ppm. This can be see in Figure 2.6, which shows a proton NMR 
of a crude sample of the sulfated 1-phenyethanol product. The shift is large and distinct 
enough that it allowed for the accurate integration of both quartets without overlap or 









Figure 2.6. 1H NMR of crude sulfated1-phenylethanol. Peaks of interest are quartet at 
4.7 ppm (HA) and 5.2 ppm (HB). Ratio of integrations were used in the optimzation of 
the sulfation reaction.
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quartet was the value used to analyze the effect different changes to the sulfation 
conditions had on the conversion of the reaction. A 1.0: 0.0 ratio would represent a 
sulfation reaction which went to completion, whereas a 1.0: 1.0 ratio would indicate a 
50% conversion of 1-phenylethanol to the sulfated product. In Table 2.1, a condensed 
version of the optimization of the sulfation reaction can be seen where 1 mmol of 1-
phenylethanol was used as the starting material. A number of different sulfation reagents 
were tested, but it was determined that sulfur trioxide·pyridine was the most effective at 
sulfating the model substrate. Additionally, sulfur trioxide·pyridine is cost-efficient, mild, 
and an easily handled, bench-stable solid. In Entry 1, 1.1 equiv of sulfur trioxide·pyridine 
(SO3·Pyr) was used with 50 mL of dichloromethane (DCM) and the reaction was stirred 
under N2 at room temperature for 72 hours resulting in a conversion slightly greater than 
50%. The target reaction time for 100% conversion was 24 hours, and in Entry 2 that was 
achieved through the use of 2.0 equiv of SO3·Pyr and 50 mL of DCM. Next, different 
additives were investigated to see if they could help increase the conversion of the 
sulfation within the 24 hour reaction time. The use of base in sulfation reactions is 
commonly seen throughout the literature, due to the base presumably neutralizing the 
alcoholic proton at some point during the transformation and thus increasing the rate of 
the reaction. Multiple different bases were employed as additives in the reaction at one 
equivalence including pyridine, imidazole, triethylamine, 4-dimethylaminopyridine, urea, 
and guanidinium chloride. The best product:starting material ratio achieved when using 
an additive was 1.0:0.13 (Entry 3) while a ratio of 1.0:0.15 was obtained using the exact 
same conditions without an additive (Entry 4). It was reasoned that the addition of base 
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had a limited effect on the conversion of the reaction due to competing coordination to 
the active sulfating agent (SO3). In Entries 5,6, and 7, a small solvent screen was 
conducted using 1.1 equiv of SO3·Pyr and 50 mL of the solvent. When reacted for 24 
hours, DCM gave the most promising ratio of 1.0: 0.79, compared to ethyl acetate 
(EtOAc) which gave 1.0:1.2 and methanol (MeOH) which did not form any desired 
product. This can be contributed to the oxygen in both MeOH and EtOAc acting as 
competing nucleophiles in the reaction, thus decreasing the amount of desired product. 
Focusing on the optimal solvent, DCM, it was found that as we decreased the volume and 
thereby increased the concentration of SO3·Pyr, the conversion of the reaction greatly 
improved. In Entry 7, utilizing 50 mL of DCM resulted in a 1.0:0.79 ratio whereas 5 mL 
DCM resulted in a 1.0: 0.27 ratio (Entry 8). In Entry 10, 5 mL of dry DCM and 1.1 equiv 
of SO3·Pyr afforded a 1.0:0.18 ratio, which indicated that the use of dry DCM increases 
the conversion rate. Now approaching 100% conversion, the equivalence of reagent was 
increased by 0.1 until a product/starting material ratio of 1.0:0.0 was achieved. This 
target ratio was reached within 24 h at room temperature using a suspension of 1.3 equiv 
of SO3·Pyr in 5 mL of dry DCM (Entry 12). Lastly, Entry 13 and 14 investigated whether 
an increase in reaction time (48 h) would permit the use of a lower equiv of SO3·Pyr. As 
can been seen, the minimal increase in conversion rate was deemed insufficient to justify 
doubling the reaction time. Thus, Entry 12 was considered the optimized conditions for 
the sulfation reaction. After the 24 hour reaction, a simple gravity filtration of the mixture 
removes the excess SO3·Pyr leaving behind a solution of the organosulfate-pyridinium 






























































































*Additives tried in 1 equivalence: pyridine, imidazole, triethylamine, 4-dimethylaminopyridine, 
urea, guanidinium chloride.











Table 2.1. Optimization of sulfation reaction via NMR spectroscopy, where 1-
phenylethanol is the model substrate and sulfur trioxie pyridine is the sulfating agent.
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require no additional purification, such as extractions or column chromatography. 
Furthermore, the optimized sulfation conditions were found to allow for 100% 
conversion of a wide range of alcohols to their respective sulfate-pyridinium complex.  
Once the sulfated product is formed using the established conditions, the 
guanidinium crystallization step proceeded with ease, as expected. The unpurified sulfate 
pyridinium complex was subjected to 1 equiv of guanidinium chloride in a common 
alcohol solvent to solubilize the components of the mixture. Slow evaporation of this 
solution resulted in large, high quality crystals of the organosulfate guanidinium salt. We 
were then able to unambiguously assign the structure and enantiomeric identity of target 
chiral compounds using single crystal X-ray diffraction employing the anomalous 








purposes providing the driving force for the crystallization and a suitable heavy atom for 
the anomalous dispersion method. Thus, this strategy for absolute stereochemical 
identification is amenable to both Cu and Mo radiation sources. After successful 
identification, the sulfate group can be readily removed by a simple hydrolysis for 
Scheme 2.10. One-pot guanidinium sulfation crystallization of 
(S)-1-phenylethanol. Two-step approach resulted in large, single 
crystals (right) used in a X-ray diffraction experiment for 
subsequent absolute structure determination. aConversion 
determined by 1H NMR spectroscopy.
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ABSTRACT: A novel technique for the absolute stereochemical
determination of alcohols has been developed that uses
crystallization of guanidinium salts of organosulfates. The simple
one-pot, two-step process leverages facile formation of guandinium
organosulfate single crystals for the straightforward determination
of the absolute stereochemistry of enantiopure alcohols by means
of X-ray crystallography. The strong hydrogen bonding network
drives the stability of the crystal lattice and allows for a diverse range of organic alcohol substrates to be analyzed.
The identity of the absolute stereochemistry of acompound is essential to a number of different disciplines
in organic chemistry including synthetic, pharmaceutical, and
biological processes. The task of assigning the absolute
stereochemistry of a small organic molecule, as opposed to
measuring the enantiomeric excess (ee) or enantiomeric ratio
(e.r.) of a scalemic sample, often can be very difficult.1
Resolution techniques, such as chiral high-performance liquid
chromatography (HPLC), have allowed for the evaluation of
the enantiomeric purity (ee or e.r.) of a sample to be
completed with relative ease. Nonetheless, determining with
certainty which enantiomer has bee generated or is lated
remains a daunting challenge.
Indeed, the critical importance of chiral identification has led
to the development of a range of techniques for the assignment
of absolute stereochemistry.2−6 The most popular practices
include chiroptical spectroscopy, stereoselective reactions,
NMR spectroscopy, and X-ray crystallography. Advances in
circular dichroism (CD) by a Nakanishi,2a Harada,2a Berova,2b
and Stephens,2c among others has made it a promising tool for
the determination of the absolute configuration of target
molecules.2 Circular dichroism can be coupled with electronic
transitions, electronic CD (ECD), to examine chiral substrates
containing electronic chromophores capable of absorbing
visible light.2a−c If the chiral molecule lacks an electronic
chromophore, circular dichroism can be coupled with
vibrational transitions (VCD) or Raman scattering known as
vibrational Raman optical activity (VROA).2d−f The major
disadvantage of these chiroptical methods is that they cannot
directly assign the absolute configuration of chiral molecules.
Theoretical methods must be used to predict the chiroptical
properties of the targeted molecule followed by comparative
analysis of the experimental and predicted chiroptical spectra
to then infer the absolute stereochemistry. More recently,
Borhan and co-workers have developed a series of metalated
bis-porphyrin tweezers that are capable of binding chiral
substrates.3 The induced helicity of the tweezer-substrate
complex is measured using exciton coupled circular dichroism
(ECCD) which then can be used to empirically predict the
absolute stereochemistry of the chiral substrate. A variety of
chiral organic compounds including carboxylic acids,3a−e 1,2-
diols, 1,2-diamines, 1,2-aminoalcohols,3f epoxy alcohols,3g 1,n-
glycols,3h amines,3i−j cyanohydrins,3k and sulfoxides3l have
been successfully identified using this method. Despite the
wide range of chiral substrates tolerated under this approach,
the strategy requires the nontrivial synthesis of the porphyrin
tweezer probes, and each different chiral functional group
demands different tweezers for analysis. The approach also
involves the use of specialized analytical equipment (circular
dichroism) which may not be universally available and is often
complicated by the need for derivatizations of the analyte
samples.
Another strategy for absolute stereochemical determination
is the competing enantioselective conversion (CEC) method.4
In this technique, both enantiomers of a kinetic resolution
reagent are reacted with the target enantiopure compound.
The conversion of this reaction is measured, and the faster
reacting substrate-reagent pair is then determined via NMR,
TLC, or GC analysis. The absolute stereochemical assignment
is deduced by comparing the kinetic resolution results to an
empirical mnemonic. Although this method has successfully
identified amines,4a−c oxazolidinones, lactams,4d and chiral
alcohols,4e−h each class of substrates requires its own unique
suitable catalyst or reagent capable of kinetic resolution.
Another common method for chiral identification is the
advanced Mosher ester analysis or the use of other chiral
derivatizing agents (CDAs) in order to solve the absolute
stereochemistry via NMR spectroscopy. Methods that utilize
NMR spectroscopy require a transformation of the chiral
molecule to two different species which can be differentiated
by their NMR spectra. The differences in chemical shifts (Δδ)
of the two species (diastereomers or conformers) along with
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subsequent recovery of the chiral organic molecule without erosion of the enantiopurity 
of the compound.                               
The optimization of the hydrolysis reaction (Table 2.2) was conducted using 
guanidinium sulfate crystals produced from (R)-1-phenylethanol. Therefore, if any of the 
(S)-enantiomer was obtained after the hydrolysis reaction, one could assume that some  
  
level of racemization had occurred. The enantiopurtity (ee) of the hydrolyzed alcohol was 
obtained via chiral stationary phase HPLC, which allowed for the easy separation of 
racemic 1-phenylethanol. Initially, the addition of base was thought to be required for the 































Table 2.2. Optimization of hydrolysis reaction using guanidinium sulfate crystals 
derived from enantiopure (R)-1-phenylethanol. Base or acid was added until the 
pH of the reaction mixture was basic or acidic, respectively. % ee was 
determined via chiral stationary phase HPLC.
NH2









7 10 mL H2O 70 9725 °C
8 H2O until SM dissolves 97 96±425 °C then Reflux
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tetrahydrofuran (THF) which gave a 95% yield and 83% ee. Entry 2 decreased the 
amount of base to 0.5 equiv and saw very similar results. In Entry 3, 1M NaOH was 
added to the reaction until the mixture became basic.  This approach resulted in similar 
yields but a decrease in enantiopurity to 76% ee. Sodium bicarbonate was also 
investigated both at room temperature (Entry 4) and at 0˚C (Entry 5). Entry 4 gave great 
yields but with low enantiopurity while Entry 5 resulted in low yields and great 
enantiopurity. The use of acid (Entry 6) was also studied in order to evaluate the effects 
of lower pH on the hydrolysis reaction. The addition of 1M HCl until the reaction 
mixture became acidic lead to an 86% yield of the product alcohol with a reduced 86% 
ee.  Further investigations revealed that the removal of the suflate group could be 
achieved simply by the use of water without any base or acid additive. Once this was 
determined, the amount of water added to the 50 mL of THF and the temperature of the 
reaction was varied. Entry 7 used 10 mL of water, 50 mL of THF, and the reaction was 
stirred at room temperature for 24 hours. These conditions produced the product in high 
enantiopurity but only moderate yields. Lastly, Entry 8 used only the necessary amount 
of water needed to dissolve the guanidinium sulfate crystals at room temperature, once 
the solution was homogenous it was refluxed for 24 hours. These optimized, mild 
conditions resulted in quantitative yields and complete enantiopurity. 
 
2.5  HYDROGEN BONDING OF GUANIDINIUM SULFATE SALTS 
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The driving force of the crystal lattice formation in these large, single crystals is 
the ample amount of hydrogen bonding that takes place between the organosulfate and 
guanidinium pair. Figure 2.7 shows multiple images of the hydrogen bonding network in 
the guanidinium sulfate salt (Figure 2.7a) derived from the model substrate, 1-
phenylethanol. In Figures 2.7b and 2.7c, one can see that the trigonal planar guanidinium 
ions are ideally configured to form hydrogen bonds with multiple organosulfates. Thus, 
the pairing forms stable cation-anion interactions as well as bridging linkers between the 
multiple organosulfates in the crystal lattice (Figre 2.7d).  This combined effect creates 
an environment that is highly favorable for the growth of large, high quality, single 
crystals of a wide range of small organic compounds. Furthermore, the sulfate-  
 
 
model substrates can then be compared to assign the absolute
configuration. Development of CDA agents that can afford the
required transformation have been ongoing since the
introduction of Mosher’s acid in the 1970s.5 CDA agents
react with the chiral substrate of interest and form a covalent
bond, while chiral solvating agents (CSAs) such as ion-pairing
or metal complexes interact with the chiral molecule through a
noncovalent interaction.5c,d Both typically depend on the use
of enantiomerically pure reagents for derivatization/coordina-
tion and the use of model compounds for comparison.5 The
major disadvantage of NMR-based methods is the need for
enantiomerically pure CDA/CSA agents to transform the
target analyte and the requirement that the functional group
undergoing derivatization must typically be on or proximal to
an asymmetric center.
While these pioneering examples have aided in the
determination of the absolute stereochemistry of organic
molecules, they are not without drawbacks. We describe,
herein, an approach using the facile formation of guanidinium
sulfate single crystals for the direct determination of the
absolute and relative stereochemistry of enantiopure alcohols
or other simple nucleophiles, via X-ray crystallography. X-ray
crystallography is commonly viewed as the most reliable and
definite method to assign the absolute configuration of chiral
molecules; however, the generation of single crystals suitabl
for analysis can be very challenging, especially when
considering small organic compounds.6 Historically, this
challenge has been overcome by the formation of derivatives
that are crystalline6a−g or, recently, employing host−guest
chemistry using crystalline sponges6h or frameworks.6i The
methodology described herein combats challenges of crystal-
lization by employing a guanidinium sulfate network which
promotes the formation of large, high quality crystals. While
these approaches clearly depend on obtaining a single crystal of
the target material, the phenomenon of anomalous dispersion
has become a useful tool for the unambiguous assignment of
absolute configuration.6a−e Modern diffractometers with
sensitive detection and advanced software can now be used
to routinely assign absolute stereochemistry with complete
reliability. The method works best when there is at least one
heavy atom (Z > 14) present. In this paper we employ sulfur as
a suitable heavy atom in all of our crystals making the method
amenable to X-ray instruments utilizing either Mo or Cu
radiation sources.
Our approach is inspired by the work of Ward et al., who
first observed that the guanidinium salts of organosulfonates
(i.e., RSO3−) readily form high quality single crystals over a
wide range of structural types because of extensive hydrogen
bonding between the sulfonate and guanidinium.7 We adapted
this approach to related organosulfates (i.e., R−OSO3−) as
described herein and find that the crystal growth can often be
very straightforward in many cases because of similar hydrogen
bonding. The H-bonding networks readily form the same
patterns as in the Ward compounds, leading to high quality,
well-formed crystals. The technique has several advantages in
comparison to other methods for absolute stereochemical
determination including that it is definite and requires no
predictive model or empirical mnemonics, it can unambigu-
ously identify all stereocenters that are present in the chiral
molecule along with their relative orientation, and it does not
require the chiral center to be coincident with the
derivatization site. While the method still depends on a
derivatization step, it bears mentioning that the derivatization
proceeds in one pot and only requires a cheap and
commercially available sulfur trioxide−pyridine complex and
guanidinium chloride. Finally, the chiral material of interest is
readily recoverable after derivatization by means of a simple
hydrolysis step. This method would also be useful as a strategy
for assigning relative stereochemistry.
This methodology (Scheme 1) for stereochemical analysis of
small organic molecules begins with the sulfation of a
nucleophilic group (i.e., an alcohol) on the substrate of
interest. The sulfated organic compound can then be
combined with guanidinium chloride to form a guanidinium
sulfate salt as a well-formed, large, three-dim nsional single
crystal containing a strong network of hydrogen bonding. This
easily formed, high-quality organic crystal can then be used in
an X-ray diffraction experiment, from which the crystal
structure can be determined and the absolute stereochemistry
of the parent substrate can be assigned. Lastly, the sulfate
group can be readily removed by simple hydrolysis for
subsequent recovery of the chiral organic analyte without
erosion of the enantiopurity of the compound.
The driving force of the crystal lattice formation in these
large organic crystals is the ample amount of hydrogen
bonding that takes place between the organic sulfate and
guanidinium pair (Figure 1). Ward and co-workers have
demonstrated that planar trigonal guanidinium ions are ideally
configured to form hydrogen bonds with multiple organo-
sulfonate donors.7 Thus, the pairing forms not only stable
anion−cation interactions but also bridging linkers between
Scheme 1. Enantiomeric Identification
Figure 1. Formation of salts of guanidinium organosulfates via
hydrogen bonding interactions. (a) Schematic of the sulfated (R)-1-
phenylethanol substrate. (b) Hydrogen bonding about the guanidi-
nium cation hydrogen bond donor (the majority of the organosulfate
anion is omitted for clarity). (c) Hydrogen bonding about the sulfate
anion hydrogen bond acceptor. (d) Packing of molecules viewed
along the b-axis. (e) Pleated 2-D sheets of guanidinium cations and
organosulfate anions viewed along the c-axis.
Organic Letters Letter
DOI: 10.1021/acs.orglett.9b03792
Org. Lett. XXXX, XXX, XXX−XXX
B
Figure 2.7. Hydrogen bonding interactions of the guanidinium organosulfate salt derived from 
(R)-1-phenylethanol. (a) Schematic f the sulfated (R)-1-phenylethanol guanidinium salt. (b) 
Hydrogen bonding a ut the guanidinium cation hydrogen bond donor (majority of the 
organosulfate anion is ommited for clarity). (c) Hydrogen bonding about the sulfation anion 
hydrogen bond acceptor. (d) Packing of molecules viewed along the b-axis. (e) Pleated 2-D 
sheet of guanidinium cations and organosulfate anions viewed along the c-axis. Dashed lines 
represent hydrogen bonds.
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guanidinium hydrogen bonding network typically forms 1-D ribbons which pair to form 
pleated 2-D sheets. In these sheets (Figure 2.7e), the organic functional groups have 
multiple options to position themselves relative to the hydrogen bonding sheet and this 
packing typically depends on the size of the group.  This ability to tune the overall 
geometry of the crystal lattice maximizes the hydrogen bonding and van der Waals 
interactions of the organic groups, while minimizing the steric interactions. This 
flexibility leads to a remarkable range of organic compounds that readily grow high-
quality, single crystals which can be used in a X-ray diffraction experiment. As 
mentioned, the high degree of hydrogen bonding drives the stability of the crystal lattice 
and in turn enables straightforward growth of single crystals from common, simple 
solvents, avoiding excessive experimental headache.  
While our efforts in the substrate scope focused on the identification of chiral 
alcohols, the methodology is applicable to chiral amines as well. The (S)-enantiomer of 
1-phenylethylamine was successfully identified using the exact same two-step 
guanidinium sulfation crystallization approach. Although this was the only chiral amine 
identified, we were pleased to see that the sulfation conditions optimized for alcohols 
afforded 100% conversion for the primary amine.  Additionally, the same critical 
hydrogen bonding network (Figure 2.8) persisted in the crystal lattice of the guanidinium 
sulfate salt derived from (S)-1-phenylethylamine (right) that was seen in the guanidinium 
salt of (R)-1-phenylethanol (left). In Figure 2.8, one can see that the crystal lattices are 
essentially mirror images of each other due to them containing the exact same network 
but being in the opposite conformation. Thus, it is reasoned that the developed 
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guanidinium sulfation crystallization methodology will have the same success identifying 




2.6 SUBSTRATE SCOPE OF GUANIDINIUM SULFATION 
CRYSTALLIZATION  
 
This facile two-step, one-pot process was effectively employed on a suite of chiral 
molecules shown in Table 2.3 and Figure 2.9.47  We successfully assigned the absolute 
stereochemistry of (R)-1-phenylethanol (II-19) and (S)-1-phenylethylamine (II-20). For 
completeness, we also examined the opposite enantiomers of these systems with the same 
success. Next, we explored the absolute stereochemical assignment of more structurally 
complex alcohols. For instance, we were able to readily sulfate, crystallize, and assign a 
series of terpenoid natural products including (–)-isopulegol (II-21), L-menthol (II-22), 
(–)-nopol (II-23), (–)-borneol (II-24), (–)-isopinocampheol (II-25), and (–)-perillyl 
alcohol (II-26). Compounds II-21 and II-22 demonstrate the ability to assign multiple 
stereocenters and their relative configuration. Compounds II-23, II-24, and II-25 are 
Figure 2.8. Comparsion of crystal lattices from the guanidinium sulfate salt derived from 
(R)-1-phenylethanol (left) and (S)-1-phenylethylamine (right). The hydrogen bonding 
network is identical producing mirror images of the individual packing diagram.
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slightly different bicylic compounds that were identified using the methodology. While 
compounds II-23 and II-26 are examples of sulfation and crystallization of primary 
alcohols; thereby, identifying chiral centers not at the derivatization site. Simple aliphatic 
chiral alcohols such as (R)-2-butanol (II-27) and (R)-2-octanol (II-28), as well as two 
!
II-19   II-20     II-21      II-22  
!
!
! II-23   II-24     II-25           II-26      II-27!











Figure 2.9. Scope of alcohol substrates crystallized as guanidinium organosulfate salts, with the 
anionic organosulfate moieties shown as 50% probability ellipsoids from the single crystal structure 
refinements. Carbon atoms are gray, oxygen atoms are red, sulfur atoms are yellow, and nitrogen 
atoms (in II-20 only) are blue.
coincident with the sulfated alcohol moiety. The structural
diversity of the 17 substrates in this study which were
successfully assigned with 100% accuracy demonstrates the
versatility and reliability of this strategy for absolute stereo-
chemical determination. The main limitation of the method-
ology is our current inability to apply the strategy for the
identification of chiral tertiary alc hols due to the reluctanc of
these species to undergo sulfation und r the present conditions
employed. We probed two such substrates: (−)-linalool and
(+)-terpinen-2-ol. In the former case, we observed incomplete
sulfation (i.e., 50% conversion) and successfully grew crystals
from the crude reaction mixture after treatemen with
guanidinium chloride. Nevertheless, the resulting crystals
were of insufficient quality for X-ray analysis. In the latter
case, the sulfation attempt failed. Finally, our strategy failed to
return X-ray quality crystals for one 1° alcohol substrate,
(−)-citronellol, despite successful sulfation and crystallization.
Further investigations to probe the limitations and potential of
this method are ongoing in our laboratory. Studies include the
optimization of this strategy for the stereochemical determi-
nation of other important functional groups.
By means of our straightforward strategy, the absolute
stereochemistry of target compounds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
utilizing X-ray equipment readily available to most research
universities and pharmaceutical laboratories. The two-step
method takes advantage of the highly flexible hydrogen
bonding network present between the sulfated organic
compound and the guanidinium moiety. This favorable lattice
allows for facile generation of large, high-quality crystals from a
diverse range of substrates that otherwise may be recalcitrant
toward facile crystallographic analysis. The sulfate group
provides sufficient anomalous dispersion such that the absolute
stereochemistry can be assigned unambiguously. This
technique has a number of advantages in comparison to
other methods, including operational simplicity, low cost, and
easy-to-interpret, absolute results. While the 17 substrates
assigned in this report demonstrate the ability of this chiral
identificatio te hnique, we hope to build on these compelling
preliminary results in the near future.
■ ASSOCIATED CONTENT
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The Supporting Information is available free of charge at
https://pubs.acs.org/doi/10.1021/acs.orglett.9b03792.
General procedures, optimization of sulfation and
desulfation protocols, tabular summary of X-ray
Figure 2. Scope of alcohol substrates crystallized as guanidinium organosulfate salts, with the anionic organosulfate moieties shown as 50%
probability ellipsoids from the single crystal structure refinements. Carbon atoms are gray, oxygen atoms are red, sulfur atoms are yellow, and
nitrogen atoms (in 2 only) are blue.
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employed. We probed two such substrates: (−)-linalool and
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from the crude reaction mixture after treatement with
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coincident with the sulfated alcohol moiety. The structural
diversity of the 17 substrates in this study which were
successfully assigned with 100% accuracy demonstrates the
versatility and reliability of this strategy f r absolute stereo-
chemical determination. The main li itation of the method-
ology is our current inability to apply the strategy for the
id ntification of chiral tertiary alcohols due to the reluctance of
these species to undergo sulfation under th present conditio s
employed. We probed tw such substrates: (−)-linal ol and
(+)-terpinen-2-ol. In the former case, we observed incomplete
sulfation (i.e., 50% conversion) and succ ssfully grew crystals
from the crude reaction mixture after treatement with
guanidinium chloride. Nevertheless, the resulti g crys als
were of insufficient quality for X-ray analysis. In the latter
case, the sulfation a tempt f iled. Finally, our strategy failed o
return X-ray quali y crystals or one 1° lco ol substra ,
(−)-cit o ellol, despite successful sulfation and crystallization.
Further investigations to probe the limitations and potential of
this ethod are ongoing in our laboratory. Studies includ the
optimizati n of this strategy for the stereochemical determi-
nation of other important function l groups.
By m ans of our straightforward strategy, the abs lute
stereochemistry of target compou ds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
utilizing X-ray equipment readily available to most research
universities and pharmaceutical laboratories. The two-step
method takes advantage of the highly flexible hydrogen
bonding network present b tween the sulfated organic
compound an the guanidinium moiety. This favorable lattice
allows for facile generation of large, high-quality crystals from a
diverse range of substrates that otherwise may be recalcitrant
towar facile crystallographic analysis. T e sulfate gro p
provides sufficient anomalous dispersion such that the absolute
stereoch mistry can be assigned unambiguously. This
techniqu has a mber of advantages in comparison to
other methods, including operational simplicity, low cost, nd
ea y-to-interpret, absolute resul s. W ile the 17 substrates
assigned in this report demonstrate the abili y of this chiral
identification technique, we hope o build on these compelling
preliminary results in the near future.
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coincident with the sulfated alcohol moiety. The structural
diversit of th 17 substrates in this study which were
successfully assigned with 100% accur cy demonstrates the
versatility and reliability of this strategy for absolute stereo-
chemi l determination. The main limitati n of the method-
ology is our c rrent inability to apply the strategy for the
identification of chiral tertiary alcohol du to the reluctance of
thes species to undergo sulfation under the present conditions
empl yed. We probed two such substrate : (−)-linalool and
(+)-terpinen-2-ol. In the for er case, we observed incomplete
sulfation (i.e., 50% conversion) and succ ssfully grew crystals
from the crud reaction mixtu e after treatement with
guanidini chlori e. Nevertheless, the resultin crystals
were of insufficient quality for X-ray analysis. In the lat r
case, he sulfation at mpt failed. Finally, ur strategy failed to
return X-ray quality crystals for one 1° alcohol substr te,
(−)-citronellol, desp te successful sulf tion an crystallization.
Further investigation to probe the limitati ns and potential of
this meth d a e ongoing in our laborat ry. Studies include the
optimizatio this stra e y f r the ste eochemical determi-
nati n of othe importan functi al groups.
By ea s of ur straightforwar strategy, the absolute
stereochemistry of target compounds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
utilizing X-ray equipment readily available to most research
universities and pha maceutical laboratorie . The two-step
meth d takes advantage of the highly flexible hydrogen
bonding network prese t between the sulfated organic
compound and the guanidinium moiety. This favorable lattice
allo s for facile generati n of large, high-quality crystals from a
divers range of substrates that otherwise may be r c lcitrant
toward facile crystallographic analysis. The s lfate group
provides sufficient a o alous dispersion such that the bs lu e
s er och mistry an be assigned unambigu usly. This
t chnique has a number of advantages in comparison to
other methods, including operational simplicity, low co t, and
easy-to-interpr t, absolute results. While the 17 substrates
assigned in thi report demonstrate the ability of this chiral
identification technique, we hope to build on these compelling
preliminary results in the near future.
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coincident with the sulfated alcohol moiety. The structu al
diver ity of the 17 substrates in this study which were
successfully assigned with 100% accuracy dem ns rates the
versatility and reli bility of this str tegy f r a solut s ereo-
che ical deter ination. The ain li itation of the method-
ology is our curr nt i ability t apply the strategy for the
id ntification f chiral tertiary alcohols due to th reluctance of
these species to und rgo sulfation unde the present conditions
e ployed. e probed tw such substrates: (−)-li al ol and
(+)-terpinen-2-ol. In the for er case, we observed incomplete
sulfation (i.e., 50 conversion) and succ ssfully grew crystals
fro the crude reaction ixture aft r treatement with
guanidiniu chloride. evertheless, the resulting crystals
ere of insu cient quality for X-r y analysis. In the latter
case, the sulfation atte pt failed. Finally, our strategy failed to
return -ray quality crystals for one 1° alcohol substrate,
( )-citro ellol, despite successful sulfation and crystallization.
Further investigations to probe the limitations and potential of
this ethod are ongoing in our laboratory. Studies include the
op i izati n of this s rategy for the stereochemical determi-
nation of other i portant functional groups.
y an of our straightf rward strat gy, the absolute
tereoche is ry of targ t co pou ds can be obtained from a
s all a ount of sa ple (less than 50 mg) in less than 48 h,
ut lizing X-r y equipment readily available to most research
universities and pharmaceutical laboratories. The two-step
method takes advantage of he highly flexibl hydrogen
bonding network present between the sulfated organic
compound and the guanidi ium mo ety. Th s favorable lattice
llows for facile generation of large, high-quality crystals from a
dive se r ng of substrates that otherwise may be recalcitrant
toward facile crystallographic analysis. The sulfate group
provides sufficient anomalous disp rsion such that the absolute
stereochemi try can be assigned unambiguously. This
tech ique has a numb r of adv ntages in compari on to
other methods, including op rational simplicity, low cost, and
easy-to-interpret, absolute results. While the 17 substrates
assigned in this report dem nstrate the ability of this chiral
identification technique, we hope to build on these compelling
preliminary results in the near future.
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coincident with the sulfated lcohol moiety. The structural
diversity of the 17 subs rates in this study which were
succe sfully ssign d with 100% accurac demonstrates th
versatility and reliability of this strategy for absolut stereo-
chemical det rmination. The main limitation of the method-
ol gy is our curre t inability to ap ly the strateg for the
identification of chiral tertiary lc hols ue to th r lucta ce f
thes species to undergo sulfation under the present conditions
employ d. We pr bed two such substrat s: (−)-linalool and
(+)-terpinen-2-ol. In the former case, we observed incomplete
sulfation (i.e., 50% conversion) and successfully grew cryst ls
from the crude reaction mixture after treatement with
guanidinium chloride. Neverthel ss, the resulting crystals
wer of insufficient quality for X-ray analysi . In the latter
case, the sulfation attempt failed. Finally, our strategy failed to
return X-ray quality crystals for one 1° alcohol substrate,
(−)-citronellol, despite successful sulfation and crystallization.
Further investigations to probe the limitations and potential of
this ethod are ong ing in our laboratory. Studies include the
optimization of this trategy for the stereochemical determi-
nation of other important functional groups.
By means of our straightforward strategy, the absolute
ster ochemistry of target compounds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
utilizing X-ray equi ment readily available to ost researc
universities and pharm c utical laboratories. h t o-ste
method takes advantage of the highly flexible hydroge
bonding network present between the sul ted org
compound and the guan dinium moiety. This favorable lattice
allows for facile generation of large, igh-quality crystals fro a
diverse range of substrates that otherwise ay be recalcitra t
toward facile cryst ll gr phic analysis. The sulfat gr
provides sufficient anomalous di persion such that the absol te
stereochemistry can be as igned una bigu usly. is
technique as a number f adva tages in co pariso t
other methods, including operational simplicity, lo cost, a
easy-to-interpret, abs lute results. hile the 17 substrates
as igned in this report demonstrate the ability of this c iral
identification technique, we hope to build on these co pelli g
preliminary results in the near future.
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coin i ent with the su fated alcohol moiety. Th structural
diversity of t 17 substrates in this stud which were
successfully assigned with 100% accuracy demo strates the
versatility and r liability of this strategy for abs lute stereo-
chemical d te minati n. T e main limitatio of the method-
ology is our current inability to apply the strategy for the
ide tification f chiral t iary alco ol d e to the eluctance f
these species t undergo sulfation under the pres nt conditions
mpl yed. W probed tw such substrates: (−)-linal l and
(+)-t rpinen-2-ol. In the former case, we observed inc mplete
sulfa i (i.e., 50% conv r ion) and su cessfully grew crystals
from th crude reaction mixture after tre tement with
guanidinium chl ride. Nevertheless, he resulting crystals
were of insufficient quality f X- ay analysis. In latter
case, the sul a ion attempt failed. Finally, our strategy failed to
return X-ray quality crystals for one 1° alcoh l substrate,
(−)-citronellol, de pite uccessful sulfation nd crystallization.
Further i vestig tions to robe the limitations a d potential of
this ethod are ongoing in our laboratory. Studies include the
optimization of this strategy for the stereochemical determi-
nation of other important functional groups.
By means of our straightforward strategy, the absolute
stereochemistry of target compounds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
tiliz g X-ray quip ent readily av ilable t most research
univ rsiti s nd p rmac ut cal labo atories. The two-step
method takes advantage of the highly flexible hydrogen
bonding etwork present betw en th sulfated organic
compound and the guanidi ium moiety. This favorable lattice
allow for fac le generatio of l rge, high-quality crystals from a
divers range of subs rates t at otherwise may be recalcitrant
toward f cile crysta lograph c analysis. The ulfate group
provi s sufficient a omal us ispersi n such th t the absolute
stereochemistry c n be assigned una biguously. This
techniq e has a number of advantages in comparison to
other methods, including operational simplicity, low cost, and
easy-to-i terpret, absolute results. While the 17 substrates
assig ed i this report demonst t the bility of this chiral
identification technique, we hope to build on these compelling
relimina y results in the near future.
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coi cident with the sulf ted a coh l moiety. The st uct ral
diversity of the 17 sub trates in thi study hic were
succes fully ass gned with 100% accuracy demonstrates the
versatility and reliability of this strategy f r absolute stereo-
chemical determi tion. The a n limitation of t e method-
ology is our cu rent inability to apply th str tegy or the
id ntification of chiral tertiary alcohols due to the eluctance of
these species to undergo sulfation under the prese t c nditions
employed. We probed two such subst at s: (−)-linalool and
(+)-terpin n-2-ol. In the form r c s , we observed incomplet
sulfation (i.e., 50% c nv sion) and successfully g ew crystal
from the crude reaction mixtur aft r treatement with
guanidinium chlorid . Nev rtheless, the resulting crystals
were of insufficient quality for X-r y analysis. In th latter
case, the sulfati n attempt failed. Finally, our strategy failed to
ret rn X-r y quality crystals for ne 1° alcohol substrate,
(−)-citronellol, despit uccess ul s lfation and cryst llization.
Furth r nvestigations to p obe he limit ti ns a d potential of
t is method are ong ing in our laboratory. Stud es nclude the
optimiz tion of his strategy for the s ereochemical d termi-
nati n of o er important functi nal group .
By m ans f our straightforwa d strategy, th absolute
ster c mistry of t r e c mpounds can be obtained from a
small am unt of sample (less than 50 mg) i less than 48 h,
utilizing X-ray equipme t re dily available to m st research
universities and pharmaceutical aboratori s. The two-step
method ta es advantag of t e highly flexible hydrogen
bo ding network present b w en the sulfated organic
c mpound and the guanidinium moiet . This favorable lattice
allows f r facile g eration of large, high-quality crystals from a
divers range f substrates that otherwise m y be recalcitrant
toward facile crystallographic analysis. T e u fate group
provid s sufficient anomalous dispersion such that the bsolute
stereo hemistry can be a signed unambiguously. This
technique has a number of advantages in comparison to
oth r methods, i cluding opera ional simplicity, low cost, and
easy-t -in erpret, absolute results. W ile the 17 substrates
assigned in this r port demonstrate the ability of this chiral
i entification te hnique, we h p to uild these compelling
preliminary results in th near future.
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coinci ent with the sulfated alcoh l oiety. Th structural
diversity of th 17 substrates in this st dy which were
successfully assigned with 100% accur cy de ns rates the
versatility and r liability f this strategy for abs lu e stereo-
chemical det rmination. The main limitation of th metho -
ology is our current inability to a ly the strategy for the
identification of chiral t rtiary alcohols du to the reluctance of
th s species unde go sulfation under the present conditions
employe . We pr bed two such ubstrates: (−)-lin lool and
(+)-te pin n-2-ol. I the former case, w obs rved incomplete
s lfation (i.e., 50% conv rsion) a succ ssfully grew crystals
fro th crude reaction mixt re fter tr ment with
guanidi ium chloride. Neverthel ss, th resulting crystals
were of insufficient quality for X-r y analy is. In the latter
case, the sulfation attempt failed. Fin lly, our strategy failed to
return X-ray quality crystals for e 1° alcoho substrate,
(−)-citr ellol, despite successful sulfat on a d crystallization.
Further investig ions to prob th limitations and potential of
this method are o goi g i ou laboratory. Studies include the
optimizati n of this strategy for th stereochemical determi-
nation of o her important fun tional groups.
By means of our straightforward strategy, the absolute
stereochemistry of target compounds can be obtained from a
small amount of sampl (less than 50 mg) in less than 48 h,
utilizing X-ray equipment r adily availa l to m st research
universities and pha maceutical laboratorie . The two-step
meth takes a vantage f t e highly flexible hydrogen
bonding twork present between the sulfated organic
compound and th gu nidi ium moiet . This f vo ble lattice
allows fo faci e eneration of large, high-q ali y crystals from a
diverse range f sub trates that otherwise may e recalcitrant
toward facile crystallographic a alys s. The sulfate group
provides sufficient an m lous dispersion such that the absolute
stereochemistry can be s igned unambiguously. This
tech ique ha a number of advantages in comparison to
other methods, includi g op rational s mplici y, low cost, a d
e sy-to-interpr t, abs lute r s lts. W ile the 17 s bstrates
assign d in this report demonstrate the ability of this chiral
identification technique, we hope to build on these compelling
preliminary results in the near future.
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coincident with the sulfated alcohol moiety. T e structural
diversity of the 17 substrates in this study whic were
successfully ssigned with 100% accuracy demonst ates th
versatility and relia ility of this s rategy or absolute stereo-
chemical determi tion. The main limitation of the m thod-
ology is our current in bility to apply the strategy f r the
id ntificatio of chiral tertiary alcohols du to the rel ctance of
thes s cies to undergo sulf tion under the present co itions
employed. We probed two such sub trat : (−)-linalool and
(+)-terpinen-2- l. In the former case, we observed incomplete
sulfatio (i.e., 50% conversion) and uccessfully grew crystals
from the c u e reacti n mixture after treat ment with
guanidinium chloride. Nevertheless, the resulting crystals
w re of insufficient quality f r X-ray analysis. In the latter
case, the sulfation attempt failed. Finally, ou str tegy failed to
return X-ray quality crys als for one 1° alc hol substrate,
(−)-citronellol, despit successful sulfation and crystallization.
Further inv stigation to pr be the limitations an po enti l f
this method are on oing in ur laboratory. Studi s include the
opti izati n f this strategy for the s e eochemical determi-
n tion of ther impor ant function l roups.
By means of our straightforward str tegy, the absolute
stereochemistry of ta get comp unds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
u ilizing X-ray equipment re dily vailable to most r search
universities and pharmaceutical laborator es. The two-step
method ta es advantag of the ighly flexible hydrogen
bonding network present between the sulfat d organic
compound and the guanidinium moiety. This favorable lattice
allows for facile g ner tion of large, hig -qual ty crystals from a
diverse ra ge of substrates that otherwise may be reca citrant
t ward facile c st ll graphic analysis. The sulfate group
provides ufficie t anomalous dispersio such that the abs lute
stereoc emistry can b assigned unambiguou ly. This
tech ique has a umber of advantages in comparison to
other methods, inc ding operational simplicity, low cost, and
easy-t -int rpr t, absolute results. While th 17 substrates
assigned in is report demonstrate the ability f this chiral
ide tification technique, we hope to build on th e compelling
preliminary results i the near future.
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coincident with the sulfated lcohol o ety. The structural
divers ty of th 17 su s rates in this tudy which er
successfully assigned wi h 1 0% accuracy demons rates he
v rsatility and reliability o his strategy for absolute stereo-
chemical det rmination. The ain limitati n of the method-
ology is our current inability to apply the strate y for th
identificat on of chiral t r iary alcoho s du to the relucta ce of
these sp cies to nd rg sulfation under he present co ditio s
employed. We probed two s ch substrat s: (−)-linalool and
(+)-t rpi -2-ol. In the forme case, we observed incompl t
sulfa ion (i.e., 50% conversion) and successfully grew crystals
from the crude rea tio ixt re fter tre tement wi h
guanidinium chlorid . Nev rthele s, the resulting crystals
were of insufficient quality fo X-ray na ysis. In the l ter
ca e, the sulf io at empt fail d. Fin lly, o r s rategy fail d o
return X-ray quality crystals for one 1° alcohol ub trate,
(−)-citronellol, despit successful sul ation and crystallization.
Further investigations to pr be th limit tions and pot nt al of
this method are o going in ur l boratory. Studies include the
optimizatio f thi strategy for the stereochemical determi-
nation of other i po tant functional gr ps.
By means of ur straightforward strategy, the absolute
stereochemistry of target compo ds can be btained from a
small amount of sample (le s than 50 mg) in less than 48 h,
utilizing X-ray equip e t readily available to m st research
univ rsities and pharmaceutical laboratories. Th two-step
method takes advantage of the highly flexible hydro en
bonding network present betwe the sulfated organic
compound and he gua idinium moi ty. This favorable l ttice
allows f r facile generation of large, high-q ality crystals fro a
div rse range of substrates that o herwi e may be recalcitra t
oward facil cryst llographic analysis. The sulfate group
provides uffici nt anomalous disp sion such t at the abs lute
ster ochemistry can be assign d unambiguously. This
technique has a numb of adva tages n comparison to
other m thods, ncludi g op rational simplic ty, low cost, and
easy-to-interpret, ab lute res lts. While the 17 substrates
assigned in this rep t dem strate the ability of this chiral
identification technique, we hope to build on these compelling
preliminary results in the near future.
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coincident with the sulfa ed alcohol moiet . Th uctural
diversity of the 17 substr tes n th s study whic w r
successf lly assigned w th 100% ccuracy dem nstrates t e
vers til ty and reliability f this strategy for absolute stereo-
che i al determinati n. The main limita ion of the meth d-
ol gy is our curren i ability to apply the str tegy for the
id ntification of chiral te tiary alcohols du to the reluctanc of
these species to undergo sulfation nder the present onditions
employed. W probed two s ch substrates: (−)-li alool and
(+)-terpinen-2-ol. In the fo m r c se, we ob erved incomplete
sulfatio (i.e., 50% conversion) and succe fully grew crystals
from the crude reaction mixtur after treatement with
guanidinium chlorid . Neverthe ess, the resul ing crystals
were of insufficient quality for X-ray al sis. In the latt r
cas , he ulf a temp fai ed. Fin lly, o strat gy f iled to
return X-ray quality crystals f o e 1° alcohol substrate,
(−)-citron lol, de pi s ccessful sulfati n and crystallization.
Further investigation o probe the limitations and potential of
this ethod are ongoing in ur labor tory. Stud s include the
opti ization f his strategy for the stere chemic l determi-
nation of other i ortant functional groups.
By means of our straightforward strategy, the absolute
stereochemistry of target compounds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
utilizing X-r y equipment readily available to most research
universities and pharmaceutical laboratories. The wo-step
method takes dva tage of t e highly flexib e hydrogen
bondi ne work present between the sulfated organic
c mp u and th u idinium moiety. This f vor ble attice
allow for facile genera i n of l rge, high-quality cry tals from
diverse range of substrates that otherwis may be rec lcitrant
toward facile crystallographic analysis. The lfate gr up
provides sufficient a o al us dispersion such that the bsolute
s ereochemistry can be a signe u ambiguo sly. This
tech qu has a numbe of advant ges in comparison to
other methods, including operational simplicity, l w cost, and
easy-to-interpret, absolute results. While the 17 substrates
assigned in this report demonstrate the ability of this chiral
identification technique, we hope to build on these compelling
preliminary results in th near future.
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oinc d nt with the sulfated alcohol mo ty. Th struc ural
diversity f the 17 subst ates in this study whi h wer
succ ssfull assig d wi h 100% accuracy d mon t s the
ver atility and reliability of is strategy for abs lute stere -
chemical determinati n. The main limitation of the method-
ology is our curre t inability to apply the strategy for h
iden ification of chi al tertiary alc hols u to the r luctanc of
these species to und rgo sulfation der he p sent co dition
employed. We pr bed two suc substr t s: (−)-li alool and
(+)-terpinen-2- l. In the form case, we bserved incomple e
sulfation (i.e., 50% conversion) and successfully grew crystals
from the crude rea tion mixture after treatement wi h
g anidinium chloride. Nev rtheless, the resulting crystals
we e of i s fficie t quality for X-ray naly is. In th l tter
case, the sulf ti n atte t f iled. Fin lly, our strategy failed to
return X-ray quality c ystal for one 1° alc hol subst ate,
(−)-citronellol, des ite successful su fati n and crystallization.
Further investigati ns to pr be the limita ions and potentia of
this meth d a e ngoing in our laboratory. Studi s i clude the
optimizatio of this strategy for the stereochemical determi-
nation of other important functional groups.
By means of our straightforward strategy, the absolute
stereoche istry of target compounds can be obtained from a
small amount of sample (less than 50 mg) in less than 48 h,
utilizing X-ray equipment readily av ilable to most resear h
univ rsities nd pharmaceutical laboratories. The two-step
metho takes advant g f h hig ly flexible hydr g n
bon ing etwork prese t betw en the sulf ted org nic
compound and the guanidi ium mo ety. This f vorable lattic
allows for f cile generatio of lar e, high-quality crystals from a
div rse range of substr t s that otherwise may be re lcitra t
toward facile rystallo ra hic a y s. The sulfate group
provid s sufficient an malous dispersion s ch that the absolute
st reochemis ry ca b assigned un mbiguously. This
technique has a numb r of advantages in comparison to
other method , including operational simplicity, low cost, and
easy-to-interpret, absolute results. While the 17 substrates
assigned in this report demonstrat the ability of this chiral
identification tech ique, we h pe to build on these comp lling
preliminary results i the ne r futur .
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univ siti and ph rmaceutical laboratories. The tw -s ep
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bon ing network present b twee the sulfat d rganic
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allows for f cile generation of l rg , hi h-quality crystals from a
diverse range of s bstrates th t therwi e may be recalcitrant
oward facil crysta l graphic a alysis. T sulfate gr up
provi es sufficient anomal u di p rsion such that t e absolute
tereochemistry can be a signed unambigu sly. This
t ch ique has a mber f advantages in comparison to
other methods, including opera ional simplicity, low cost, and
e sy-to-interpret, absolute results. While the 17 substrates
assigned in this report demonstrate the ability of this chiral
identification technique, we hope to build on these compelling
preliminary results in the near future.
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diols (11,12) were also readily sulfated, and their absolute stereochemical identity was 
assigned. The assignment of (S)-2-phenylpropan-1-ol (II-31) is another example that 
demonstrates that the chiral center of interest does not need to reside directly on the 
carbinol moiety. The process is also compatible with relatively sensitive molecules 
including those bearing enolizable chiral centers like the one resident in (+)-methyl-D-
lactate (II-32). Propargylic alcohols also proceed well in the process allowing for the 
assignment of (S)-3-butyne-2-ol (II-33). The methodology also tolerates substrates with 
acid labile groups such as acetals in the protected sugar (II-34) and esters/lactones in the 
Corey lactone benzoate (II-35). The latter two substrates further highlight the ability of 
this method to identify more complex molecules which have multiple stereocenters and 
whose chiral centers are not coincident with the sulfated alcohol moiety. 
 
The structural diversity of the seventeen substrates in this study which were 








II-19 (R) P21 0.0270 0.02(2) R 
II-20(S) P21 0.0253 0.00(2) S 
II-21 (–) P21 0.0496 o.o1(4) R,S,R 
II-22 (L) P212121 0.0358 0.02(5) R,S,R 
II-23 (–) P212121 0.0338 0.00(3) S,S 
II-24 (–) P3221 0.0766 0.05(4) R,S,S 
II-25 (-) C2221 0.0340 0.03(2) R,R,R,S 
II-26 (S) P21 0.0375 0.00(3) S 
II-27 (R) P1 0.0554 0.02(2) R 
II-28 (R) P21 0.0350 0.05(3) R 
II-29 (S,S) P212121 0.0228 0.00(1) S,S 
II-30 (R,R) P1 0.0290 0.06(6) R,R 
II-31 (S) P212121 0.0329 -0.01(3) S 
II-32 (D) C2 0.0298 0.07(3) R 
II-33 (S) P21 0.0490 0.06(5) S 
II-34 (D) P21 0.0270 0.04(2) R,S,S,R,S 
II-35 (–) P21 0.0794 -0.10(4) S,R,S,R 
 
Table 2.3. Stereochemical information obtained by 
X-ray crystallography.
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this strategy for absolute stereochemical determination. In addition, it bears mentioning 
that all of the crystal structures contained the critical hydrogen bonding network and this 
flexible lattice allowed for straightforward growth of large, single crystals. Figure 2.10 
displays several crystals of the guanidinium organosulfate salts that were generated using 








2.7 ADVANTAGES, LIMITATIONS, AND FUTURE WORKS 
The presented guanidinium sulfation crystallization technique has several 
advantages in comparison to other methods that were previously mentioned in this 
chapter for the absolute stereochemical determination of chiral organic compounds. The 
Figure 2.10. Pictures of various single crystals generated using the two-step, one-
pot guanidinium sulfation crystallization approach. The guanidinium organosulfate 
salts were derived from: (R)-1-phenylethanol (top left), (!)-isopinocampheol (top 
right), (")-menthol (bottom left), and (!)-isopulegol (bottom right).
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first being that it is definite and requires no predictive model or empirical mnemonics. It 
can unambiguously identify all stereocenters that are present in the chiral molecule along 
with their relative orientation, and it does not require the chiral center to be coincident 
with the derivatization site. While the method still depends on a derivatization step, this 
step proceeds in one-pot, at room temperature, and only requires cheap and commercially 
available sulfur trioxide pyridine and guanidinium chloride. The procedure is extremely 
user friendly and common conditions work on a wide suite of chiral substrates. Finally, 
the chiral material of interest is readily recoverable after successful identification without 
erosion of the enantiopurity of the compound.  
The major limitation of the presented methodology is the requirement that the 
chiral substrate of interest must have a nucleophilic group capable of undergoing 
sulfation. Other minor limitations include the inability to identify chiral tertiary alcohols 
using our approach due to their reluctance to undergo sulfation under the present 
conditions employed.  Figure 2.11 displays two tertiary substrates that were attempted, (–
)-linalool and (+)-terpinen-2-ol. In addition, our strategy failed to return X-ray quality 
crystals for one 1˚ alcohol substrate, (–)-citronellol, despite successful sulfation and 












Figure 2.11. Limitations of the guandinium sulfation crystallization 
including tertiary alcohols, one primary alcohol, and 1,2-diols.
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epoxides during the sulfation step. 
Further investigations to address the limitations and probe the potential of this 
method are on-going in our laboratory (Figure 2.12). For example, we are exploring 
different sulfation conditions and reagents that will allow for successful sulfation of 
tertiary alcohols and 1,2-diols. Studies also include the optimization of this strategy for 
the stereochemical determination of other important functional groups. There are number 
of moieties that can serve the purpose of the required nucleophilic group including 
oximes, secondary/tertiary amines, cyanohydrins, thiols, and sulfoxides. Lastly, there are 
specific classes of compounds that we aim to employ under our approach such as 






























































Figure 2.12. Future works to probe the potential of the guandinium sulfation crystallization. Important functional 
groups (top row) and other classes of compounds (bottom row) to be investigated.
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2.8  EXPERIMENTAL 
 
2.8.1  GENERAL INFORMATION  
 
All reagents and chemicals were obtained from commercial sources and used 
without further purification unless stated otherwise. Dichloromethane (DCM) was dried by 
refluxing over phosphorous pentoxide (P2O5) and distilling under nitrogen prior to use. 1H 
and 13C NMR spectra were recorded at ambient temperature on a 300 MHz NMR 
spectrometer (Bruker). Proton and carbon chemical shifts were reported in parts per million 
(ppm) downfield from tetramethylsilane (TMS). Spectra were referenced to the deuterated 
solvent as the internal standard (i.e., δ 2.50 ppm for 1H NMR, 39.51 ppm for 13C NMR in 
DMSO-d6). Data are presented as follows: chemical shift, integration, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), and coupling 
constants (J, in hertz).  
 
2.8.2  GENERAL PROCEDURE FOR X-RAY DIFFRACTION 
 
Structural data of the guanidinium organosulfate salts II-19 to II-35 were obtained 
by single crystal X-ray diffraction.  Diffraction data were collected under a cold nitrogen 
stream using a Bruker D8 Venture diffractometer equipped with Mo Kα radiation (λ = 
0.07107 Å) from an Incoatec IµS source and a Photon 100 detector.  Instrument control, 
data processing (SAINT), and data scaling (SADABS, spherical multi-scan absorption 
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correction) were performed using the Bruker Apex3 software package.55  Space group 
determinations were made based on the systematic absences, and the structures were solved 
by intrinsic phasing, then refined on F2 using full matrix least squares techniques with the 
SHELXTL software suite.56  All non-hydrogen atoms were refined anisotropically.  All 
structures were determined in chiral space groups, having absolute structure parameters 
(Flack) of zero within three times the standard uncertainty, indicating the proper absolute 
structure model.  A summary of the crystallographic data and structure refinements is given 
in Tables 2.3-2.5.  The molecular structures of the salts II-19 – II-35, as well as selected 
projections of the molecular packing are shown in Figures 2.13 – 2.29.  Data are deposited 
with the CCDC under the following deposition numbers: 1954250 – 1954266. 
In the case of salts II-27 and II-35, some disorder was included in the structural 
models.  For II-27, the disorder may be a manifestation of stacking faults in the crystals, 
which were micaceous in nature.  Six of the twelve unique anions exhibited disorder of 
their carbon chains, and the disordered atoms were well behaved without the use of 
restraints.  The occupancy of the disordered components was allowed to freely refine to a 
unity sum, with nearly 50% occupancy found for each arrangement.  For all of the 
disordered arrangements, the (R) chirality was maintained.  For II-35, a positional disorder 
occurred in the nitrogen atoms of the guanidinium cation (and thus their riding hydrogen 
atoms), which was also accompanied by a slight elongation of the ellipsoids of the three 
oxygen atoms of the sulfate group that act as the hydrogen bond acceptors. Here, SIMU 
and SADI restraints were utilized to ensure chemically reasonable behavior. As with II-
27, this disorder did not affect the identification of the chiral centers. 
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2.8.3  GENERAL PROCDURE FOR SULFATION SYNTHESIS 
 
To a flame dried 10 mL round-bottomed flask equipped with a stir bar was added 
technical grade (≥45% SO3 basis) sulfur trioxide/pyridine complex (1.3 mmol, 0.207 
grams, 1.3 equiv) and dry DCM (5 mL). The suspension was stirred under N2 and the 
substrate was added dropwise (1 mmol, 1 equiv). The resulting solution was stirred for 24 
h, and after completion the unreacted SO3·Pyr was filtered off. The filtrate can then be 
concentrated in vacuo or used directly in the subsequent guanidinium crystallization.  
 




To the sulfate pyridinium complex, guanidinium chloride (1.0 mmol, 0.095 grams, 
1.0 equiv) is added. An alcohol solvent (methanol, ethanol, or iso-propyl alcohol) is then 
added dropwise until the solution becomes homogenous.  Slow evaporation of the 
homogenous solution (additional modifications will be noted below) results in single 
crystals which can be used in an X-ray diffraction experiment. 
 




To a suspension of sulfate guanidinium crystals in tetrahydrofuran (THF), 
deionized water was added dropwise until the mixture became homogenous. The solution 
was then refluxed for 12 h. After completion, the THF layer was separated in a separatory 
funnel. The aqueous layer was extracted with diethyl ether (3 x 25 mL). The combined 
organic phases were washed with brine and dried over anhydrous sodium sulfate. The 


















2.8.6   CRYSTALLOGRAPHIC DATA FOR GUANIDINIUM SULFATES 
 
 
Table 2.4. Crystallographic data for II-19 to II-22.
 II-19 II-20 II-21 II-22 
empirical formula C9H15N3O4S C9H16N4O3S C11H23N3O4S C11H25N3O4S 
formula weight (g/mol) 261.30 260.32 293.38 295.40 
crystal system monoclinic monoclinic monoclinic orthorhombic 
space group, Z P21, 2 P21, 2 P21, 2 P212121, 4 
temperature (K) 100 100 100 140 
crystal size (mm) 0.26 x 0.17 x 0.09 0.15 x 0.12 x 0.04 0.23 x 0.17 x 0.03 0.30 x 0.13 x 0.07 
a, Å 7.6128(4) 7.5877(9) 7.6792(12) 7.4624(5) 
b, Å 12.0610(6) 12.0192(16) 11.0650(16) 12.4204(6) 
c, Å 7.7450(4) 7.8292(11) 9.5792(15) 17.0545(10) 
α,° 90 90 90 90 
β, ° 119.252(2) 118.328(4) 98.393(6) 90 
γ, ° 90 90 90 90 
volume (Å3) 620.45(6) 628.50(14) 805.2(2) 1580.71(16) 
Dcalc (g/cm
3) 1.399 1.376 1.210 1.241 
abs. coeff. (mm-1) 0.269 0.261 0.214 0.218 
F(000) 276 276 316 640 
Tmax, Tmin 1.0000, 0.9531 1.0000, 0.9665 1.0000, 0.7241 1.0000, 0.9141 
Θ range for data 3.02-27.99 2.96-25.50 2.68-25.25 2.03-26.49 
reflections collected 14535 15923 8609 13107 
data/restraints/parameters 2977 / 1 / 155 2346 / 2 / 159 2696 / 43 / 174 3278 / 0 / 172 
R(int) 0.0359 0.0367 0.0515 0.0456 
final R [I> 2σ(I)] R1, wR2 0.0270, 0.0631 0.0253, 0.0655 0.0496, 0.1085 0.0358, 0.0884 
final R (all data) R1, wR2 0.0287, 0.0640 0.0265, 0.0660 0.0729, 0.1190 0.0437, 0.0954 
goodness-of-fit on F2 1.081 1.122 1.115 1.109 
flack parameter 0.02(2) 0.00(2) 0.01(4) 0.02(5) 
larg. diff. peak, hole, eÅ-3 0.182, -0.285 0.201, -0.286 0.361, -0.280 0.239, -0.465 






Table 2.5. Crystallographic data for II-23 to II-26.
 II-23 II-24 II-25 II-26 
empirical formula C12H23N3O4S C11H23N3O4S C11H23N3O4S C11H21N3O4S 
formula weight (g/mol) 305.39 293.38 293.38 291.37 
crystal system orthorhombic trigonal orthorhombic monoclinic 
space group, Z P212121, 4 P3221, 6 C2221, 8 P21, 4 
temperature (K) 150 100 140 140 
crystal size (mm) 0.26 x 0.05 x 0.04 0.27 x 0.10 x 0.04 0.26 x 0.17 x 0.02 0.30 x 0.11 x 0.07 
a, Å 7.1991(11) 7.3276(17) 7.4804(7) 7.1985(6) 
b, Å 12.9020(16) 7.3276(17) 12.4522(7) 13.1366(13) 
c, Å 16.883(2) 50.639(12) 33.315(2) 15.5582(15) 
α,° 90 90 90 90 
β, ° 90 90 90 101.980(3) 
γ, ° 90 120 90 90 
volume (Å3) 1568.1(4) 2354.7(12) 3103.2(4) 1439.2(2) 
Dcalc (g/cm
3) 1.294 1.241 1.256 1.345 
abs. coeff. (mm-1) 0.223 0.220 0.222 0.239 
F(000) 656 948 1264 624 
Tmax, Tmin 1.0000, 0.9030 1.0000, 0.7469 1.0000, 0.9059 1.0000, 0.9529 
Θ range for data 2.41-26.08 2.41-25.25 2.44-26.00 2.68-26.50 
reflections collected 44201 13612 28535 38487 
data/restraints/parameters 3093 / 0 / 183 2801 / 0 / 175 3036 / 0 / 175 5966 / 1 / 345 
R(int) 0.0755 0.0493 0.0394 0.0566 
final R [I> 2σ(I)] R1, wR2 0.0338, 0.0769 0.0766, 0.1469 0.0340, 0.0874 0.0375, 0.0811 
final R (all data) R1, wR2 0.0413, 0.0798 0.0854, 0.1501 0.0361, 0.0885 0.0480, 0.0854 
goodness-of-fit on F2 1.048 1.264 1.146 1.043 
flack parameter 0.00(3) 0.05(4) 0.03(2) 0.00(3) 
larg. diff. peak, hole, eÅ-3 0.129, -0.316 0.375, -0.618 0.204, -0.360 0.176, -0.385 






Table 2.6. Crystallographic data for II-27 to II-30.
 II-27 II-28 II-29 II-30 
empirical formula C5H15N3O4S C9H23N3O4S C8H24N6O8S2 C10H28N6O8S2 
formula weight (g/mol) 213.26 269.36 396.45 424.50 
crystal system triclinic monoclinic orthorhombic triclinic 
space group, Z P1, 12 P21, 2 P212121, 8 P1, 1 
temperature (K) 100 150 100 140 
crystal size (mm) 0.40 x 0.30 x 0.04 0.29 x 0.26 x 0.06 0.36 x 0.06 x 0.02 0.24 x 0.18 x 0.07 
a, Å 7.4168(15) 7.3114(9) 7.4321(11) 7.1420(5) 
b, Å 12.696(3) 14.9419(18) 12.090(2) 7.4076(6) 
c, Å 34.447(7) 7.3338(10) 21.442(4) 10.9517(9) 
α,° 93.160(5) 90 90 71.946(3) 
β, ° 91.006(6) 117.080(4) 90 80.030(2) 
γ, ° 90.837(6) 90 90 64.665(2) 
volume (Å3) 3237.7(11) 713.36(16) 1926.7(6) 497.34(7) 
Dcalc (g/cm
3) 1.313 1.254 1.367 1.417 
abs. coeff. (mm-1) 0.292 0.235 0.322 0.316 
F(000) 1368 292 840 226 
Tmax, Tmin 1.0000, 0.9006 1.0000, 0.9059 1.0000, 0.9167 1.0000, 0.9250 
Θ range for data 2.05-25.25 2.73-25.48 2.54-25.69 3.16-26.99 
reflections collected 57376 7114 59194 22914 
data/restraints/parameters 23308 / 3 / 1658 2530 / 1 / 156 3645 / 0 / 217 4250 / 3 / 237 
R(int) 0.0441 0.0407 0.0277 0.0321 
final R [I> 2σ(I)] R1, wR2 0.0554, 0.1271 0.0350, 0.0730 0.0228, 0.0611 0.0290, 0.0754 
final R (all data) R1, wR2 0.0904, 0.1409 0.0426, 0.0762 0.0239, 0.0619 0.0311, 0.0764 
goodness-of-fit on F2 1.033 1.097 1.129 1.081 
flack parameter 0.02(2) 0.05(3) 0.000(9) 0.059(19) 
larg. diff. peak, hole, eÅ-3 0.411, -0.375 0.183, -0.315 0.143, -0.362 0.246, -0.381 






Table 2.7. Crystallographic data for II-31 to II-34.
 II-31 II-32 II-33 II-34 
empirical formula C10H17N3O4S C5H13N3O6S C5H11N3O4S C13H25N3O9S 
formula weight (g/mol) 275.32 243.24 209.23 399.42 
crystal system orthorhombic monoclinic monoclinic monoclinic 
space group, Z P212121, 4 C2, 4 P21, 4 P21, 2 
temperature (K) 100 100 140 100 
crystal size (mm) 0.36 x 0.03 x 0.03 0.47 x 0.02 x 0.02 0.21 x 0.21 x 0.07 0.23 x 0.19 x 0.03 
a, Å 7.5302(2) 12.2663(5) 11.0497(17) 7.2984(4) 
b, Å 11.7747(5) 6.8868(3) 7.5032(11) 12.2350(6) 
c, Å 16.2810(6) 12.8139(5) 12.5089(17) 10.9474(6) 
α,° 90 90 90 90 
β, ° 90 105.105(2) 103.284(5) 103.795(2) 
γ, ° 90 90 90 90 
volume (Å3) 1443.57(9) 1045.06(8) 1009.3(3) 949.36(9) 
Dcalc (g/cm
3) 1.267 1.546 1.377 1.397 
abs. coeff. (mm-1) 0.235 0.326 0.311 0.221 
F(000) 584 512 440 424 
Tmax, Tmin 1.0000, 0.9384 1.0000, 0.9392 1.0000, 0.9109 1.0000, 0.9599 
Θ range for data 2.50-26.42 3.29-25.50 2.80-25.25 2.54-26.49 
reflections collected 12906 10262 17632 24549 
data/restraints/parameters 2959 / 0 / 164 1961 / 1 / 138 3629 / 1 / 237 3914 / 1 / 239 
R(int) 0.0434 0.0414 0.0674 0.0389 
final R [I> 2σ(I)] R1, wR2 0.0329, 0.0721 0.0297, 0.0655 0.0490, 0.0980 0.0270, 0.0665 
final R (all data) R1, wR2 0.0392, 0.0745 0.0358, 0.0678 0.0696, 0.1054 0.0288, 0.0674 
goodness-of-fit on F2 1.034 1.102 1.070 1.104 
flack parameter -0.01(3) 0.07(3) 0.06(5) 0.04(2) 
larg. diff. peak, hole, eÅ-3 0.159, -0.333 0.173, -0.367 0.239, -0.331 0.180, -0.343 






Table 2.8. Crystallographic data for II-35.
 II-35 
empirical formula C16H21N3O8S 
formula weight (g/mol) 415.42 
crystal system monoclinic 
space group, Z P21, 2 
temperature (K) 140 
crystal size (mm) 0.31 x 0.24 x 0.05 
a, Å 7.6959(13) 
b, Å 10.7718(15) 
c, Å 11.8878(18) 
α,° 90 
β, ° 103.111(5) 
γ, ° 90 
volume (Å3) 959.8(3) 
Dcalc (g/cm
3) 1.437 
abs. coeff. (mm-1) 0.218 
F(000) 436 
Tmax, Tmin 1.0000, 0.8180 
Θ range for data 2.72-25.22 
reflections collected 12776 
data/restraints/parameters 3431 / 61 / 282 
R(int) 0.0402 
final R [I> 2σ(I)] R1, wR2 0.0794, 0.1936 
final R (all data) R1, wR2 0.0886, 0.2025 
goodness-of-fit on F2 1.050 
flack parameter -0.10(4) 
larg. diff. peak, hole, eÅ-3 0.787, -0.528 
CCDC Deposition No. 1954266 
!
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Figure 2.13. Molecular structure and packing in II-19.




Figure 2.15. Molecular structure and packing in II-21.
Figure 2.16. Molecular structure and packing in II-22.












Figure 2.18. Molecular structure and packing in II-24.
Figure 2.19. Molecular structure and packing in II-25.
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Figure 2.20. Molecular structure and packing in II-26.









Figure 2.22. Molecular structure and packing in II-28.








Figure 2.24. Molecular structure and packing in II-30.





Figure 2.26. Molecular structure and packing in II-32.






Figure 2.28. Molecular structure and packing in II-34.
Figure 2.29. Molecular structure and packing in II-35.
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2.8.8  1H AND 13C NMR DATA FOR SULFATE PYRIDINIUM COMPLEXES 
1-Phenylethanol, II-36:  
Following general procedure, with the use of MeOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 14.46 (s, 1H), 8.86 (d, J= 5.3 Hz, 2H), 8.56 (t, J=3.9 
Hz, 1H), 8.02 (t, J= 7.1 Hz, 2H), 7.30 (d, J= 7.5 Hz, 2H), 7.41 (t, J= 7.4 Hz, 2H), 7.12 (t, 
J= 7.2 Hz, 1H), 5.35 (q, J= 6.5 Hz, 1H), 1.45 (d, J=6.6 Hz, 3H).13C NMR (75 MHz, 
DMSO-d6) δ 146.9 (2C), 143.6, 142.0 (2C), 128.2 (2C), 127.6, 127.2 (2C), 126.1, 74.5, 
23.5. 
1-Phenylethanamine, II-37:  
 
Following general procedure, with the use of a 1:1 mixture of MeOH:IPA as the polar 
solvent.  
1H NMR (300 MHz, DMSO-d6) δ 9.1 (s, 1H), 8.86 (d, J= 5.3 Hz, 2H), 8.33 (s, 1H), 7.93-
7.90 (m, 1H), 7.50-7.19 (m, 5H), 4.46-4.40 (m, 1H), 1.48 (t, J= 7.6 Hz, 3H).13C NMR (75 
MHz, DMSO-d6) δ 148.72 (2C), 143.56, 139.73 (2C), 138.37 (2C), 129.15, 128.6 (2C), 
127.31 (2C), 124.96, 54.87, 23.01.  
 (–)-Isopulegol, II-38:  
Following general procedure, with the use of MeOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 14.47 (s, 1H), 8.95 (d, J= 5.2 Hz, 2H), 8.65 (t, J=8.4 
Hz, 1H), 8.12 (t, J= 7.1 Hz, 2H), 4.60 (t, J=3.6 Hz, 1H), 4.51 (t, J= 2.6 Hz, 1H), 4.00 (td, 
J= 10.7 Hz, J= 4.1 Hz, 1H), 2.44 (d, J= 12.1 Hz, 1H), 1.93 (sextet, J= 5.2 Hz, 1H), 1.64 
(s, 3H), 1.57-1.24 (m, 4H), 0.91-0.76 (m, 5H). 13C NMR (75 MHz, DMSO-d6) δ 147.4, 
146.7(2C), 142.1(2C), 127.4, 111.1, 76.2, 51.3, 41.3, 33.9, 30.9, 30.7, 22.1, 18.7.  
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L-Menthol, II-39:  
 Following general procedure, with the use of MeOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 15.36 (s, 1H), 8.96 (d, J= 5.4 Hz, 2H), 8.66 (t, J=7.6 
Hz, 1H), 8.12 (t, J= 7.1 Hz, 2H), 3.85 (sex, J=5.1 Hz, 1H), 2.30 (d, J= 12.1 Hz, 1H), 
2.15-2.03 (m, 1H), 1.50 (t, J= 5.8 Hz, 2H), 1.26 (s, 1H), 1.10-0.82 (m, 2H), 0.82-0.64 (m, 
11H).13C NMR (75 MHz, DMSO-d6) δ 146.7(2C), 142.1(2C), 127.4, 76.1, 47.7, 42.0, 
34.1, 31.0, 24.9, 23.0, 22.2, 20.1, 16.1.  
(–)-Nopol, II-40:  
Following general procedure, with the use of concentrated sulfate pyridinium complex 
and EtOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 14.89 (s, 1H), 8.96 (d, J= 6.2 Hz, 2H), 8.66 (t, J=7.8 
Hz, 1H), 8.13 (t, J= 7.1 Hz, 2H), 5.18 (s, 1H), 3.74 (t, J= 7.3 Hz, 2H), 2.27-1.88 (m, 7H), 
1.14 (s, 3H), 0.97 (d, J= 8.4 Hz, 1H), 0.69 (s, 3H).13C NMR (75 MHz, DMSO-d6) δ 
146.9(2C), 144.6, 142.1(2C), 127.6, 117.5, 64.3, 45.2, 40.2, 37.5, 36.6, 31.2, 30.9, 26.1, 
21.0.  
(–)-Borneol, II-41:  
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 13.53 (s, 1H), 8.97 (d, J= 6.2 Hz, 2H), 8.68 (t, J=7.4 
Hz, 1H), 8.14 (t, J= 6.7 Hz, 2H), 4.29 (d, J= 7.0 Hz, 1H), 2.12-1.98 (m, 1H), 1.79-1.65 
(m, 1H), 1.61-1.44 (m, 2H), 1.17-0.97 (m, 3H), 0.74-0.67 (m, 9H).13C NMR (75 MHz, 
DMSO-d6) δ 146.9(2C), 142.1(2C), 127.6, 80.8, 48.6, 46.9, 44.3, 36.6, 27.8, 26.4, 19.6, 
18.6, 13.3.  
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(–)-Isopinocampheol, II-42:  
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 13.56 (s, 1H), 8.97 (d, J= 6.4 Hz, 2H), 8.67 (t, J=7.7 
Hz, 1H), 8.13 (t, J= 6.6 Hz, 2H), 4.41 (q, J= 4.8 Hz, 1H), 2.35 (t, J= 11.9 Hz, 1H), 2.27-
2.15 (m, 1H), 1.93 (q, J=6.8 Hz, 1H), 1.86-1.73 (m, 2H), 1.64 (t, J=5.6 Hz, 1H), 1.01 (s, 
3H), 0.99 (d, J=7.3 Hz, 3H), 0.85 (d, J=9.6 Hz, 1H), 0.79 (s, 3H) .13C NMR (75 MHz, 
DMSO-d6) δ 147.2(2C), 142.5(2C), 127.9, 75.9, 47.5, 44.7, 41.4, 38.3, 36.9, 33.8, 27.8, 
23.9, 20.5. 
(–)-Perillyl Alcohol, II-43:  
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 14.93 (s, 1H), 8.96 (d, J= 5.2 Hz, 2H), 8.66 (t, J=1.7 
Hz, 1H), 8.12 (t, J= 7.0 Hz, 2H), 5.58 (s, 1H), 4.59 (s, 1H), 4.15 (s, 1H), 1.95 (t, J= 12.0 
Hz, 4H), 1.78 (d, J= 13.4 Hz, 1H), 1.66 (d, J=12.5 Hz, 1H), 1.60 (s, 4H), 1.26 (q, J= 5.48 
Hz, 1H).13C NMR (75 MHz, DMSO-d6) δ 149.1 146.9(2C), 142.1(2C), 127.6, 123.5, 
108.8, 70.2, 40.4, 29.9, 27.0, 25.9, 20.6.  
(R)-2-Butanol, II-44:  
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 12.19 (s, 1H), 8.95 (d, J= 5.8 Hz, 2H), 8.67 (t, J= 7.8 
Hz, 1H), 8.13 (t, J= 6.9 Hz, 2H), 4.13 (sextet, J= 6.2 Hz, 1H), 1.52-1.26 (m, 2H), 1.08 (d, 
J= 6.3 Hz, 3H), 0.72 (t, J= 7.5 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 147.0(2C), 
142.1(2C), 127.7, 74.4, 29.4, 20.3, 9.6.  
(R)-2-Octanol, II-45:  
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Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 9.85 (s, 1H), 8.96 (d, J= 5.2 Hz, 2H), 8.67 (t, J= 7.8 
Hz, 1H), 8.13 (t, J= 7.1 Hz, 2H), 4.20 (sextet, J= 6.2 Hz, 1H), 1.51-1.37 (m, 1H), 1.36-
1.01 (m, 14H), 0.96 (d, J= 6.1 Hz, 1H), 0.73 (t, J= 6.7 Hz, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 147.2(2C), 142.4(2C), 127.9, 77.3, 37.1, 31.7, 29.1, 25.2, 22.4, 21.1, 14.2.  
(2S, 5S)-Hexanediol, II-46:  
 
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 13.06 (s, 2H), 8.95 (d, J= 5.9 Hz, 4H), 8.69-8.62 (m, 
2H), 8.11 (t, J= 6.8 Hz, 4H), 4.17 (sextet, J= 6.2 Hz, 2H), 1.56-1.29 (m, 4H), 1.10 (d, J= 
6.18, 6H). 13C NMR (75 MHz, DMSO-d6) δ 146.6(2C), 142.1(2C), 127.7, 72.4(2C), 
32.6(2C), 21.1(2C).   
(3R, 6R)-Octanediol, II-47:  
Following general procedure, with the use of concentrated sulfate pyridinium complex 
and MeOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 12.80 (s, 2H), 8.95 (d, J= 5.9 Hz, 4H), 8.69-8.62 (m, 
2H), 8.11 (t, J= 6.7 Hz, 4H), 4.03 (t, J= 4.8 Hz, 2H), 1.58-1.37 (m, 8H), 0.75 (t, J= 7.4 
Hz, 6H). 13C NMR (75 MHz, DMSO-d6) δ 146.7(2C), 142.1(2C), 127.4, 77.20(2C), 
28.9(2C), 26.6(2C), 9.1(2C).   
(S)-2-Phenylethanol, II-48:  
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 11.63 (s, 1H), 8.93 (d, J= 6.3 Hz, 2H), 8.62 (t, J= 7.9 
Hz, 1H), 8.08 (t, J= 6.6 Hz, 2H), 7.29-7.12 (m, 5H), 3.84 (sextet, J= 7.4 Hz, 2H), 2.99 
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(sextet, J= 7.0 Hz, 1H), 1.16 (d, J= 7.0 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 
146.6(2C), 144.1, 142.1(2C), 128.2(2C), 127.4, 127.3(2C), 126.2, 70.9, 18.5. 
(+)-Methyl-D-Lactate, II-49:  
 
Following general procedure, with the use of concentrated sulfate pyridinium complex 
and MeOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 14.30 (s, 1H), 8.92 (d, J= 5.2 Hz, 2H), 8.65 (t, J=8.0 
Hz, 1H), 8.11 (t, J= 7.2 Hz, 2H), 4.59 (q, J= 6.9 Hz, 1H), 3.54 (s, 3H), 1.2 (d, J= 6.9 Hz, 
3H). 13C NMR (75 MHz, DMSO-d6) δ 172.7, 147.0(2C), 142.1(2C), 127.7, 70.7, 51.9, 
18.8. 
(S)-3-Butyne-2-ol, II-50:  
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 13.43 (s, 1H), 8.90 (d, J= 5.2 Hz, 2H), 8.64 (t, J=7.9 
Hz, 1H), 8.10 (t, J= 7.0 Hz, 2H), 4.82 (qd, J= 6.7 Hz, J=6.9 Hz, 1H), 3.26 (d, J=2.1 Hz, 
1H), 1.31 (d, J= 6.7 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 147.0(2C), 142.1(2C), 
127.7, 84.6, 75.1, 62.4, 23.0.  
1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose, II-51: 
Following general procedure, with the use of MeOH as the polar solvent. 
1H NMR (300 MHz, DMSO-d6) δ 11.87 (s, 1H), 8.93 (d, J= 5.3 Hz, 2H), 8.65 (t, J=7.9 
Hz, 1H), 8.11 (t, J= 7.1 Hz, 2H), 4.53 (dd, J= 3.9 Hz, 1H), 4.27 (dd, J=2.5 Hz, 1H), 4.19 
(d, J= 9.2 Hz, 1H), 3.98-3.76 (m, 3H), 1.33 (s, 3H), 1.26 (s, 3H), 1.21 (s, 3H). 13C NMR 
(75 MHz, DMSO-d6) δ 146.8(2C), 142.0(2C), 127.5, 8108.4, 107.9, 95.7, 70.5, 70.0, 
69.8, 66.1, 65.2, 25.9, 25.8, 24.9, 24.2.  
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(–)-Corey Lactone Benzoate, II-52:  
 
Following general procedure, with the use of concentrated sulfate pyridinium complex 
and MeOH as the polar solvent.  
1H NMR (300 MHz, DMSO-d6) δ 12.84 (s, 1H), 8.94 (d, J= 5.4 Hz, 2H), 8.63 (t, J=7.9 
Hz, 1H), 8.10 (t, J= 7.1 Hz, 2H), 7.88 (d, J= 7.4 Hz, 2H), 7.62 (t, J=7.4 Hz, 1H), 7.47 (t, 
J= 7.6 Hz, 2H),  5.26 (t, J=2.6 Hz, 1H), 5.07 (t, J= 6.05  Hz, 1H), 3.80 (d, J= 6.6 Hz, 2H), 
3.04-2.78 (m, 2H), 2.56 (d, J= 17.7 Hz, 1H), 2.48-2.41 (m, 2H), 2.13 (d, J=15.7 Hz, 
1H).13C NMR (75 MHz, DMSO-d6) δ 177.1, 165.1, 146.7(2C), 142.1(2C), 133.4, 
129.7(2C), 129.2(2C), 128.6, 127.5, 84.8, 78.6, 66.1, 52.3, 40.2, 37.9, 35.8. 
 





 Figure 2.30. 
1H NMR (top) and 13C NMR (bottom) spectra for II-36.
















































































































































































































 Figure 2.31. 
1H NMR (top) and 13C NMR (bottom) spectra for II-37.
































































































































































































































 Figure 2.32. 
1H NMR (top) and 13C NMR (bottom) spectra for II-38.




























































































































































































































































































































 Figure 2.33. 
1H NMR (top) and 13C NMR (bottom) spectra for II-39.





































































































































































































































































































 Figure 2.34. 1H NMR (top) and 13C NMR (bottom) spectra for II-40.






































































































































































































































































 Figure 2.35. 
1H NMR (top) and 13C NMR (bottom) spectra for II-41.














































































































































































































































































 Figure 2.36. 
1H NMR (top) and 13C NMR (bottom) spectra for II-42.




















































































































































































































































































 Figure 2.37. 
1H NMR (top) and 13C NMR (bottom) spectra for II-43.



























































































































































































































 Figure 2.38. 
1H NMR (top) and 13C NMR (bottom) spectra for II-44.
















































































































































































 Figure 2.39. 
1H NMR (top) and 13C NMR (bottom) spectra for II-45.





























































































































































































































 Figure 2.40. 
1H NMR (top) and 13C NMR (bottom) spectra for II-46.

































































































































































































 Figure 2.41. 
1H NMR (top) and 13C NMR (bottom) spectra for II-47.










































































































































































 Figure 2.42. 
1H NMR (top) and 13C NMR (bottom) spectra for II-48.





































































































































































































































































 Figure 2.43. 
1H NMR (top) and 13C NMR (bottom) spectra for II-49.
































































































































































 Figure 2.44. 
1H NMR (top) and 13C NMR (bottom) spectra for II-50.









































































































































































 Figure 2.45. 
1H NMR (top) and 13C NMR (bottom) spectra for II-51.
















































































































































































































































































































 Figure 2.46. 
1H NMR (top) and 13C NMR (bottom) spectra for II-52.
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RESOLUTION OF ENANTIOMERS 
 
 
3.1!   GENERAL REMARKS 
 
 
The desire and need to access a single enantiomer is present in a wide suite of 
fields including the synthesis of natural products, agrochemicals, and pharmaceuticals. 
As detailed in Chapter One of this thesis, the use of a single enantiomer in these fields is 
often preferred over racemic mixtures due to the single active enantiomer providing a 
more predictable, effective, and economical agent for the desired function. With this 
being said, chiral products are still regularly marketed and employed as racemic mixtures. 
The major reason for this is because the separation of racemic mixtures is not a trivial 
task due to the fact that enantiomers possess identical physical and chemical properties, 
such as boiling point and solubility. This prevents the use of simple separation techniques 
like distillation and direct recrystallization which are commonly used to separate non-
enantiomeric components of a mixture. The resolution of racemic mixtures necessitates 
the presence of a resolving agent because typically enantiomers only behave differently 
under the influence of some type of chiral reagent or chiral environment.  
The pharmaceutical industry is one of the major driving forces for the 
development of separation techniques in the last several decades. A drugs action is 
contingent upon its bioavailability, distribution, metabolic, and excretion behavior within 
the body. These pharmacological and pharmacokinetic processes can vary depending on 
which enantiomer of the drug is present.1-6 For this reason, there is a desire for 
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pharmaceuticals to be sold as single enantiomers on the drug market. Of all the FDA 
(Food and Drug Administration) approved drugs, 58% of them are chiral and out of the 
58%, 44% of them are being sold as single enantiomers.1 In Figure 3.1, two of the top 
selling enantiopure drugs are shown. Both of these drugs belong to the statin family class, 
medications used to lower lipid levels in our bodies. Atorvastatin, market name Lipitor, 
has sold over 125 billion dollars in the past 15 years.1  
 
Drugs that are sold as racemic mixtures are comprised of an eutomer and a 
distomer. The eutomer is the bioactive enantiomer, the enantiomer that has the higher 
pharmacological activity for the desired therapeutic. The distomer, its stereocomplement, 
is the enantiomer that is either less active, inactive, or in the worst cases can cause 
undesired or toxic side effects. A recent trend in the pharmaceutical industry to address 
the effects and limitations present in racemic drugs has been coined chiral switching. 
Chiral switching is a procedure used to transform an old racemic drug, whose patent has 
expired, into its single active enantiomer.1-6 The new enantiopure drug developed by the 
pharmaceutical manufacturer will then receive patent protection and a new generic name. 
















Figure 3.1. Two of the top selling enantiopure drugs: Atorvastatin and Simvastatin. 
Both belong to the statin family class.
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Levalbuterol is a sympathomimetic drug used as a bronchodilator in the treatment of 
asthma. The (R)-enantiomer is the only active enantiomer increasing the airflow in our 
respiratory system, while the (S)-enantiomer is inactive and has been shown to cause 
unwanted side effects that are associated with the drug.1 The FDA has recently approved 
the single enantiomer drug, albuterol, and is now being sold up to five times as much as 
the old racemic drug. There are many drugs that are still being sold as racemic mixtures, 
but would make great candidates for chiral switching. Two such examples, propranolol 
and levomethadone, are shown in Figure 3.2.  Propranolol is a beta-blocker used to treat 
high blood pressure and levomethadone is a central acting analgesic used to treat opiate 
dependence and cancer pain. In both cases, the eutomer is 50-100 times more active than 
its distomer counterpart.1 However, both drugs are still administered as racemic mixtures 
due to the difficulty and cost associated with preparing the single active enantiomer.  
 
Thus, there is a need to develop methods that allow for easier separation of these types of 
racemic drugs and/or their chiral building blocks. This in return would allow the 
physicians to administer the eutomer at much lower doses compared to the racemic drug 












Figure 3.2. The eutomer of three different pharmaceutical drugs. (R)-Albuterol being an 
example of a drug that has undergone chiral switching. Propranolol and Levomethadone 
are two examples of drugs still being sold as racemates but would make great candidates 
for chiral switching.
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3.2!   METHODS OF ENANTIOMERIC SEPARATION 
 
The economic and scientific relevance of enantiopure substances has favored the 
development of separations techniques for racemic mixtures.7-10 While a number of 
stereoselective syntheses have been reported and employed for the production of 
scalemic compounds, their applicability in pharmaceutical preparations is limited. In the 
early stages of new drug development, there are often time constraints to have samples of 
pure enantiomers for the initial pharmacological testing before a manufacture route has 
been selected. The development of an asymmetric synthesis would be expensive in both 
time and material at these early stages. Additionally, catalysts that are used in asymmetric 
synthesis can be very expensive and rarely are effective at more than one type of 
stereoselective reaction. Thus, techniques that have the ability to separate enantiomers 
have an exciting potential and are in high demand. In this chapter, several resolution 
methods will be discussed including, preparative high performance liquid 
chromatography (HPLC),11-15 kinetic resolution,17-32 enzymatic resolution,33-39 and the 
formation and subsequent separation of diastereomers.40-45  
HPLC is a very common resolution technique and has been proven to be one of 
the most effective methods for the direct separation and analysis of enantiomers.11-15 
There are two techniques when considering liquid phase chromatography, indirect and 
direct HPLC. Indirect HPLC utilizes a chiral reagent to derivatize the sample of interest 
forming two diastereomers which then can be separated by a classical reversed-phase 
column packed with an achiral stationary phase. Direct HPLC involves the use of a 
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column packed with a chiral stationary phase.  In this case the elution of one of the 
enantiomers is slowed relative to the other by stereoselectively constructing chiral 
complexes between the enantiomers and the chiral stationary phase. Preparatory direct 
HPLC is a popular practice used in industry to produce large amounts of enantiopure 
compounds. Figure 3.3 shows several pharmaceutical drugs that were separated using 
preparatory direct HPLC. 
 
 This study afforded separation of the racemic drugs using Chiralpak and Chiralcel 
columns which are packed with amylose and cellulose based silica particles, 
respectively.15 Table 3.1 displays the pharmaceutical, column type, and mobile phase 
used for resolution.  The major benefit of direct HPLC is that no derivatization step is 



















Figure 3.3. Four different pharmaceutical drugs that were separated using preparatory direct high 
performance liquid chromatography (HPLC).
Compound Column Mobile Phase
Chlorcyclizine HCl Chiralpak AD Heptane/IPA/DEA (99/1/0.1)
Methaqualone Chiralpak AS IH/1-PrOH/MeOH/DEA (90/8/2/0.1)
Promethazine HCl Chiralcel OJ IH/IPA/DEA (99/1/0.1)
Metoprolol tartrate Chiralcel OD IH/IPA/DEA (80/20/0.1)
Table 3.1. Pharmaceuticals and their corresponding column and mobile phase that afforded 
resolution of the racemic mixtures. AD= tris-(3,5-dimethyl-phenyl-carbamate), AS= tris-(1-(S)
-phenylethylcarbamate), OJ= tris-(4-methylbenzoate), OD= tris-(3,5-dimethyl-phenyl-
carbamate). IPA= 2-propanol, DEA= diethylamine, IH= isohexane, 1-PrOH= 1-propanol.
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need of additional synthetic steps to recover the enantiopure compound. A significant 
drawback of this method is that there is no universal column that can guarantee 
separation of a wide range of substrates. As seen in Table 3.1, each compound required a 
different chiral column and a unique set of mobile phase conditions.  The process of 
choosing the appropriate column for enantioseparation can be difficult and primarily 
relies on empirical data and experience. Another negative is that the chiral columns and 
large amounts of HPLC solvents required for direct HPLC can be very expensive. Lastly, 
industrial scale direct HPLC uses large volumes of organic solvents which are considered 
as hazardous waste once they have been run through the column. 
 Another common separation technique is kinetic resolution (KR), which is based 
upon the fact that enantiomers typically display different reaction rates when in the 
presence of a chiral reagent or chiral catalyst by means of energetically distinct 
diastereomeric transition states. In kinetic resolution experiments, a racemic mixture is 
subjected to an enantioselective transformation, where the chiral catalyst or reagent will 
undergo preferential (i.e. faster) reaction with only one of the two enantiomers. Ideally, at 
50% conversion the other, slower reacting enantiomer is un-modified and can be isolated 
as a pure enantiomer of the starting material. The practical limitation of this method is the 
more reactive enantiomer is usually not recoverable. Therefore, kinetic resolutions cannot 
produce enantioenriched products in greater than 50% yield. This limitation has been 
addressed through the development of dynamic kinetic resolution (DKR) which allows 
for rapid interconversion of the reactant enantiomers in the presence of the chiral reagent 
or catalyst.16 While dynamic kinetic resolution leads to full conversion of the racemic 
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mixture to a single, enantioenriched product, both types of resolution (KR and DKR) 
suffer from the lack of enantiopurity. Hence, a desired 100% enantiomeric excess is often 
very difficult to obtain when using this methodology.  
 There have been several kinetic resolution reagents that have been developed for 
the separation of alcohols and amines including work done by Sharpless,17-20 Noyori,21-27 
and Fu.28-32 K. Barry Sharpless in 1980 developed the Sharpless epoxidation (Scheme 
3.1) for the kinetic resolution of racemic allylic alcohols.17 Sharpless and Katsuki 
discovered that a combination of titanium tetraisopropoxide, diethyl tartrate (DET), and 
tert-butyl hydroperoxide afforded the epoxides of a wide variety of allylic alcohols in 
high yields and with excellent enantiomeric excess (>90% ee). There are several features 
of this asymmetric epoxidation that are worth noting including that the methodology is 
limited to allylic alcohols since the presence of the hydroxyl group is essential. This also 
provides great chemoselectivity for epoxidation of the allylic alcohol in the presence of 
other olefins. The epoxidation is completely reagent controlled, meaning by using either 
the (+)- or (−)-DET, the corresponding enantiomer of the 2,3-epoxy alcohol can be 
obtained. Thus, the enantiofacial selectivity can be predicted for most allylic alcohols 
using the model seen in Scheme 3.1.  One of the major disadvantages of this approach is 
that the catalyst must be prepared fresh in order to achieve high yields and enantiomeric 
excess, solutions of the titanium(IV) iso-propoxide and DET are mixed followed by 
addition of the TBHP at −20 °C. After mixing for 20-30 minutes, the allylic alcohol 
substrate can be added. The mechanism involves the rapid ligand exchange of Ti(Oi-Pr)4 
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with DET, and the resulting complex undergoes further ligand exchange with the allylic 
alcohol and then TBHP. The transition state of the epoxidation can be seen in Figure 3.4 
where the hydroperoxide and the allylic alcohol occupy the axial coordination sites on the 





































 O＂     ＂
(–)-diethyl tartrate (DET)
 O＂     ＂
Scheme 3.1. Sharpless Epoxidation: kinetic resolution of allylic alcohols resulting in enantiopure epoxy 
alcohol and enantiopure allylic alcohol. Enantiofacial selectivity of the epoxidation is controlled by use of the 
(–)- or (+)-diethyl tartrate (DET). Once the allylic alcohol is positioned as seen in box, the (–)-DET 
enantiomer forms epoxide on top face of alkene and the (+)-DET enantiomer forms epoxide on bottom face 



















Figure 3.4. Transition state of epoxidation. Note: the 
exact structure of the active catalyst is difficult to 
determine due to rapid exchange. This model does 
account for the enantiofacial selectivity. E = CO2Et and 
t-Bu = tert-butyl group.
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In 1996, Ryoji Noyori and co-workers reported a ruthenium(II)-catalyzed 
asymmetric transfer hydrogenation of ketones using a formic acid and triethylamine 
mixture (Scheme 3.2).23 They were able to reduce a range of aromatic ketones (III-1 to 
III-6) to their secondary alcohols with high chemical yields and satisfactory enantiomeric 
excess (83-99% ee). Scheme 3.2, also shows both enantiomeric forms of their 
RuCl[(1,2)-p-TsNCH(C6H5)CH-(C6H5)NH2](n6-mesitylene) catalyst of choice. The 
reactivity and enantiofacial-differentiation ability of the Ru complex (III-7) results from 
the compromise between the steric and electronic properties of the arene ligand and the  
 
chiral diamine auxiliary. In 1997, Noyori’s group followed up this initial report with 
modifications that allowed for 2-propanol to serve as the hydrogen source.  Using this 
strategy, the reverse of the reaction depicted in Scheme 3.2 allows for the kinetic 









III-1: R1= CH3; R2= H
III-2: R1= CH3; R2= Cl
III-3: R1= CH3; R2= CN
III-4: R1= CH3; R2= OCH3
III-5: R1= C2H5 R2= H














Scheme 3.2. Noyori Asymmetric Hydrogenation: enantioselective 
catalysis of aromatic ketones resulting in enantiopure secondary 
alcohols. Enantiofacial selectivity of the Ru complex (III-7) results 
from the steric and electronic properties of the arene ligand and 
the chiral diamine auxillary.
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oxidation of the fast-reacting enantiomer.24 The asymmetric oxidation utilizes the same 
ruthenium catalyst which oxidizes the more reactive enantiomer while reducing acetone, 
yielding the product ketone, iso-propyl alcohol, and the unreacted enantiopure alcohol. 
This kinetic resolution performed in acetone resulted in high recovery and good 
enantioselectivity (92-99% ee) of seven different racemic alcohols. The highlight of 
Noyori’s work is that both resolutions are based off a hydrogen transfer reaction which is 
reversible. This allows for both the forward and reverse reactions, depending on the 
starting materials, to be viable tools for optical resolution.21-27 Additionally, the use of 
acetone and 2-propanol are inexpensive, well-behaving hydrogen acceptor and donor, 
respectively.  
Gregory C. Fu and co-workers reported a kinetic resolution of aryl alkyl 
carbinols, propargylic alcohols, and allylic alcohols catalyzed by a planar-chiral 



















Scheme 3.3. Fu Nonezymatic Acylation: kinetic resolution of 
secondary alcohols via planar-chiral catalyst, (+)-C5Ph5-
DMAP (III-8). R1= aryl, R2= alkyl.
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reaction utilizes 1 to 2.5 mol % loading of the catalyst (III-8), acetic anhydride, triethyl 
amine, and tert-amyl alcohol (Scheme 3.3). One disadvantage of this methodology is that 
this resolution requires low temperatures (0 °C) for optimal conversions and 
enantioselectivities (95-99% ee). Additionally, they reported a kinetic resolution of 
benzylic amines30 and indolinones31 by means of a nonenzymatic acylation. However, 
they had to develop a new chiral catalyst and novel acylating agent for these resolutions 
and each had different reactions conditions.  
In 2012, Fu and co-workers, modified their initial kinetic resolution and published 
the first dynamic kinetic resolution of secondary alcohols via nonenzymatic 
enantioselective acylation (Scheme 3.4).32 They were able to achieve this through the use 
of their planar-chiral DMAP derivative (acylation catalyst) in combination with a 







5.2% RuCl/ 4.4% KOt-Bu












Scheme 3.4. Fu Modified Nonezymatic Acylation: dynamic 
kinetic resolution of secondary alcohols via combination of 
planar-chiral DMAP derivative (acylation catalyst) and Ru 
complex (racemization catalyst). R1= aryl, R2= alkyl.
1.5 equiv
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variety of aryl alkyl carbinols were tolerated in this process, resulting in high yields (89-
99%) and moderate enantioselectivities (i.e. 82-93% ee). One limitation that was found 
during the study was that if the alkyl group was branched the DKR was unsuccessful. The 
proposed mechanism can be seen in Scheme 3.5, where the suggested acyl transfer from 
the catalyst to the alcohol is the rate-determining step of the DKR.  
 
 Enzymatic resolution depends on a biochemical process to degrade or modify one 
of the two enantiomers of a racemic mixture, leaving one enantiomer untouched and 
isolable.33-39 Certain microorganisms such as baker’s yeast have been shown to 
selectively oxidize secondary alcohols.33-36 Also, various enzymes such as lipase from 
























Scheme 3.5. Outline of a proposed mechanism for the nonenzymatic 
dynamic kinetic resolution of 1-phenylethanol catalyzed by DMAP 
derivative and Ru complex. Acyl transfer from catalyst to alcohol is 
suspected to be the rate-determining step of the DKR.
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enzymatic acylation using isoprenyl acetate.37-39 The obvious drawback of using 
enzymatic resolution is the same as the limitation seen with kinetic resolution, one of the 
two enantiomers is going to be non-recoverable. 
Lastly, one of the more established methods, both in industry and research labs, is 
the formation and subsequent separation of diastereomers.40-45 Enantiomers are 
commonly converted into diastereomers via salt formation with a chiral acid or base. 
Diastereomers have different chemical and physical properties allowing them to be 
separated using common techniques such as crystallization or chromatography using a 
non-chiral stationary phase. Many commonly used drugs are resolved on an industrial 
scale using a diastereomeric crystallization approach.  Figure 3.5 shows a few examples. 
 
Their corresponding acid or base resolving agents and therapeutic class can be seen in 

































Pharmaceutical Agent Resolving Agent Therapeutic Class
!-Camphorsulphonic Acid Antibiotic
(+)-Phenylethyl Amine Calcium Antagonist
(–)-Cinchonidine Anti-Inflammatory
ʟ-Tartaric Acid Tuberculostatic
Table 3.2. Pharmaceutical agents and their corresponding acid or base resolving 
agents and therapeutic class.
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chiral reagent. Salt formation is typically preferred due to the recovery of enantiomers 
and the resolving agent being easier if no covalent bonds are formed.  
 Scheme 3.6, displays the typical protocol used to separate racemic alcohols using 
a diastereomeric crystallization approach.45 The racemic alcohol, 1-phenylethanol (III-9) 
in this example, is converted into a half-ester of a dicarboxylic acid (III-10) using its 
corresponding anyhydride, phthalic anhydride. This intermediate (III-10) can now serve 
as an acid and react with a chiral base, (−)-brucine, to form two diastereomers. These 
diastereomeric salts (III-11) have different properties and are typically separated via 
crystallization, exploiting their difference in solubility. The last step is a hydrolysis to 
recover the enantiopure original chiral substrate of interest. While this method is a viable  
 
technique, the major drawback is that it can be very difficult to identify the appropriate 
resolving agents and separation conditions for a given pair of enantiomers. Often, the 
separation by crystallization can take substantial trial and error experimentation, which 
can be expensive in time, labor, and materials. While there have been considerable efforts 
invested to create rational concepts for diastereomeric salt crystallization, the possibility 
of predicting ideal combinations of resolving agents and solvents for a given racemic 

































(R)-III-9Scheme 3.6. Resolution of 1-phenylethanol via diastereomeric crystallization. Protonated brucine counter ions in diastereomeric salts (III-11) are shown as generic ammonium salts for simplicity.
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As mentioned previously, techniques that have the ability to separate enantiomers 
are of high interest and can make a significant impact on a variety of fields in organic 
chemistry. The above examples of HPLC, KR, DKR, and the formation/separation of 
diastereomers all add to the important toolbox of resolution methods for chiral organic 
compounds. However, there is still a demand for a separation technique that allows for 
the resolution of a wide suite of racemic compounds without the need for excessive time 
and money spent on identifying conditions for individual substrates. Our hope is that by 
exploiting the unique and stable hydrogen bonding network formed in the organosulfate 
guanidinium salts, described in Chapter Two of this thesis, we can address this issue and 
allow for simple and common conditions to be used in the resolution of a broad range of 
chiral organic compounds.  
 
3.3 INITIAL ENANTIOMERIC SEPARATION EFFORTS: FLAT 
GUANIDINIUM CHLORIDE 
 
The methodology for the separation of racemic alcohols began with the same 
optimized sulfation reaction used in the enantiomer identification process46 described in 
Chapter Two. Initially, we sought the spontaneous resolution of racemic organic 
compounds via sulfation of the racemic alcohol and crystallization with the flat 
guanidinium chloride (Scheme 3.7). It is known that racemic mixtures will occasionally 
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spontaneously resolve by crystallizing in chiral space groups forming conglomerates.47-49 
However, we hoped that the novel guanidinium sulfate hydrogen bonding network would 
increase the chances of this spontaneous resolution event. This process was attempted on 
the four different racemic alcohols shown in Scheme 3.8. Unfortunately, all of these 
substrates crystallized in centrosymmetric, achiral space groups indicating that each unit 
R1 R3R2
Sulfation
X = Suitable Functional































Scheme 3.7. Proposed resolution of organic compounds equipped with a functional group 











Scheme 3.8. Guanidnium sulfation crystallization of racemic aromatic alcohols. All four crystallized in a 
centrosymmetric, achiral space group. III-12 and III-13 were both Pca21 while III-14 and III-15 were both 
P21/n. !
!



































cell contained both enantiomers of the racemic mixture. Thus, for these examples the 
resolution was unsuccessful.  
Next, we aimed to resolve the racemic alcohols via the selective ripening of 
enantiopure guanidinium sulfate seed crystals. Scheme 3.9 shows how this seeded 
guanidinium sulfation crystallization resolution was envisioned to occur. The resolution 
would begin with the sulfation of the racemic mixture, here 1-phenylethanol, using the 
established sulfation conditions. The sulfated racemic mixture would then be subjected to 
guanidinium chloride to produce the racemic growth fluid. Enantiopure guanidinium 
 
sulfate seed crystals would be grown straightforwardly and prior to the resolution. These 
enantiopure seeds can then be simultaneously ripened in the racemic growth fluid and 
induce the resolution of the racemic growth fluid by means of balanced crystal growth on 
the two enantiopure seeds. Upon resolution of the enantiomers, the resulting enlarged 
enantiopure organosulfate seeds can then be hydrolyzed to the now resolved original 
substrate of interest with complete stereochemical fidelity. Experimentally, the proposed 
resolution (Figure 3.6) closely resembles a simplified approach of the Holden crystal 
growth apparatus. In 1949, Holden patented this innovative approach to grow large 
piezoelectric ammonium dihydrogen phosphate crystals from a nutrient-rich solution.50
Scheme 3.9. Proposed resolution of 1-phenylethanol via seeded guanidinium 
sulfation crystallization. (R)- and (S)-organosulfate guanidinium seeds were 





























This invention was aimed to prevent the formation of extraneous seeds within the 
solution in order to improve the desired growth exclusively on the seed. The seeded 
resolution was attempted on two different racemic alcohols: 1-phenylethanol and 
menthol. As stated above, the enantiopure organosulfate guanidinium seeds of both 




































Scheme 3.10. Synthesis of enantiopure organosulfate guanidinium seeds. Starting material was (S)-1
-phenylethanol (top) and !-menthol (bottom). While only one enantiomer for each racemic mixture is 
shown above, both enantiomers were synthesized for resolution experiments.
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resolved enantiomers for both alcohols were sulfated, subjected to guanidinium chloride, 
and methanol was used to solubilize the components of the mixture (Scheme 3.10). Slow 
evaporation of this solution produced single crystals that were then re-suspended in an 
enantiopure growth fluid for ripening. An example of the ripening of the (R) and (S) 
enantiomers of 1-phenylethanol can be seen in Figure 3.7.  
 
The original seeds derived from the (L) and (D) enantiomers of menthol were sufficient in 
size that ripening was not required to obtain seeds large enough (Figure 3.8) for the 
resolution experiments. However, one can see the ripening of an (L)-seed for proof of 
concept in Figure 3.8. Successful ripening of the enantiopure seeds occurred in both 
systems resulting in the expansion of the seed via high quality crystal growth producing a 



























Figure 3.7. Ripening of the (R)- and (S)-enantiomers of the organosulfate guanidinium salt 
derived from 1-phenylethanol. Seeds on the left were the original crystals produced from the 
one-pot, two-step guanidinium sulfation crystallization process. Seeds on the right were 
produced via ripening of original seeds.
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sufficiently large to allow for manual manipulation.  Thus, they were tied to a silver wire 
and suspended in the racemic solutions. Larger seeds are easier to handle and provide 
more surface area for growth to occur when placed in the racemic growth fluid. Also, if 
the racemic growth fluid is not completely saturated, then a larger, more robust crystal 
will have a better chance of surviving and not being fully dissolved. Ripening can also 
cover or encapsulate any defects that the original seed might have. Likewise, ripening can 














Figure 3.8. Ripening of the (!)-enantiomer of the organosulfate guanidinium salt derived from 
!-menthol. The large seeds on the left were the original crystals produced from the one-pot, 
two-step guanidinium sulfation crystallization process. While these are sufficient in size for the 










Figure 3.9. High quality ripened seeds of the (R)- and (S)-enantiomers of the organosulfate 
guanidinium salt derived from 1-phenylethanol (right and left, respectively) produced from the 
developed ripening process.
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highest quality seed crystals for 1-phenylethanol, the system that required ripening, can 
be seen in Figure 3.9. 
The ripened enantiopure seeds for both 1-phenyethanol and menthol were then 
used in an attempted guanidinium sulfation crystallization separation of their respective 
racemic mixtures. A variety of separation conditions and changes to the apparatus were 
attempted for both systems. Different changes included the degree of saturation of the 
growth fluid, evaporation rate, temperature, size of glassware, agitation, and how the 
seeds were suspended. The degree of saturation was changed through the use of different 
amounts of the organosulfate guanidinium salt while also varying the types, ratios, and 












Figure 3.10. Seeded guanidinium sulfation crystallization resolution of 1-phenylethanol. The 
ripened seeds of the (S)- and (R)-enantiomers of the organosulfate guanidinium salt were 
suspended in the racemic growth fluid (GF).
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amounts of holes through the lid of container and changing the flow rate of nitrogen into 
the system. Other variations included the size of the container, stirring the solution, 
rotating the seeds, and the temperature (room temperature vs 5 ˚C). The optimal 
resolution experiments for 1-phenylethanol and menthol are shown in Figure 3.10/3.11 
and 3.12, respectively. After the separation experiment, the enantiopurity of the crystal 
growth from the racemic growth fluids was then analyzed using two different methods. 
First, parts of the seeds that resulted from crystallization in the growth fluid were chipped 
off and subjected to a X-ray diffraction experiment. In addition, the entire seed after 
crystallization in the racemic growth fluid was hydrolyzed using our stereoselective 
































Figure 3.11. Seeded guanidinium sulfation crystallization resolution of 1-phenylethanol. 
This resolution used un-ripened seeds of the (S)- and (R)-enantiomers of the 
organosulfate guanidinium salt which were suspended in the racemic growth fluid (GF).
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stationary phase chromatography (HPLC or GC). Regrettably, both methods proved that 
the growth from the racemic mixture for each system (1-phenylethanol and menthol) was 
not enantiopure. The crystal structure for the growth revealed that the newly formed 
crystal portion was the racemic mixture of the organosulfate guanidinium salt. While the 
chiral HPLC showed diminished enantiopurity (5% – 37% ee) of the resulting alcohol 
from the 100% ee seed crystals that were suspended in the racemic growth fluid, 
confirming that both enantiomers of organosulfate guanidinium were crystallizing on 
each individual seed. The calculated percent enantiomeric excess varied depending on the 
ratio of the weight of initial enantiopure seed relative to the amount of growth that 
occurred in the experiment. 
In conclusion, the aspired preferential enantioselective crystal growth from the 















Figure 3.12. Seeded guanidinium sulfation crystallization resolution of menthol. The 
ripened seeds of the (!)- and (")-enantiomers of the organosulfate guanidinium salt were 










resolution of both enantiomers of the racemic alcohol was unsuccessful. Although these 
efforts did not afford the desired results, they did reveal important information that 
guided future experiments. The most useful outcome of these initial experiments was 
understanding the parameters necessary to promote the growth of large, high quality 
crystals of the guanidinium sulfate salts in a very well controlled manner.  In addition, we 
established a reliable working protocol to analyze new crystal growth on seeds after 
separation experiments. Lastly, while the exact reasoning of why the crystal growth was 
not enantioselective is unknown, it is clear that the flat guanidinium will not afford the 
resolution of racemic mixtures and a chiral guanidinium is required.  
 
3.4 DIASTEREOMERIC RESOLUTION: CHIRAL GUANIDNIUM 
BROMIDE 
 
After the initial efforts of enantiomeric separation, we turned our focus toward the 
development of a diastereomeric resolution of racemic alcohols while still utilizing the 
established guanidinium sulfation crystallization methodology. The formation of 
diastereomers with the sulfated alcohol requires the use of a chiral guanidinium 
counterion. A literature search for chiral compounds containing a guanidinium motif 
revealed three potential candidates, compounds III-19 to III-21. Scheme 3.11, shows the 
synthesis of all three compounds where products III-19 and III-20 use one equivalent of 
diamine nucleophile and product III-21 uses two equivalents of monoamine nucleophile. 
All three chiral guanidiniums were accessed in moderate to good yields via refluxing a 
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solution of cyanogen bromide in acetonitrile. Two of the three products were solids, and 





























Scheme 3.11. Synthesis of chiral guanidinium bromides. Products III-19 and III-20 used 1.0 
equivalence of the corresponding diamine starting material. Product III-21 used 2.0 



























Figure 3.13. Crystal structures for the two solid guanidinium bromides (III-19 and 
III-20) obtained from single crystal X-ray diffraction.
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Both formed high quality single crystals (Figure 3.13) and further studies determined that 
the diphenyl guanidinium bromide (III-19) was the best candidate for the diastereomeric 
resolving agent. The synthesis for the resolving agent is user friendly, reliable, high 


























Scheme 3.12. Synthesis of both enantiomers of the diphenyl 
guanidinium bromide resolving agent.
!
!
Figure 3.14. Vials showing the various stages of the work-up protocol for the 
diphenyl guanidinium bromide, III-19. From left to right: crude oil product, 
impurity washed away, pure solid product, crystalline form of product.
114 
multi-gram scale. Additionally, we were able to develop a simple work-up protocol that  
generates the pure solid product from the crude reaction mixture. After the 24 h reflux, 
the reaction mixture is directly concentrated in vacuo. The crude oil can then be re-
dissolved in dichloromethane and upon addition of ethyl acetate and hexanes the pure 
solid is precipitated. Furthermore, the solid can be easily recrystallized to generate high 
quality crystals (Figure 3.14). Figure 3.15 shows a powder diffraction experiment 
comparing the precipitated solid and the single crystal. The matching patterns are 
identical, indicating that the two samples have similar purity and the solid can be used in 
diastereomeric resolution experiments.  
3.5 DIASTEREOMERIC RESOLUTION: SUBSTRATE SCOPE 
 
 Now, having the enantiopure diphenyl guanidinium resolving agent in hand, it 
was tested in the diastereomeric resolution of several racemic alcohols. The optimized 




















Figure 3.15. Picture on the left shows a large batch of high quality crystal of the diphenyl 
guanidinium bromide, (R,R)-III-19. Graph on the right is a powder diffraction experiment 
comparing the pure solid (experimental) and crystal form (calculated) of (R,R)-III-19.
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guanidinium bromide (III-19) was added to the sulfate pyridinium complex. Again, the 
crystallization of the organosulfate guanidinium salts occurred with ease. The high 
quality, large single crystals were then used in an X-ray diffraction experiment. Once the 
crystal structure was solved, analysis of one individual unit cell can determine the ratio of 
(R)- and (S)-enantiomer of the sulfated alcohol that is present in the single crystal. 
Ideally, only one enantiomer of the sulfated alcohol will crystallize and be present in the 
unit cell suggesting that the diastereomeric resolution was successful. In Scheme 3.13, 
one can see the crystallization of six different racemic alcohols with the diphenyl 
guanidinium bromide. Three of the six showed complete selectivity on the unit cell level, 
meaning only one enantiomer of the sulfated alcohol was present in the unit cell with the 
diphenyl guanidinium. While it is still unclear why the three substrates (III-24, III-25, 






























Unit Cell 50:50 80:20 100:0 100:0 75:25 100:0
III-22 III-23 III-24 III-25 III-26 III-27*
Scheme 3.13. Screening of racemic alcohols in the diastereomeric crystallization via chiral guanidinium sulfation. 
Separation scheme (top) showing a general resolution using the two enantiomers of the diphenyl guanidinium bromide. 
Reported ratios represent the percentage of the (R) and (S) enantiomers of the sulfated alcohol in the unit cell of the single 
crystal produced in the two-step process. *Chiral center is benzylic carbon.
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crystallize more racemic alcohols and collect more data points a trend will emerge. One 
thing to note is that several different crystallization conditions were used and all resulted 
in crystals with relatively the same ratio of enantiomers. Furthermore, all three substrates 
that showed selectivity in the crystallization used the exact same crystallization 
conditions: solvent diffusion where iso-propyl alcohol was the polar solvent and pentanes 
were the non-polar solvent.   
 The racemic alcohols that exhibited selectivity on the unit cell level were then 
carried through the entire diastereomeric resolution process. Thus, instead of using a 
single crystal in the X-ray diffraction experiment, the entire batch of crystals were 
harvested and hydrolyzed to afford the desired alcohol. The enantiopurity of the resulting 
alcohol was then analyzed via chiral stationary phase chromatography. The first system 
investigated was the racemic alcohol, 3-butyne-2-ol, shown in Scheme 3.14. If we 
sulfated 3-butyne-2-ol and added the (R,R)-guanidinium bromide, then only the (R)-
enantiomer of the sulfated alcohol was crystallized (Figure 3.16). The opposite was true 
if the (S,S)-guanidinium bromide was added to the racemic sulfated pyridinium complex, 
 
OH 1.) SO3•Pyr (1.3 equiv)




















Scheme 3.14. Diastereomeric resolution of 3-butyne-2-ol via chiral guanidinium sulfation crystallization.
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then only the (S)-enantiomer was crystallized. After crystallization, the crystals were 
collected, hydrolyzed, and analyzed for conversion and enantiopurity. To be able to 
determine the percent enantiomeric excess of the hydrolyzed alcohol, the racemic mixture 
of 3-butyne-2-ol needed to be resolved on a chiral column. For this system, chiral 
stationary phase gas chromatography (GC) was used and resolution was achieved after 
acylation of the racemic alcohol (Scheme 3.15 A). Control reactions were conducted to 
ensure that the % ee calculated on the final chromatogram was a true representation of 
the enantiopurity of the collected crystals. In other words, it was necessary to 
demonstrate that the two subsequent steps of the process (i.e. hydrolysis and acylation) 
did not erode the enantiopurity of the sample. Thus, a commercial sample of (S)-3-
butyne-2-ol was acylated and determined to have an enantiopurity of 93% ee by means of 
chiral stationary phase GC analysis (Scheme 3.15 B) . The residual amount of the minor 
(R)-enantiomer was arose from the commercial source, not racemization of the sample. 
Next, the diastereomeric resolution process was conducted using the commercial (S)-3-















Figure 3.16. Thermal ellipsoid plot (left) and packing diagram (right) of the (R)-(R,R) 
organosulfate diphenyl guanidinium (III-24) derived from the racemic 3-butyne-2-ol.
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the (S)- (S,S)-dyad, allowing us to evaluate the degree to which racemization might occur 
during the course of the sulfate hydrolysis reaction. Once the crystals were harvested, the 
same optimized hydrolysis conditions from the enantiomeric identification methodology 
were employed. The resulting product was first analyzed via 1H NMR, which confirmed 
100% conversion of the organosulfate to the hydrolyzed alcohol. Next, the hydrolyzed 
alcohol was acylated and assessed by GC analysis.  This operation resulted in a sample of 
the chiral alcohol with 100% ee, indicating that the hydrolysis of the organosulfate 
crystals proceeds without erosion of enantiopurity,  and the diastereomeric crystallization 
event actually enriched the enantiopurity of the commercial source (Scheme 3.15 C). 
Lastly, the most important experiment was completed which was the diastereomeric 












































Scheme 3.15. (A) Acylation of racemic 3-butyne-2-ol with corresponding retention times for each enantiomer. 
(B) Acylation of (S)-3-butyne-2-ol showing commercial source has an enantiopurity of 93% ee. (C) 
Diastereomeric resolution using (S)-3-butyne-2-ol as the starting material to ensure hydrolysis of the 
organosulfate guanidinium salt is 100% enantioselective. (D) Diastereomeric resolution of racemic 3-butyne-2-
ol. Guanidinium sulfation crystallization yielded 68% of targeted organosulfate guanidinium crystals and 
hydrolysis of those crystals produced (S)-3-butyne-2-ol in 100% ee. % ee determined via chiral GC.
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butyne-2-ol and (S,S)-guanidinium bromide yielded roughly 70% of the targeted crystals. 
After hydrolysis and acylation, the chiral GC showed no detectable (R)-enantiomer, 
revealing a sample of the desired (S)-enantiomer in 100% ee (Scheme 3.15 D). Therefore, 
the diastereomeric crystallization was successful and the process is able to isolate one 
enantiomer selectively from the racemic mixture. The entire method is stereoselective 
and control of which enantiomer is generated is easily manipulated by the addition of the 
appropriate chiral guanidinium bromide. 
2-Phenyl-1-propanol was the next racemic alcohol that was employed under the 
diastereomeric resolution process. Similar to the last sample, if the (R,R)-guanidinium 
bromide is added to the sulfate pyridinium complex then the (R)-enantiomer crystallizes 
from the racemic mixture (Scheme 3.16). Again, the (S)-enantiomer of the 
 
racemic mixture will form if the (S,S)-guanidinium bromide is added (Figure 3.17). 
Chiral stationary phase high performance liquid chromatography (HPLC) was used to 
analyze the enantiopurity of the alcohol, taking advantage of the photoactive aromatic 
ring. Acylation was still required to afford good resolution of the racemic alcohol, 2-
phenyl-1-propanol (Scheme 3.17 A). While the acylation and hydrolysis were proven to 
be enantioselective in the last system, racemization was not a concern for this sample due 
1.) SO3•Pyr 
(1.3 equiv)























Scheme 3.16. Diastereomeric resolution of 2-phenyl-1-propanol via chiral guanidinium sulfation crystallization.
120 
to the derivatization site not being at the chiral center. Sulfation of the racemic mixture, 
2-phenyl-1-propanol, and addition of (S,S)-guanidinium bromide resulted in 73% of the 
targeted crystals. The crystals were hydrolyzed, acylated, and analyzed on the chiral 
HPLC which showed a 96% ee (Scheme 3.17 B). Thus, another successful diastereomeric 
resolution was realized, understanding that the chiral HPLC has an experimenta. error of 















Figure 3.17. Thermal ellipsoid plot (left) and packing diagram (right) of the 


























Scheme 3.17. (A) Acylation of racemic 2-phenyl-1-propanol with corresponding retention times for each enantiomer. (B) 
Diastereomeric resolution of racemic 2-phenyl-1-propanol. Guanidinium sulfation crystallization yielded 73% of targeted 
organosulfate guanidinium crystals and hydrolysis of those crystals produced (S)-2-phenyl-1-propanol in 96% ee. % ee 
determined via chiral HPLC with an error of plus/minus 4% ee.
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The last system studied under the diastereomeric resolution process was 4-phenyl-
3-butyne-2-ol.   This substrate was synthesized by means of an acetylide alkylation of 
acetaldehyde (Scheme 3.18). This sample was unique in the fact that if the (R,R)-  
 
enantiomer of the guanidinium bromide was added, the (S)-enantiomer of sulfated 
alcohol was crystallized and vice versa (Scheme 3.19).  This was the first “mis-matched” 
 
organosulfate guanidinium system seen in our studies. The racemic mixture of the 
synthesized alcohol separates directly by chiral stationary phase HPLC without the need 
of derivatization. After analyzing the enantiopurity of several batches of organosulfate 
guanidinium crystals that were isolated in 60–70% of the theoretical yield, it appeared 
there was barrier of around 60% ee of the hydrolyzed alcohol.  After recrystallization of 
H
O
1.) n-BuLi (1.6 M in THF)
OH
–78 °C, THF, 1 h
2.)
75%
Scheme 3.18. Synthesis of 4-phenyl-3-butyne-2-ol.
1.) SO3•Pyr 
(1.3 equiv)
2.)  (R,R)-III-19 
(1.0 equiv)




















Scheme 3.19. Diastereomeric resolution of 4-phenyl-3-butyne-2-ol via chiral guanidinium sulfation crystallization.
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the original 60% ee batch of crystals, the enantiopurity increased to 90% ee (Scheme 
3.20). Although it was disappointing that 4-phenyl-3-butyne-2-ol was the only system  
that did not display the same selectivity on a batch scale that was seen on the unit cell 
level, it did reveal that recrystallization is a viable option to increase the enantiopurity of 
organosulfate guanidinium crystals. 
 















Ret. Time (min): 
11.9, 13.5
Scheme 3.20. Diastereomeric resolution of racemic 4-phenyl-3-butyne-2-ol. Guanidinium sulfation crystallization yielded 
63% of targeted organosulfate guanidinium crystals and hydrolysis of recrystallized crystals produced (S)-4-phenyl-3-
butyne-2-ol in 90% ee. % ee determined via chiral HPLC with an error of plus/minus 4% ee. *After one recrystallization of 
















Figure 3.18. Thermal ellipsoid plot (left) and packing diagram (right) of the 
(S)-(R,R) organosulfate diphenyl guanidinium (III-25) derived from the 
racemic 4-phenyl-3-butyne-2-ol.
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 In conclusion, a novel chiral guanidinium bromide resolving agent was 
synthesized and used in the diastereomeric resolution of three racemic alcohols. One of 
the biggest advantages of the developed technique is that all three resolutions used the 
exact same sulfation and crystallization conditions to generate the enantiopure 
organosulfate guanidinium crystals. The entire process is operationally simple and 
relatively inexpensive including the synthesis of the guanidinium bromide, the optimized 
sulfation reaction, the crystallization, and the stereoselective hydrolysis. Although all six 
racemic alcohols investigated in the process were not selective in the diastereomeric 
crystallization, they all contained the critical hydrogen bonding network between the 
sulfate and guanidinium moieties.  
 While this methodology has shown the potential to be a viable resolution 
technique for racemic alcohols, it still has a tremendous amount of work and questions 
that need to be addressed. Currently, a screening of a wide variety of racemic alcohols is 
being completed to determine which substrates will be selective in the diastereomeric 
resolution process. Additionally, optimization of the various steps in the process is on-
going. This includes finding ways to improve the yield of the crystallization without 
decreasing the enantiopurity of the crystals, as well as a method to easily separate the 
resolved alcohol from the guanidinium counterion. Recycling of the guanidinium 
resolving agent is also being investigated since it remains intact through the 
crystallization and hydrolysis steps.     
 Finally, a seeded resolution experiment will be investigated for absolute 
resolution of both the racemic alcohol and the guanidinium bromide (Figure 3.19). For 
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example, a seed of the (R)-(R,R) and (S)-(S,S) organosulfate guanidinium salt would be 
suspended in a racemic growth fluid that contains both the sulfated alcohol and the 
guanidinium bromide. Thus, resolution of both the alcohol and the guanidinium would 
occur in this proposed method. There are some major advantages of the envisioned 
separation specifically when thinking about performing it on an industrial scale. The most 
obvious of these is that it would allow for direct access to both enantiomers of the 
sulfated alcohol, which was not possible in the first generation diastereomeric resolution 
described above. In theory, the growth that occurs on the enantiopure seed should be 
100% selective. In this case, at the end of the separation one should be harvesting a 
relatively large block of enantiopure crystals in a short amount of time. The entire 
process should be fairly easy to handle and scale-up, while also not requiring expensive 
reagents or instruments. The method should also prove to be efficient, as the racemic 
growth fluid slowly evaporates it can also be replenished allowing for an easy way to  
control the size of the enantiopure crystal. Additionally, the racemic growth fluid can also 
be recycled permitting a single growth fluid solution to be used for a number of 
!
!
Figure 3.19. Proposed seeded guanidinium sulfation crystallization resolution experiment of both the 












enantiopure seeds. The simplicity and selectivity of the proposed method would 
undoubtedly provide several benefits compared to some of the herculean efforts seen 

















3.7  EXPERIMENTAL  
 
3.7.1  GENERAL INFORMATION 
 
All reagents and chemicals were obtained from commercial sources and used 
without further purification unless stated otherwise. Dichloromethane (DCM) was dried by 
refluxing over phosphorous pentoxide (P2O5) and was distilled under nitrogen prior to use. 
1H and 13C NMR spectra were recorded at ambient temperature on a 300 MHz NMR 
spectrometer (Bruker). Proton and carbon chemical shifts were reported in parts per million 
(ppm) downfield from tetramethylsilane (TMS). Spectra were referenced to the deuterated 
solvent as the internal standard (i.e., δ 2.50 ppm for 1H NMR, 39.51 ppm for 13C NMR in 
DMSO-d6). Data are presented as follows: chemical shift, integration, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), and coupling 
constants (J, in hertz).  
 
3.7.2  GENERAL PROCEDURE FOR X-RAY DIFFRACTION 
 
Structural data of the flat guanidinium organosulfate salts (III-12 to III-16, and 
III-18), guanidinium bromides (III-19 and III-20), and chiral guanidinium organosulfate 
salts (III-22 to III-27) were obtained by single crystal X-ray diffraction.  Diffraction data 
were collected under a cold nitrogen stream using a Bruker D8 Venture diffractometer 
equipped with Mo Kα radiation (λ = 0.07107 Å) from an Incoatec IµS source and a 
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Photon 100 detector.  Instrument control, data processing (SAINT), and data scaling 
(SADABS, spherical multi-scan absorption correction) were performed using the Bruker 
Apex3 software package.55 Space group determinations were made based on the 
systematic absences, and the structures were solved by intrinsic phasing, then refined on 
F2 using full matrix least squares techniques with the SHELXTL software suite.56  All 
non-hydrogen atoms were refined anisotropically.  All structures were determined in 
chiral space groups, having absolute structure parameters (Flack) of zero within three 
times the standard uncertainty, indicating the proper absolute structure model.  A 
summary of the crystallographic data and structure refinements is given in Tables 3.3-
3.6.  The molecular structures of the salts III-12 to III-16, III-18 to III-20, and III-22 to 
III-27, as well as selected projections of the molecular packing are shown in Figures 
3.20-3.33.  
 
3.7.3  GENERAL PROCEDURE FOR SULFATION  
 
To a flame-dried 10 mL round bottom equipped with a stir bar was added 
technical grade (≥45% SO3 basis) sulfur trioxide/pyridine complex (1.3 mmol, 0.207 
grams, 1.3 equiv) and anhydrous DCM (5 mL). The suspension was stirred under N2 and 
the substrate was added dropwise (1 mmol, 1 equiv). The resulting solution was stirred 
for 24 h, and after completion the unreacted SO3·Pyr was filtered off. The filtrate was 
then either concentrated in vacuo or used directly in the subsequent guanidinium 
crystallization. 
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3.7.4  GENERAL PROCEDURE FOR GUANIDINIUM CRYSTALLIZATION  
 
Flat guanidinium organosulfate salts (III-12 to III-16, and III-18): To the sulfate 
pyridinium complex, guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 equiv) is added. 
Methanol was then added dropwise until the solution becomes homogenous.  Slow 
evaporation of the homogenous solution resulted in single crystals which were used in an 
X-ray diffraction experiment. 
 
3.7.5 GENERAL PROCEDURE FOR THE SYNTHESIS OF CHIRAL 
GUANIDINIUM BROMIDE REAGENTS  
 
Chiral guanidinium bromides III-19 and III-20: To a flame dried 50 mL round 
bottom equipped with a stir bar was added diamine nucleophile (5.0 mmol, 1.0 equiv) 
and anhydrous acetonitrile (25 mL). The suspension was stirred under N2 and cooled to 0 
°C. A 5 M solution of cyanogen bromide in acetonitrile was added dropwise (5 mmol, 1 
mL, 1 equiv). The resulting solution was refluxed for 24 h, and after completion the 
reaction mixture was filtered and concentrated in vacuo. The resulting  oil was re-
dissolved in DCM and upon addition of ethyl acetate and hexanes a pure solid was 
precipitated.  
Chiral guanidinium bromide III-21: To a flame dried 50 mL round bottom 
equipped with a stir bar was added 1-phenylethyl amine (5.0 mmol, 2.0 equiv) and 
anhydrous acetonitrile (25 mL). The suspension was stirred under N2 and cooled to 0 °C.  
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A 5 M solution of cyanogen bromide in acetonitrile was added dropwise (2.5 mmol, 0.5 
mL, 1 equiv). The resulting solution was refluxed for 24 h, and after completion the 
reaction mixture was filtered and concentrated in vacuo.   
 
3.7.6 GENERAL PROCEDURE FOR CHIRAL GUANIDINIUM 
CRYSTALLIZATION  
 
Chiral guanidinium organosulfate salts (III-22 to III-27): To the concentrated 
sulfate pyridinium complex, diphenyl guanidinium bromide (R,R)-III-19 or (S,S)-III-19 
(1.0 mmol, 0.318 grams, 1.0 equiv) was added. Iso-propyl alcohol (IPA) was then added 
dropwise until the solution became homogenous.  Pentanes were layered on top of the IPA 
layer and solvent diffusion resulted in the formation of single crystals which were used in 
an X-ray diffraction experiment.  
 
3.7.7 GENERAL PROCEDURE FOR HYDROLYSIS OF SULFATE 
GUANIDINIUM  
 
To a suspension of sulfate guanidinium crystals in tetrahydrofuran (THF), 
deionized water was added dropwise until the solution became homogenous. The solution 
was then refluxed for 12 h. After completion, the THF layer was separated in a separatory 
funnel. The aqueous layer was extracted with diethyl ether (3 x 25 mL). The combined 
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organic phases were washed with brine and dried over anhydrous sodium sulfate. The 
drying agent was filtered off and the filtrate was concentrated in vacuo.  
 
3.7.8 GENERAL PROCEDURE FOR PROPARGYLIC ALCOHOL 
SYNTHESIS  
 
In a flame-dried 100 mL round bottom flask was added a stir bar and a solution of 
the terminal alkyne (1 equiv) in THF (10 mL for 1 mmol of alkyne) under an argon 
atmosphere.  The solution was cooled to –78 ˚C. A solution of n-BuLi (1.1 equiv, 1.6 M 
in hexane) was added. The reaction solution was stirred for 30 min, and 1 equiv of the 
terminal aldehyde was then added drop-wise. The resulting mixture was stirred for 1 h at 
–78 ˚C and allowed to gradually warm to –25 ˚C. After 24 h, the reaction mixture was 
quenched with saturated aqueous NH4Cl (5 mL for 1 mmol of alkyne). The reaction 
mixture was then poured into a separatory funnel, and the aqueous layer was extracted 
with diethyl ether (3 x 5 mL for 1 mmol of alkyne). The combined ether extracts were 
washed with saturated aqueous brine (5 mL for 1 mmol of alkyne). The organic layer was 
then dried over Na2SO4, decanted, and the solvent was evaporated by rotary evaporation. 
The crude residue was then purified by flash chromatography (silica gel, hexane) to 





3.7.9  CRYSTALLOGRAPHIC DATA FOR GUANIDINIUM SULFATES 
 
 
 III-12 III-13 III-14 III-15 
empirical formula C9H15N3O4S C10H17N3O4S C11H19N3O4S C10H14F3N3O4S 
formula weight (g/mol) 261.30 275.32 289.35 329.30 
crystal system orthorhombic monoclinic monoclinic monoclinic 
space group, Z Pca21, 4 Pca21, 4 P21/n, 4 P21/n, 4 
temperature (K) 100 100 100 100 
crystal size (mm) 0.03 x 0.14 x 0.16 0.02 x 0.17 x 0.2 0.03 x 0.09 x 0.2 0.02 x 0.03 x 0.4 
a, Å 13.0722(17)  13.420(2)  7.4359(10)  7.3666(7)  
b, Å 7.6053(11)  7.7329(12)  15.647(2)  11.9807(11) 
c, Å 12.359(2)  12.7633(17)  12.6290(18)  17.1028(16)  
α,° 90 90 90 90 
β, ° 90 90 90.484(5) 112.738(3) 
γ, ° 90 90 90 90 
volume (Å3) 1228.7(3) 1324.5(4) 1469.3(3) 1392.1(2) 
Dcalc (g/cm
3) 1.412 1.381 1.308 1.571 
abs. coeff. (mm-1) 0.271 0.256 0.234 0.287 
F(000) 552 584 616 680 
Tmax, Tmin 1.0000, 0.9417 1.0000, 0.8552 1.0000, 0.9017 1.0000, 0.9054 
Θ range for data 2.68- 25.50 2.63-25.15 2.07-25.50 2.58-25.24 
reflections collected 12578 5306 21346 2584 
data/restraints/parameters 2258 / 1 / 155 2083 / 1 / 164 2718 / 0 / 174 2584 / 12 / 211 
R(int) 0.0504 0.0635 0.0461 0.0722 
final R [I> 2σ(I)] R1, wR2 0.0387, 0.0842 0.0698, 0.1372 0.0377, 0.0967 0.0550, 0.1221 
final R (all data) R1, wR2 0.0455, 0.0870 0.0914, 0.1461 0.0503, 0.01130 0.0658, 0.1309 
goodness-of-fit on F2 1.088 1.087 1.184 1.224 
flack parameter -0.0(0) 0.1(1) - - 
larg. diff. peak, hole, eÅ-3 0.569, -0.255 0.922, -0.458 0.286, -0.454 0.570, -0.584 
CCDC Deposition No. - - - - 
!




 III-16 III-18 III-19 III-20 
empirical formula C9H15N3O4S C11H25N3O4S C15H16BrN3 C7H14BrN3 
formula weight (g/mol) 261.30 295.40 318.22 220.12 
crystal system monoclinic orthorhombic orthorhombic orthorhombic 
space group, Z P21, 2 P212121, 4 P212121, 4 P212121, 4 
temperature (K) 100 140 100 150 
crystal size (mm) 0.26 x 0.17 x 0.09 0.30 x 0.13 x 0.07 0.12 x 0.14 x 0.2 0.04 x 0.06 x 0.2 
a, Å 7.6128(4) 7.4624(5) 9.1539(6)  8.2727(6)  
b, Å 12.0610(6) 12.4204(6) 10.0272(7)  9.7515(7)  
c, Å 7.7450(4) 17.0545(10) 15.6352(10)  11.5087(9)  
α,° 90 90 90 90 
β, ° 119.252(2) 90 90 90 
γ, ° 90 90 90 90 
volume (Å3) 620.45(6) 1580.71(16) 1435.12(17) 928.42(12) 
Dcalc (g/cm
3) 1.399 1.241 1.473 1.575 
abs. coeff. (mm-1) 0.269 0.218 2.854 4.372 
F(000) 276 640 648 448 
Tmax, Tmin 1.0000, 0.9531 1.0000, 0.9141 1.0000, 0.8609 1.0000, 0.8087 
Θ range for data 3.02-27.99 2.03-26.49 3.30-28.00 4.11 to 26.49 
reflections collected 14535 13107 22982 4325 
data/restraints/parameters 2977 / 1 / 155 3278 / 0 / 172 3432 / 0 / 188 1908 / 0 / 100 
R(int) 0.0359 0.0456 0.0284 0.0302 
final R [I> 2σ(I)] R1, wR2 0.0270, 0.0631 0.0358, 0.0884 0.0184, 0.0431 0.0335, 0.0573 
final R (all data) R1, wR2 0.0287, 0.0640 0.0437, 0.0954 0.0202, 0.0438 0.0427, 0.0598 
goodness-of-fit on F2 1.081 1.109 1.078 1.010 
flack parameter 0.02(2) 0.02(5) 0.022(3) 0.012(12) 
larg. diff. peak, hole, eÅ-3 0.182, -0.285 0.239, -0.465 0.244, -0.262 0.473, -0.396 
CCDC Deposition No. 1954250 1954253 - - 
!
Table 3.4. Crystallographic data for III-16, III-18 (flat guanidinium organosulfate salts) 
and III-19, III-20 (chiral guanidinium bromides).
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 III-22 III-23 III-24 III-25 
empirical formula C19H25N3O4S C19H23N3O4S C19H21N3O4S C25H25N3O4S 
formula weight (g/mol) 391.48 389.46 387.45 463.54 
crystal system triclinic orthorhombic orthorhombic hexagonal 
space group, Z P212121, 4 P212121, 4 P212121, 4 P61 
temperature (K) 100 100 100 100 
crystal size (mm) 0.10 x 0.18 x 0.23 0.09 x 0.09 x 0.10 0.21 x 0.22 x 0.28 0.11 x 0.29 x 0.55 
a, Å 8.3743(5)  8.1983(3)  8.0276(2)  20.6244(18)  
b, Å 11.4617(8)  11.7238(5)  12.4093(4)  20.6244(18)  
c, Å 20.5882(14)  20.2613(8)  19.5841(5)  10.4884(10)  
α,° 90 90 90 90 
β, ° 90 90 90 90 
γ, ° 90 90 90 120 
volume (Å3) 1976.1(2) 1947.42(13) 1950.91(9) 3863.7(8) 
Dcalc (g/cm
3) 1.316 1.328 1.319 1.195 
abs. coeff. (mm-1) 0.193 0.196 0.195 0.159 
F(000) 832 824 816 1464 
Tmax, Tmin 1.0000, 0.9282 1.0000, 0.9556 1.0000, 0.9214 0.9820, 0.9170 
Θ range for data 3.14-25.50 2.66-25.25 3.53-25.50 3.42-28.32 
reflections collected 28211 37530 25134 87835 
data/restraints/parameters 3664 / 6 / 272 507 / 0 / 245 3615 / 0 / 245 6376 / 1 / 315 
R(int) 0.0301 0.0504 0.0325 0.0373 
final R [I> 2σ(I)] R1, wR2 0.0392, 0.0981 0.0594, 0.1484 0.0387, 0.0963 0.0543, 0.1584 
final R (all data) R1, wR2 0.0431, 0.0996 0.0668, 0.1546 0.0398, 0.0874 0.0551, 0.1593 
goodness-of-fit on F2 1.153 1.061 1.065 1.078 
flack parameter 0.0(0) 0.2(2) 0.0(0) 0.009(12) 
larg. diff. peak, hole, eÅ-3 0.280, -0.242 0.695, -0.453 0.756, -0.293 1.111, -0.311 
CCDC Deposition No. - - - - 
!





 III-26 III-27 
empirical formula C29H33N3O4S C24H27N3O4S 
formula weight (g/mol) 519.64 453.54 
crystal system monoclinic orthorhombic 
space group, Z P21, 4 P212121, 4 
temperature (K) 100 100 
crystal size (mm) 0.04 x 0.19 x 0.28 0.07 x 0.08 x 0.17 
a, Å 11.2262(7)  9.3839(3)  
b, Å 10.0030(6)  12.0826(5)  
c, Å 13.1011(8)  20.3702(9)  
α,° 90° 90 
β, ° 106.248(2)° 90 
γ, ° 90° 90 
volume (Å3) 1412.44(15) 2309.61(16) 
Dcalc (g/cm
3) 1.222 1.304 
abs. coeff. (mm-1) 0.152 0.176 
F(000) 552 960 
Tmax, Tmin 0.9940, 0.9590 1.0000, 0.9201 
Θ range for data 3.47-25.49 2.75-25.50 
reflections collected 15311 11073 
data/restraints/parameters 5251 / 77 / 409 4252 / 7 / 306 
R(int) 0.0552 0.0610 
final R [I> 2σ(I)] R1, wR2 0.0528, 0.1246 0.0566, 0.1339 
final R (all data) R1, wR2 0.0647, 0.1320 0.0652, 0.1428 
goodness-of-fit on F2 1.034 1.076 
flack parameter 0.06(5) 0.01(7) 
larg. diff. peak, hole, eÅ-3 0.336, -0.458 1.032, -0.354 
CCDC Deposition No. - - 
!
Table 3.6. Crystallographic data for III-26 and II-27 (chiral guanidinium organosulfate salts).
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Figure 3.28. Molecular structure and packing in III-22.
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Figure 3.30. Molecular structure and packing in III-24.
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Figure 3.33. Molecular structure and packing in III-27.
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3.7.11 1H AND 13C NMR DATA FOR INTERMEDIATE SULFATE 
PYRIDINIUM COMPLEXES 
 
1-Phenylethanol, III-16:  
1H NMR (300 MHz, DMSO-d6) δ 14.46 (s, 1H), 8.86 (d, J= 5.3 Hz, 2H), 8.56 (t, J=3.9 
Hz, 1H), 8.02 (t, J= 7.1 Hz, 2H), 7.30 (d, J= 7.5 Hz, 2H), 7.41 (t, J= 7.4 Hz, 2H), 7.12 (t, 
J= 7.2 Hz, 1H), 5.35 (q, J= 6.5 Hz, 1H), 1.45 (d, J=6.6 Hz, 3H).13C NMR (75 MHz, 
DMSO-d6) δ 146.9 (2C), 143.6, 142.0 (2C), 128.2 (2C), 127.6, 127.2 (2C), 126.1, 74.5, 
23.5. 
L-Menthol, III-18:  
1H NMR (300 MHz, DMSO-d6) δ 15.36 (s, 1H), 8.96 (d, J= 5.4 Hz, 2H), 8.66 (t, J=7.6 
Hz, 1H), 8.12 (t, J= 7.1 Hz, 2H), 3.85 (sex, J=5.1 Hz, 1H), 2.30 (d, J= 12.1 Hz, 1H), 
2.15-2.03 (m, 1H), 1.50 (t, J= 5.8 Hz, 2H), 1.26 (s, 1H), 1.10-0.82 (m, 2H), 0.82-0.64 (m, 
11H).13C NMR (75 MHz, DMSO-d6) δ 146.7(2C), 142.1(2C), 127.4, 76.1, 47.7, 42.0, 
34.1, 31.0, 24.9, 23.0, 22.2, 20.1, 16.1.  
2-Butanol, III-22:  
1H NMR (300 MHz, DMSO-d6) δ 12.19 (s, 1H), 8.95 (d, J= 5.8 Hz, 2H), 8.67 (t, J= 7.8 
Hz, 1H), 8.13 (t, J= 6.9 Hz, 2H), 4.13 (sex, J= 6.2 Hz, 1H), 1.52-1.26 (m, 2H), 1.08 (d, 
J= 6.3 Hz, 3H), 0.72 (t, J= 7.5 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 147.0(2C), 
142.1(2C), 127.7, 74.4, 29.4, 20.3, 9.6.  
3-Butene-2-ol, III-23:  
 143 
1H NMR (300 MHz, DMSO-d6) δ 11.31 (s, 1H), 8.94 (d, J= 5.5 Hz, 2H), 8.66 (t, J= 7.8 
Hz, 1H), 8.12 (t, J= 7.0 Hz, 2H), 5.83 (sep, J= 5.5 Hz, 1H), 5.0 (dd, J=17.0 Hz, J= 14.0 
Hz, 2H), 4.68 (quint, J= 6.1 Hz, 1H), 1.18 (d, J= 6.5 Hz, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 147.1(2C), 142.5(2C), 140.8, 127.9, 114.2, 73.1, 21.2.  
3-Butyne-2-ol, III-24:  
1H NMR (300 MHz, DMSO-d6) δ 13.43 (s, 1H), 8.90 (d, J= 5.2 Hz, 2H), 8.64 (t, J=7.9 
Hz, 1H), 8.10 (t, J= 7.0 Hz, 2H), 4.82 (qd, J= 6.7 Hz, J=6.9 Hz, 1H), 3.26 (d, J=2.1 Hz, 
1H), 1.31 (d, J= 6.7 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 147.0(2C), 142.1(2C), 
127.7, 84.6, 75.1, 62.4, 23.0.  
4-Phenyl-3-Butyne-2-ol, III-25:  
1H NMR (300 MHz, DMSO-d6) δ 10.53 (s, 1H), 8.92 (d, J= 6.0 Hz, 2H), 8.62 (t, J= 8.0 
Hz, 1H), 8.09 (t, J= 7.2 Hz, 2H), 7.32 (s, 5H), 5.13 (q, J= 6.3 Hz, 1H), 1.48 (d, J= 6.7 Hz, 
3H) 13C NMR (75 MHz, DMSO-d6) δ 147.1(2C), 142.4(2C), 131.7, 129.1, 127.8, 122.4, 
90.8, 83.8, 84.6, 63.1, 23.3.  
8-Phenyl-7-Octyne-6-ol, III-26:  
1H NMR (300 MHz, DMSO-d6) δ 10.17 (s, 1H), 8.95 (d, J= 6.3 Hz, 2H), 8.64 (t, J= 7.9 
Hz, 1H), 8.1 (t, J= 6.7 Hz, 2H), 7.33 (s, 5H), 5.0 (t, J= 6.4 Hz, 1H), 1.86-1.65 (m, 2H), 
1.49-1.34 (m, 2H), 1.29-1.10 (m, 4H), 0.79 (t, J= 7.2 Hz, 3H).  13C NMR (75 MHz, 
DMSO-d6) δ 147.1(2C), 142.4(2C), 131.7, 129.0(2C), 128.9(2C), 127.8, 122.6, 89.9, 
84.5, 66.9, 36.1, 31.3, 24.6, 22.5, 14.3.   
2-Phenyl-1-Propanol, III-27:  
 144 
1H NMR (300 MHz, DMSO-d6) δ 11.63 (s, 1H), 8.93 (d, J= 6.3 Hz, 2H), 8.62 (t, J= 7.9 
Hz, 1H), 8.08 (t, J= 6.6 Hz, 2H), 7.29-7.12 (m, 5H), 3.84 (sextet, J= 7.4 Hz, 2H), 2.99 
(sextet, J= 7.0 Hz, 1H), 1.16 (d, J= 7.0 Hz, 3H).13C NMR (75 MHz, DMSO-d6) δ 
146.6(2C), 144.1, 142.1(2C), 128.2(2C), 127.4, 127.3(2C), 126.2, 70.9, 18.5. 
 
3.7.12 1H AND 13C NMR DATA FOR CHIRAL GUANIDINIUM BROMIDES 
 
III-19:  
1H NMR (300 MHz, CDCl3) δ 8.01 (s, 2H), 7.71 (s, 2H), 7.36-7.29 (m, 6H), 7.18-7.12 
(m, 4H), 4.67 (s, 2H). 13C NMR (75 MHz, CDCl3) δ 159.5(2C), 137.7(4C), 129.3(4C), 
129.10(2C), 126.3(2C), 67.9.  
III-20:  
1H NMR (300 MHz, DMSO-d6) δ 8.10 (d, J=6.4 Hz, 4H), 3.42 (s, 1H), 3.15-3.02 (m, 
2H), 2.01 (d, J=10.12 Hz, 2H), 1.70 (d, J=7.5 Hz, 2H), 1.44-1.19 (m, 4H).  13C NMR (75 
MHz, DMSO-d6) δ 162.2, 62.6 (2C), 28.9 (2C), 23.8 (2C).   
III-21:  
1H NMR (300 MHz, CDCl3) δ 8.30 (s, 2H), 7.54 (d, J= 1.8 Hz, 2H), 7.37-7.27 (m, 8H), 
4.56 (s, 1H), 4.52-4.36 (m, 1H), 1.99 (s, 1H), 1.70 (d, J= 6.9 Hz, 3H), 1.54 (d, J= 6.6 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 141.5, 137.2, 129.1 (2C), 128.9 (2C), 128.3 (2C), 
127.2 (2C), 126.2, 125.5, 55.5, 52.2, 23.5, 22.1, 20.42.  
3.7.13 1H AND 13C NMR DATA FOR PROPARGYLIC ALCOHOLS 
III-25:  
 145 
1H NMR (300 MHz, CDCl3) δ 7.50- 7.41 (m, 2H), 7.36- 7.26 (m, 3H), 4.79 (q, J= 6.58 
Hz, 1H), 2.89 (s, 1H), 1.58 (d, J= 6.63 Hz, 3H). 13C NMR  (75 MHz, CDCl3) δ 131.7, 
128.4(2C), 128.3(2C), 122.7, 91.1, 83.9, 58.7, 24.4.   
III-26:  
1H NMR (300 MHz, CDCl3) δ 7.50- 7.41 (m, 2H), 7.36- 7.26 (m, 3H), 4.62 (t, J= 6.80 
Hz, 1H), 2.72- 2.52 (m, 1H), 1.88-1.72 (m, 2H), 1.62- 1.48 (m, 2H), 1.43- 1.30 (m, 4H), 
0.93 (t, J= 6.27 Hz, 3H).  13C NMR  (75 MHz, CDCl3) δ 131.7, 128.3(2C), 128.2(2C), 
122.7, 90.3, 84.9, 63.0, 37.9, 31.5, 25.0, 22.6, 14.0.  
 
3.7.14  1H NMR AND 13C NMR SPECTRA FOR SULFATE PYRIDINIUM 
COMPLEXES 
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 Figure 3.34. 
1H NMR (top) and 13C NMR (bottom) spectra for III-16.
















































































































































































































 Figure 3.35. 
1H NMR (top) and 13C NMR (bottom) spectra for III-18.





































































































































































































































































































 Figure 3.36. 
1H NMR (top) and 13C NMR (bottom) spectra for III-22.
















































































































































































 Figure 3.37. 
1H NMR (top) and 13C NMR (bottom) spectra for III-23.







































































































































































































 Figure 3.38. 
1H NMR (top) and 13C NMR (bottom) spectra for III-24.









































































































































































 Figure 3.39. 
1H NMR (top) and 13C NMR (bottom) spectra for III-25.


































































































































































 Figure 3.40. 
1H NMR (top) and 13C NMR (bottom) spectra for III-26.

























































































































































































































































 Figure 3.41. 
1H NMR (top) and 13C NMR (bottom) spectra for III-27.






































































































































































































































































3.7.15 1H NMR AND 13C NMR SPECTRA FOR CHIRAL GUANIDINIUM 
BROMIDES 
 Figure 3.42. 
1H NMR (top) and 13C NMR (bottom) spectra for III-19.






































































































 Figure 3.43. 
1H NMR (top) and 13C NMR (bottom) spectra for III-20.
























































































































 Figure 3.44. 


















3.7.16 1H NMR AND 13C NMR SPECTRA FOR PROPARGYLIC ALCOHOLS 
 Figure 3.45. 
1H NMR (top) and 13C NMR (bottom) spectra for III-25.








































































































































 Figure 3.46. 
1H NMR (top) and 13C NMR (bottom) spectra for III-26.
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CHAPTER FOUR 
MODIFICATION OF NATURALLY OCCURING MATIERALS FOR  
ENIRONMENTAL POLLUTION REMEDIATION  
 
4.1  GENERAL REMARKS 
 
The use of pesticides and subsequent exposure to them has become a huge 
environmental issue arousing significant public concern. The development and practice 
of pesticides has been on-going since the discovery of dichlorodiphenyltrichloroethane 
(DDT) in 1939.1 Pesticides are a broad group of heterogeneous chemicals that are used to 
prevent, repel, or destroy pests.2 Pest are organisms that can compete for food supply, 
adversely affect comfort, or endanger human health. There are more than 20,000 
pesticide products with close to 900 active ingredients that have been registered for the 
use as insecticides, miticides, herbicides, rodenticides, nematocide, fungicides, 
fumigants, wood preservatives, and plant growth regulators.2 Pesticides provide a 
significant economic, environmental, and public health impact on the world. Pesticides 
help human nutrition by increasing production, availability, and the storage life of food. 
They can also lower the cost of food and reduce the human labor requirements in the food 
production chain. Additionally, pesticides aid in the control of food-borne and vector-
borne diseases, which affect millions of children and adults. Although it is clear 
pesticides have a positive impact on human life, it is also known that they pose serious 
health hazards towards the public and non-targeted ecological species.1-4  
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Synthetic pesticides in agriculture is a common practice today that does not seem 
to be changing. According to the most recent report from United States Environmental 
Protection Agency (U.S. EPA), the world pesticide usage totals nearly 6 billion pounds 
annually with the U.S. accounting for 1.1 billion pounds per year. Herbicides, compounds 
used to destroy unwanted vegetation, accounted for the largest portion of global and U.S. 
pesticide use at 50% and 60%, respectively. One can envision that this global usage of 
pesticides will continue to rise due to the rapidly increasing world population and 
subsequent food demands. Furthermore, pesticides are often employed to control and 
maintain weed and forage growth, urban plantations, and mosquito control. This 
widespread application of pesticides has made them ubiquitous in the environment; they 
can be detected in food, water, homes, schools, workplaces, lawns, gardens, and parks.  
While the toxic actions of these pesticides are targeted at specific pest species, they 
undoubtedly pose severe health hazards to the human population and non-targeted 
species due to their potentially toxic, stable, and less soluble active ingredients of the 
pesticides formulations.5-9 
 The World Health Organization (WHO) classifies active ingredients of pesticides 
based on their 50% lethal dose (LD50) values as extremely hazardous (class 1A), highly 
hazardous (class 1B), moderately hazardous (class 2), and slightly hazardous (class 3). 
One of the major problems caused by the increase in use of these pesticides is that the 
insects and targeted plants have developed partial resistance to the toxic active 
ingredients. Thus, the required dosage of pesticide to counteract the targeted organism 
has increased. Over time there has been an accumulation of pesticides, their active 
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ingredients, and their degradants in the environment as a result of this increase in 
pesticide use along with their slow environmental degradation profile. Unfortunately, this 
accumulation that can be seen in bodies of water and soil has negative effects on humans 
and ecosystems. This persistent use and concerning adverse effects generates the need to 
be able to remediate pesticides and their residues from non-targeted sources.11-14 
 
4.2  CLASSES OF PESTICIDES  
 
 There are two main ways to classify pesticides: they can be grouped into 7 major 
classes according to the types of pest they target (Table 4.1) or based on their chemical 
composition and nature of active ingredients (Figure 4.1). The most widely used 
pesticides belong to one of four classes of compounds: organochlorines (OC), 
organophosphates (OP), carbamates, and pyrethroids.15-16 
 
OC pesticides are a group chlorinated compounds that were very popular for over 






Table 4.1. Classes of pesticides 












































































Figure 4.1. Examples of pesticides divided into four classes based on their chemical composition.
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to control a number of diseases, such as malaria and typhus, they were then banned or 
restricted after the 1960s in the majority of countries. The mechanism of action of OC 
pesticides involves the depolarization of nerve membranes which can lead to an impaired 
nervous system.  OC pesticides belong to the class of persistent organic pollutants (POPs) 
due to their high stability and persistence in the environment. Additionally, OC pesticides 
exhibited significant toxicity to plants and animals and were found to be easily absorbed 
by organisms and foods. For these reason, OC pesticides like DDT and Aldrin are no 
longer produced and have been replaced by safer alternatives.12-13, 16 Introduction of other 
synthetic pesticides in the 1960s included OP insecticides which now account for 
approximately half of the insecticides used in the United States.  
  OP pesticides are generally regarded as a safe alternative for use on crops and 
animals due to their relatively fast degradation rates. The mechanism of action for these 
pesticides are based on inhibiting the activity of acetylcholinesterase at nerve endings 
resulting in an excess of acetylchloline that impairs nervous system function.  Although 
these pesticides are widely used in homes, gardens, and farms, they have been associated 
with toxicity to domestic animals, wildlife, as well as humans. In fact, there have been 
several epidemics of OP poisoning that have occurred in the past 30 years, including 
Ginger Jake paralysis, the Moroccan oil crisis, Spanish toxic oil syndrome, and Cuban 
blindness syndrome. In addition to these epidemics, OPs such as malathion have been 
shown to be mutagenic causing chromatic aberrations and other genetic toxicity to 
humans. Malathion, a nonsystematic insecticide with highly selective toxicity, has also 
been linked to hormone mimicks or endocrine disrupters. These devastating effects of OP 
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pesticides on human health and animals have been well reported throughout the 
literature.17-19 
 Carbamate pesticides are derived from carbamic acid, and their mechanism of 
action is comparable to that of OP pesticides. Carbamates also have the ability to inhibit 
the acetylcholinesterase in the nervous system while also inhibiting other esterases. The 
first carbamate pesticide, carbaryl, was introduced in 1956 and its use throughout the 
world exceeds all other carbamates combined. Metalaxyl, a carbamate fungicide, is used 
to control diseases caused by air- and soil-borne Peronosporales on a diverse range of 
crops. While carbamates are considered to be very similar to OPs, one major difference is 
that they tend to be less hazardous with respect to human exposure due the inhibitory 
effect on cholinesterase being relatively brief. Nonetheless, there still have been several 
reports detailing the negative effects of carbamate pesticides on the reproductive systems 
of non-targeted species.19-22   
 Lastly, pyrethroids are a group of synthetic pesticides that are derivatives of the 
natural pesticide pyrethrum which is produced by Chrysanthemum cinerariaefolium 
flowers. Although over a 1,000 pyrethroids have been synthesized, only a few are utilized 
in the United States including permethrin, sumithrin, deltamethrin, alpha-cypermethrin, 
and resmethrin. Pyrethroids have been found to be 2250 times more toxic to insects than 
to vertbrates due to insects’ smaller size, lower body temperature, and increased number 
of sodium channels. These compounds are commonly used as insecticides and are 
recommended for in-home insect control because they are considered to be relatively 
non-toxic to humans in all stages of life. However, there has been recent data reported 
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that contradicts this statement and provides serious concern. They can enter the body 
through skin contact, by inhalation, and by food or water. Data suggest that permethrin 
can have an adverse effect on fertility, the immune system, cardiovascular, and hepatic 
metabolism as well as enzymatic activity. Deltamethrin has been linked to inducing 
inflammation, nephron- and hapatoxicitiy, and influencing the activity of antioxidant 
enzymes in tissues.  While pyrethroids are an effective class of pesticides, there are 
concerns due to their toxic properties that may have adverse effects on humans.23-25  
 
4.3  TRADITIONAL PESTICIDE REMEDIATION TECHNIQUES  
 
 The routine use and well-documented negative side effects of pesticides has led to 
the development of a wide range of remediation strategies. Remediation methods of 
pollutants in different matrices can be divided into three different classes including 
biological, chemical, and physical approaches. Each one of these classes can then be 
broken down into a number of different techniques that have been developed for specific 
environmental situations with a certain set of conditions. Although there are many 
remediation techniques available, they all depend on a long the list of factors including 
pH, type of matrix, temperature, the nature of the pesticide, and the cost/time investment 
of the treatment, among other considerations. Thus, there is a need for a simple, universal 
method for pesticide remediation that can be effective in a diverse range of conditions.26-
27  
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Bioremediation or biological remediation is an attractive technique due to its low-
cost and environmental friendliness compared to physical or chemical methods. 
Bioremediation utilizes microorganisms to assist in the conversion of organic compounds 
into less harmful end products such as H2O and CO2. There are three types of 
bioremediation with microorganisms: (1) remediation through improved natural 
attenuation, (2) bioaugmenatation, and (3) biostimulation. Type 1 takes advantages of the 
natural capacities of the microorganism present in the matrix, Type 2 introduces a non-
native and/or genetically modified microorganisms, and Type 3 uses the addition of 
electroacceptors or nutrients. There are several examples of bacteria and fungi already 
present in the ecosystem, such as marine sediments, that are able to degrade pesticide 
residues (Type 1). Table 4.2 lists several of these diverse bacterial and fungal strains and 
their matrix. In theory, the use of naturally abundant bacteria would be the most cost-
effective and environmentally friendly technique. Nevertheless, the native bacteria 
 
require a long time to degrade the pesticide and this impractical timeframe was also 
shown to be affected by environmental factors (i.e. temperature and pH). Therefore, to 
decrease this timeframe, non-native or genetically modified microorganisms (Type 2) can 
be used that are specifically chosen for a given pesticide and matrix. Some key factors 
Pesticide Degrading Baterial/Fungal Strain
Atrazine Pseudomonas spp.
Carbofuran Trametes versicolor
3,5,6-trichloro-pyridinol (TCP) Enterobacter spp.
Phorate Pseudomonas aeruginosa
Table 4.2. Examples of bioremediation of pesticides in different matrices.








that are considered when using bioaugmentation strategies include acquiring knowledge 
about the microbial metabolic processes, monitoring techniques, single inoculation versus 
continuous application, and immobilization technique, among many others. 
Biostimulation (Type 3) is described as the addition of electron acceptors, electron 
donors, or nutrients in order to enhance the activity of indigenous microbial degraders or 
to promote co-metabolism. The goal of biostimulation is to boost the intrinsic 
degradation potential of a polluted matrix through the accumulation of amendments, 
nutrients, or other limiting factors.28-37  
 An extensive study completed by Pimmata and co-workers compared the 
efficiency of bioremediation by natural attenuation, bioaugmenatation, and biostimulation 
of a contaminated rice field soil with carbofuran.35 First, using natural attenuation they 
found that carbofuran presented a t1/2 of 16.6 days. Next, they used bioaugmentation with 
Burkholderia cepacia PLC3 and a bacterial consortium capable of degrading carbofuran. 
The best results obtained when unsterilized soil with mixed culture and B.cepacia was a 
t1/2 of 1.6 days while sterilized soil with mixed culture and B.cepacia  was a t1/2 of 2.7 
days. In their biostimulation trial, sludge from ethanol production process (ET), hydrogen 
fermentation process (HY), and methane production process (ME), as organic 
amendments were used. The best result was observed when HY was used as the 
biostimulating agents resulting in a t1/2 of 9.53 days. In conclusion, this study found that 
the bioaugmentation using B.cepacia was the best remediation strategy for carbofuran in 
contaminated rice field soil.35 
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 Advancements for bioremediation techniques include the identification and use of 
enzymes, such as oxidoreductase, dioxygenase, carboxylesterase, and hydrolases, from 
microorganisms capable of degrading pesticides. These enzymes have the potential to 
activate the pesticides in situ allowing for the degradation process to occur on a shorter 
time scale. Additionally, studies have probed the immobilization of enzymes on solid 
supports to enable their recovery from processed solutions, thus permitting their reuse 
and lowering the cost of the treatment. While this alternative approach has been shown to 
be effective and provide advantages, the enzymes are extremely sensitive to pH, organic 
solvents, temperature, and environmental conditions. Certain changes among the above 
conditions may cause the enzymes to lose their ability to degrade specific pesticides.36-37 
 Chemical remediation methods use specific agents to transform hazardous 
chemicals such as pesticides into less harmful or harmless products through chemical 
reactions. Some popular chemical remediation strategies include advanced oxidation 
processes (AOPs), photocatalysis, Fenton reaction, and photodegradation.26-27 AOPs are 
considered environmentally friendly because they are able to degrade a wide range of 
organic pollutants into harmless products avoiding the transfer of contaminants from one 
phase to another.39 These processes are based on the production of hydroxyl radicals, 
which have a redox potential of 2.8 V making these almost as reactive as fluorine. The 
hydroxyl radical can initiate a series of oxidative reactions transforming pesticides into 
mineralization products like H2O and CO2. Often, a source of UV light is used in 
combination with an oxidizing source to enhance the remediation in aqueous 
substrates.39-41 The most common combinations in these processes are UV-peroxide and 
 175 
UV-ozone. The UV-peroxide system uses high intensity UV light to catalyze the 
formation of hydroxyl radicals from hydrogen peroxide while the UV-ozone uses the 
synergy of UV light and ozone to oxidize the pollutants. In both systems, the UV light 
has the ability to weaken some of the bonds in the organic contaminant and with enough 
exposure to the light and oxidation the pesticide can be degraded to CO2, H2O, and their 
respective inorganic salt. The biggest disadvantage of these methods is that they cannot 
be successfully employed in commonly encountered turbid solutions.42 
 One effective method for the oxidation of organic pollutants is called the Fenton 
reaction. The Fenton reaction utilizes Fe(II) and hydrogen peroxide to generate in situ the 
oxidizing hydroxyl radical. The Fenton process has been improved through the 
application of light (photo- Fenton), electrical current (electro-Fenton), and ultrasound 
(sono-Fenton).43-48 A number of reports have been published demonstrating and 
comparing the efficiency of the Fenton process in the degradation of various pesticides. 
For example, Malato and co-workers showed 100% degradation of diuron, formetanatem 
imidacloprid, and methomyl in aqueous solutions using a photo-Fenton process.46 In 
2010, Abdessalem et al. studied the efficiency of photo- and electro-Fenton processes for 
the degradation of a mixture of bentazon, carbofuran, and chlortoluron. They saw that the 
photo-Fenton process (2 h) was much quicker at degrading the mixture compared to the 
electro-Fenton process (8h).47 Lastly, Wand and Shih reported close to 100% degradation 
of diazinon in aqueous solution using a sono-Fenton process.48  
 Photodegradation, or photolysis, is another remediation technique which can 
occur in two different manners: direct or indirect. Direct photolysis involves the pesticide 
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of interest absorbing light energy and being excited to a higher energy state. From here, 
the activated pesticide can then undergo a chemical transformation depending on the 
availability of energy to overcome the activation barrier. Indirect photolysis occurs when 
the pesticide reacts with other species that have been photochemically produced causing 
degradation or conversion into other products. One of the limitations of photolysis is that 
it only works in shallow layers of soil and surface water due to the need for direct 
irradiation of the contaminated matrix with the appropriate wavelength of light. 
Photodegradation has been improved by the use of light sources with greater intensity 
like pulsed light. Pulsed light is generated by electrical discharges of high power pulses 
on a flash lamp filled with a rare gas (xenon or krypton) which produces intense pulses 
lasting 50-3000 µs with wavelengths between 200-1000 nm. Thus, these lamps produce 
light pulses with UV irradiations up to three to four order of magnitudes higher than 
standard mercury lamps.  This strategy has been successfully applied in the degradation 
of chlorpyrifos-methyl, atrazine, pirimiphos-methyl, phosmet, azinphos-ethyl, and 
simazine from an aqueous source. 
Photocatalysis uses metal oxide semiconductors to catalyze the degradation of 
pesticides. Metal oxides, such as TiO2 and WO3, contain a valence band which is 
occupied with stable energy electrons, and an empty conduction band of higher energy. 
The initiation step is when the semiconductor absorbs radiation which causes electrons 
from the valence band to be transferred to the excited conduction band. Next, the excited 
electrons are transferred to the oxidant while electrons from the reductant fill the empty 
holes left in the semiconductor valence band. Hydroxide radicals and superoxide radical 
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anion (O2•%–) may be formed in the process as well if there is a presence of water and/or 
hydroxyl ions. Additionally, electrons can react with the pesticide directly through the 
reductive process. While this method is typically limited to the treatment of contaminated 
soils, it has been shown to successfully degrade chlorinate, triazine, and carbamic.53-56  
Physical remediation strategies depend on removing the pesticide from the matrix 
by physical means. For example, clays, such as kaolinite, are hydrophilic and negatively 
charged, and thus they have been used for the retention of cationic pesticides.57 Many 
groups have performed modifications on natural clays to functionalize them for specific 
pesticides and increase the efficiency of the physical remediation process.58 Other 
physical remediation agents include activated carbon,59 zeolites,60 and polymeric 
materials.61 Activated carbon is considered a high adsorbent material that contains a high 
surface area for trapping pesticides. There are a variety of forms of activated carbon 
including granular active carbon, powdered active carbon, carbon cloth, electrodes, 
fibers, and carbon black. The most commonly used formats are granular active carbon 
(GAC) and powdered active carbon (PAC). PAC has been shown as an effective 
remediation strategy for the removal of residual amounts of pesticides in raw water 
during drinking water treatment. Furthermore, PAC has several advantages over GAC 
such as its low cost and ease of manipulation.61  
One of the major matrices of pesticide contamination is found in aqueous systems 
including wastewaters, streams, rivers, lakes, and drinking water. When pesticides are 
applied to crops and fields, they can reach the soil through rain, irrigation water, and 
wind. Afterward, they can enter surface watercourses and ground water from the soil 
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through run-off and infiltration processes. As mentioned previously, once in the water 
they can cause negative health effects on humans, animals, the environment, and 
biodiversity. The main method of remediation from aqueous systems is hydrolysis, where 
degradation of the pesticide involves the use of water to afford a substitution or 
elimination reaction. Hydrolysis can occur at low pH (acidic hydrolysis) or high pH 
(basic hydrolysis) depending on the pesticide of interest. Often, the temperature of the 
system will be increased (>100 ˚C) to accelerate the rate of hydrolysis and allow for 
degradation to occur within 24 h. The obvious advantages of using hydrolysis in aqueous 
systems is that the initial matrix is already water based and the pH of the system can be 
easily adjusted resulting in an economical and effective remediation strategy.62 
 Another promising strategy for water pollution remediation is the use of 
nanomaterials and nanocomposites. Nanotechnology has revolutionized many different 
fields and pesticide remediation is no exception. There are many reports detailing the use 
of nanomaterials for the purification of water through the adsorption of heavy metals or 
other pollutants, the removal and inactivation of pathogens, and the transformation of 
toxic materials into less toxic compounds. This purification process allows for removal of 
some pollutants for which conventional water treatments including osmosis, distillation, 
bio-sand, coagulation-flocculation, and filtration are unsuitable.63-66 In general, 
nanotechnology can be divided into two different types: homogenous and heterogeneous. 
For example, in the homogenous purification of an aqueous system, nanoparticles are 
dispersed in the water sample containing the pesticide and have the ability to degrade the 
pesticide of interest. The major advantage of homogeneous processes is the utilization of 
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the high surface area of the nanoparticles. The disadvantage is that it can be very difficult 
to remove the nanoparticles in the aqueous system, thus they may actually contribute to 
the contamination. In the heterogeneous purification of an aqueous system, the 
nanoparticles are immobilized on a separate support material before being placed in the 
contaminated system to degrade the pesticide. The major advantage of the heterogeneous 
system is the potential for reusing the solid support system for the purification of 
different water samples. Also, the ability to remove the nanoparticles from the samples 
prevents agglomeration and further contamination. While there are several advantages of 
the heterogeneous set-up, one should note there have been reports detailing changes in 
the behavior and properties of the nanoparticles after immobilization on the solid support 
system.67 Some common examples of nanomaterials for pesticide remediation include 
iron nanoparticles and metal oxide nanoparticles such as TiO268-69 and ZnO.79 
Additionally, nanocomposites (graphene oxide and silver nanoparticles) and nanotubes 
(halloysite) have also been explored for pesticide remediation.63-66  These below 
examples (Table 4.3) have all been shown to successfully remediate pesticides in aqueous 
systems to some degree due to their attractive characteristics including optimal 
morphology, size, and adsorption capacity.   
  
Type of Nanomaterial Modification
Silver NPs Conjugation with anti-DDT anitbodies
SiO2 NPs Immobilization of AChe
Carbon nanotubes Immobilization of silver NPs
Halloysite nanotubes Immobilization of TiO2 NPs
Table 4.3. Examples of modified nanomaterials for the remediation of pesticides. 








Cellulose nanocrystals (CNC) is a class of nanomaterials that presents several 
advantages in comparison to other nanotechnology previously mentioned. Cellulose is a 
naturally occurring polymer that is comprised of β-(1,4)-linked D-glucose units. The 
polysaccharide is an ideal system for pollution remediation due to its high natural 
abundance, availability, biodegradability, renewability, and low price. Cellulose can be 
obtained from a variety of different sources (i.e. wood, plants, algae, bacteria, etc.) and 
depending on the source, different particle types can be obtained. Additionally, each type 
presents its own distinct size, morphology, crystal structure, crystallinity, porosity, 
mechanical strength, and surface chemistry. A variety of functionalization methods have 
been reported in the literature for the modification of the cellulose surface to obtain high 
performance materials for specific applications.  
Previous work in our group investigated the use of amine-decorated naturally 
occurring materials for different environmental applications.71-75 For example, the group 
has prepared poly(ethylenimine) functionalized kaolinite clay for the remediation of 
volatile organic compounds (VOCs) including aldehydes, carboxylic acids, and 
disulfides.71 Additionally, the group explored grafting various amine-bearing compounds 
(i.e. poly(ethylenimine) (PEI), ethylendiamine (EDA), and tris(2-aminoethyl)amine 
(TRIS)) to the surface of cellulose microcrystals (CMCs) and cellulose nanocrystals 
(CNCs). The amine-modified cellulose materials were then characterized and their ability 
to capture two illustrative aldehyde volatile organic compounds (VOCs), hexanal and 
octanal, in the gas phase was analyzed.  
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VOCs are chemicals with low vapor pressures which can be emitted into the 
atmosphere via biogenic or anthropogenic sources. VOCs and their remediation are of 
high interest because they are a main contributor of major air quality problems being 
faced today including photochemical smog and ground-level ozone. Additionally, these 
wide range of compounds pose a serious threat to human health due to their known 
toxicity and malodorous characteristics. The ability of VOCs to deteriorate air quality and 
human health has generated the need to control and capture air pollutants worldwide. 
Many capturing techniques of VOCs closely resemble those described for pesticide 
remediation above including biological oxidation, chemical oxidation, and adsorption.71-
74  
VOC capturing studies of our synthesized cellulose products revealed that CNC-
PEI was the optimal material and outperformed all other amine-modified materials in the 
investigation. CNC-PEI was able to capture VOCs efficiently and showed promising 
results as a universal environmental remediation agent.74 Additional studies in our group 
have explored the use of CMC-PEI for the removal of poly- and perfluorinated alkyl 
substances from water under environmentally relevant conditions.75 As an extension of 
our efforts in environmental remediation, we wanted to explore the use of these amine-
modified cellulose nanocrystals for the remediation of pesticide residues from aqueous 
systems.  
 
4.4  RESULTS AND DISCUSSION 
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The amine-modified CNC materials were synthesized following a protocol 
previously reported by our group (Scheme 4.1).74 The first step of the synthesis is a 
TEMPO-mediated oxidation of the commercially available cellulose nanocrystals. This 
reaction takes place at room temperature via 10% by weight of (2,2,6,6-
tetramethylpiperidin-1-yl)oxyl (TEMPO) and 1% weight of sodium bromide employing 
bleach as the terminal co-oxidant. In this step, the primary C6-alcohols of the CNC 
material are selectively oxidized into their corresponding sodium carboxylates. After 
successful oxidation, the resulting material is subjected to an ion-exchange treatment 
using 0.1 M aqueous HCl to convert the C6 sodium carboxylates to their neutral 
counterparts. The final step is the conjugation of the oxidized CNC and the amine-
bearing molecules which is carried out at room temperature in the presence of 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide (EDC). This water soluble carbodiimide coupling 
produces the desired CNC-EDA, CNC-TRIS, and CNC-PEI material. 
 
 The amine-modified CNC materials were then characterized by Fourier-transform 
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PEI (8.3 wt. equiv)
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Amine-modified CNC
Scheme 4.1. Synthesis of amine-modified CNC materials.
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chemical modification process was easily monitored through diagnostic changes in the 
carbonyl stretching frequency via FTIR (Figure 4.2 A). The successful TEMPO oxidation 
was confirmed by the emergence of the identifiable C=O stretch at 1712 cm-1 
corresponding to the new C-6 carbonyl, which was not present in the unmodified CNC 
starting material. Upon successful EDC coupling of the amine compound (EDA, TRIS, or 
PEI), the carbonyl stretch is shifted to smaller wavenumbers, roughly  1585 cm-1. This  
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diagnostic shift is attributed to the larger extent of electron donation into the carbonyl 
moiety from the more electropositive amide bond compared to its carboxylic acid 
predecessor. While the characteristic amine N-H sp3 stretches in the final modified CNC 
products are obscured due to the OH stretches from the CNC core, the carbonyl shift does 
confirm the critical EDC amide coupling occurred. Additional evidence of successful 
modification was clear from thermogravimetric analysis (Figure 4.2 B). All of the amine-
modified materials had very similar TGA profiles with degradation occurring below 200 
˚C. Furthermore, these degradation profiles differ compared to unmodified CNC starting 
material which begins degrading at approximately 300 ˚C. 
After a comprehensive characterization of the unmodified CNC (starting material) 
and modified CNC materials (synthesized product), we sought to evaluate their ability in  
the degradation of several pesticides via gas chromatography (GC) analysis. The 
pesticides of interest were organophosphorus pesticides, which as are currently the most 
commonly used pesticide class in agrochemicals. OP pesticides, such as malathion, have 
been the popular replacement of the traditional organochlorine compounds that have been 
phased out due to their highly toxic and biocumulative nature. Although OP pesticides do 
serve as the safer alternative, they are still considered a major environmental concern.76-77 
While it was desired to perform the degradation experiments in aqueous environments, 
the initial studies were completed using a dichloromethane solution spiked with 
malathion. OP pesticides, specifically malathion, are poorly water soluble and thus, the 
spiked DCM solutions allowed for an easy assessment of the modified CNC materials, a 
higher degree of malathion solubility, and a clean chromatogram for analysis.  
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 The GC experiments to analyze the pesticide degradation were as follows: a 1.5 
mL glass screw top GC vial was charged with a certain loading of the modified CNC 
material followed by a 1 mL aliquot of a 165 ppm malathion in DCM solution. In 
addition to the treated vials, control vials were prepared consisting of only the 1 mL 
aliquot of a 165 ppm malathion in DCM solution. Next, the vials were capped, sealed, 
and analyzed via GC for time point 0 h. The vials were then placed on an orbital shaker 
and were agitated for 24 h. After the 24 h, the vials were subjected to the GC analysis to 
determine the degradation of malathion with respect to the 0 h time point. The above 
outlined experiments were conducted in triplicate and the percent degradation was 
calculated as an average of the three runs.  
 The first study completed was a loading study of CNC-PEI to achieve 100% 
degradation of the malathion sample in the DCM solution (Table 4.4). Samples of 10, 20, 
30, 40, 50, 60, and 70 mg of the CNC-PEI were prepared and analyzed. While pleased 
that 10 mg of CNC-PEI was able to degrade 76% of the malathion, 100% remediation 
was achieved using 50 mg of CNC-PEI. An additional study revealed that agitation was 










Table 4.4. CNC-PEI loading experiment 








the same study was completed with no agitation, then only a 74% reduction was seen in 
the malathion peak area.  
Now having the optimal loading (50 mg), a comparative analysis of all three 
different amine modified CNC materials for the remediation of malathion was completed 
(Figure 4.3). A 50 mg loading of EDA-, TRIS-, and PEI-modified CNC resulted in 59%, 
50%, and 100% remediation of the malathion in the DCM solution, respectively. The 
larger remediation capacity for CNC-PEI is attributed to the additional reactive sites 
available on the polymeric cap as compared to the mono- and di-functional EDA and 
TRIS caps, respectively. A control experiment using the unmodified CNC did not result 
in any degradation of the malathion sample over 24 h. Additionally, it is suspected that 
 that these amine derivatizing agents have the capability to degrade malathion to some 
degree on their own based on the confirmed degradation pathway and by-products. 
However, grafting the amine compounds on the solid CNC provides a number of 






















Figure 4.3. Malathion remediation assay with PEI-, TRIS-, and EDA-modified CNC. 
Untreated sample (t= 0 h) and control (t= 24 h) only contained pesticide solution.
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compounds, the ability to re-use the sample, and the capability of using it as a solid or in 
solution. 
 Moving forward with the superior CNC-PEI, we next sought to evaluate its 
potential to remediate pesticides in an aqueous environment. Commercially available 
pesticide formulations of malathion, permethrin, and deltamethrin were used in place of 
the spiked DCM solution. The commercial formulations were purchased and prepared 
according to the package instructions. The formulations contain a mixture of the active 
ingredient and other components which are then mixed with water so it can be utilized as 
a liquid or spray. The active ingredient is the pesticide, thus pure standards of each 
(malathion, permethrin, and deltamethrin) were used to identify the peaks in the complex 
GC chromatograms that correspond to the pesticide of interest being degraded. Following 
the same GC experiment outlined above, it was found that 50 mg of CNC- PEI resulted in 
100%, 95%, and 82% degradation of malathion, deltamethrin, and permethrin, 
respectively (Figure 4.4). Note, the degradation of permethrin was complicated by the 
fact that the active ingredient exists as a pair of identifiable cis/trans stereoisomers about 
the central cyclopropane ring. The reported degradation was an average of the percent 
reduction of the peaks corresponding to the cis and trans isomers (84% and 78%).  In the 
case of permethrin, the treatment with CNC-PEI also required the use of slightly elevated 
temperatures of 35 ˚C. Thus, CNC-PEI does have the ability to remediate pesticides in 
environmentally relevant aqueous conditions. Furthermore, one significant advantage of 
the developed material is that the degradation process that occurs in water does not 
require the use of acidic or basic solutions unlike the common hydrolysis pathway. 
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 After demonstrating the ability of CNC-PEI to degrade three different 
commercially available pesticides, the time course of the degradation was analyzed. A 
GC experiment was conducted using 50 mg of CNC-PEI and 165 ppm solution of 
malathion in water (Figure 4.5 A). The degradation efficiency was monitored through GC 
analysis after 10, 20, and 30 minutes of treatment time. It was found that malathion was 
degraded by 63% at 10 minutes, 94% at 20 minutes, and greater than 99% after 30 


















































































Figure 4.4. Pesticide remediation assay with CNC-PEI. (A) Degradation of malathion, 
(B) degradation of deltamethrin, (C) degradation of permethrin. Untreated/control 
samples only contained pesticide solution. Degradation of malathion and deltramethrin 






returned a line with slop –k, indicating that the degradation event is first order in 
malathion (k=0.17). Using the expression, t1/2= ln2/k, the half-life of the degradation of 
malathion via CNC-PEI was found to be 4.1 minutes. These results suggest that the 
degradation of malathion by CNC-PEI occurs by a rapid β-elimination, and is complete 
in a matter of minutes.    
In order to corroborate the rapid time course of the CNC-PEI remediation agent, 
the mechanism of degradation was investigated. In order to probe the mechanism, we set 
out to identify the by-products resulting from the interaction between the CNC-PEI and 
the pesticide in water. The standard GC experiment was conducted except instead of 
analyzing for percent remediation, the reaction mixture was filtered to remove the CNC-
PEI and the filtrate was then analyzed by GC-MS. The pesticide of interest was 







































Figure 4.5. (A) Time course study of malathion degradation via CNC-PEI. (B) First order kinetic analysis: plot of ln[malathion] vs. time.
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dimethyl phosphorodithioc acid (IV-2, DMTP) and diethyl fumarate (IV-3). It is believed 
that these products arise from the facile elimination of the alpha-protons from malathion 
which is induced by the CNC-PEI remediation agent (Scheme 4.2).  Furthermore, these  
 
compounds have been cited by other groups as common structures produced via 
hydrolytic degradation of malathion.78-79 To ensure that the degradation by-products  
have a direct correlation to the interaction of malathion and CNC-PEI, control reactions 
were conducted using the same protocol without the loading of CNC-PEI. These 
untreated samples showed no detectable degradation of the malathion and the peaks for 
the by-products (IV-2, IV-3) were not present in the GC-MS chromatogram. Therefore, it 
is reasoned that the degradation of malathion via CNC-PEI is the result of a simple 
elimination event supporting the rapid time-course of 100% remediation.   
As mentioned previously, one of the highlights of the developed material is the ability to 
re-use the same solid sample for multiple remediation cycles. Used CNC-PEI samples 
that had resulted in 100% degradation of malathion in the first experiment were re-
subjected to additional aliquots of malathion (165 ppm) contaminated water (Figure 4.6). 
Before treatment of additional malathion aliquots, the spent CNC-PEI samples were 
filtered from the pesticide solution and washed with 10 mL aliquots of deionized water 
















IV-3, m/z = 172IV-1
H+ Transfer
Scheme 4.2. Suggested degradation pathway for malathion via CNC-PEI.
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 with no pesticide contaminants or degradation products. The washed CNC-PEI material 
was then dried and analyzed via FTIR and TGA (Figure 4.7). This analysis ensured that 
the CNC-PEI did not undergo any significant changes, no drastic PEI loss was seen after 
the first remediation experiment and washing cycle. Following the wash and analysis, the 
CNC-PEI was re-subjected to a fresh sample of malathion contaminated water and 
percent remediation was determined via GC analysis (Figure 4.6). The first re-use cycle 
resulted in a 98% degradation of malathion, demonstrating that the washed CNC-PEI was 
equally effective at remediating malathion and can be recycled. Unfortunately, the second 
and third re-use cycle saw a decrease in efficiency at 50% and 0% remediation, 
respectively. Thus, while it is clear that the CNC-PEI can be re-used, it also true that the 



































Figure 4.6. CNC-PEI reuse experiments for the degradation of malathion. CNC-PEI 
was able to be recyled one time with near complete retention of degradation acitivity. 
Complete loss of degradation activity was observed at reuse cycle 3.
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4.5 OPTIMIZATION OF CNC-PEI SYNTHESIS  
 
 The efforts by our group has established CNC-PEI as an effective remediation 
agent for two different types of environmental pollution, VOCs74 and pesticides. Excited 
by the potential of CNC-PEI to be used in industry, we wanted to optimize the synthesis 































































Figure 4.7. Charcterization of CNC-PEI in reuse experiments. (A) Infrared spectra 
of fresh CNC-PEI, CNC-PEI after reuse cycle 1, CNC, and PEI. (B) TGA analysis of 
fresh CNC-PEI, CNC-PEI after reuse cycle 1, CNC, and PEI.
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Chapter, the exact weight equivalences (wt. equiv.) of the reagents in reference to starting 
cellulose nanocrystal slurry are as follow: 0.1 wt. equiv. of TEMPO, 0.0125 wt. equiv. of 
NaBr, and 0.3 wt. equiv. of NaClO (12% in H2O) for step one, the oxidation. For the PEI 
coupling, 0.11 wt. equiv. of EDC and 8.3 wt. equiv. of PEI. The two critical, expensive 
reagents for the oxidation and the coupling are the TEMPO and PEI, respectively. Thus, 
the wt. equiv. for both compounds were reduced in separate syntheses and the resulting 
CNC-PEI material was analyzed via FTIR and TGA.  The performance of the material in 
the adsorption of VOCs was probed by GC. For TEMPO, the wt. equiv. was reduced to 
half the original loading (0.05) and zero for two separate batches of the CNC-PEI. For the 
PEI loading experiments, three different wt. equiv. were investigated in the coupling 
reaction: 8.3, 4.0, and 2.0. All five batches of the CNC-PEI were characterized and used 
in a capturing studying for hexanal. For the capturing assay (Figure 4.8), a 10 mg sample 
of the prepared CNC-PEI was suspended on a tissue paper barrier above a 1 µL of the 
target analyte, hexanal. The CNC-PEI material was then allowed to interact with the 

















The particle size of the PDLLA-PEG-COOH and PDLLA-PEG-
PEI NPs were assessed by using a transmission electron micro-
scope (TEM) operating at 100.0 kV beam (Figure 5).[36] The
PDLLA-PEG-COOH NPs have spherical shape and are under
100 nm in diameter, confirming that the synthesized materials
were indeed within the nanoscale range (Figure 5 A). After
functionalization, the PDLLA-PEG-PEI NPs present similar mor-
phology and size as shown in Figure 5 B, exhibiting an average
diameter of approximately 60 nm.
Elemental analysis was also obtained for PDLLA-PEG-COOH
and PDLLA-PEG-PEI nanoparticles, confirming the presence of
nitrogen on the surface of the functionalized nanoparticles
(Figures S1 and S2 in the Supporting Information).
Degradation profile
A degradation study was done by using a sample of the
PDLLA-PEG-PEI NPs. The functionalized NPs were obtained as
described in the method section and the resulting freeze-dried
solid was kept under two different temperature environments,
25 and 35 8C, during a period of 28 days in the absence of
water. Samples were collected for six time points : day 0, 1, 3,
6, 14, and 28. The thermogravimetric analysis results of the
time points collected for this study indicated no appreciable
degradation over the period of 28 days, indicating that the re-
sulting powder material was stable under the two tempera-
tures analyzed (Figure S3 in the Supporting Information). We
elected to initially evaluate the biodegradation profile of the
PDLLA-PEG-PEI NPs in solid form, because the materials were
evaluated as freeze-dried powders in the vapor capture assays
described below. Further, practically relevant applications in-
cluding packed-bed filter cartridges would certainly employ
freeze-dried solids in lieu of NP solutions. From the degrada-
tion analysis, we concluded that adventitious (i.e. , atmospher-
ic) concentrations of water at both room temperature or at
35 8C does not affect the structural integrity of our materials.
Neverth l ss, previous degradation studie by others have
demonstrated that PLA-PEG based NPs are indeed biodegrad-
able in aqueous solution.[37]
Vapor assays
After thorough characterization of the synthesized PDLLA-PEG-
PEI N s, w set out to evaluate their ability to cap ure g seous
vapors comprised of aldehyde and carboxylic acid functional
groups.
In our standard assay, a 10 mg sample of freshly prepared
PDLLA-PEG-PEI NPs was suspended on a tissue paper barrier
above a 1 mL aliquot of t rget analyte in a GC vial (Figur 6 A),
a d the NPs were allowed to interact with the vapor portion
of the analyte sample for 30 minutes. Headspace analysis was
conducted by gas chromatography (FID detection). The GC
Figure 4. Thermogravimetric analysis of thermal decomposition of non-func-
tionalized PDLLA-PEG-COOH, non-functionalized PDLLA-PEG-OCH3 nanopar-
ticles, functionalized PDLLA-PEG-PEI NPs, and PEI. The temperature at which
the first thermal degradation of PEI functionalized NPs was observed is
lower when compared to both non-functionalized NPs due to the presence
of PEI in the functionalized material.
Figure 5. TEM images obtained for A) PDLLA-PEG-COOH NPs and B) PDLLA-
PEG-PEI NPs.
Figure 6. A) Cartoon diagram of the vapor capture studies. B) Cartoon dia-
gram for the competition vapor assay showing competitive capture of the
hexanal analyte over 1-nonene.
Chem. Eur. J. 2015, 21, 14834 – 14842 www.chemeurj.org ⌫ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim14837
Full Paper
(B)(A)
Figure 4.8. Apparatus for hexanl capturing assay via GC analysis. (A) Treated 
sample. (B) Untreated controls. Nanoparticles= 10 mg of CNC-PEI and analyte= 
1 !L of hexanal.
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headspace analysis was conducted by gas chromatography. The determined GC 
headspace concentration of hexanal was then compared to untreated control headspace 
samples to obtain the percent reduction of the CNC-PEI material.  
 The optimization experiments not only revealed a new set of conditions for the 
synthesis of CNC-PEI but also gave insight into the interaction and structure of the core 
CNC and PEI modified surface. As seen in Figure 4.9, the two batches where the wt. 
equiv. of TEMPO was either reduced by a half or omitted gave similar percent reductions 
of hexanal (after subsequent PEI coating) as the standard CNC-PEI with the batch that 
employed 0.05 wt. equiv. having a slightly higher percentage. The successful 
performance of the PEI coated CNC that had not undergone oxidation (i.e. with no 
TEMPO added) suggests that PEI coating of CNC can be acheived through electrostatic 
interactions in addition to covalent bonding.  After this result, we sought to prove the 
above hypothesis by attempting to disrupt this electrostatic interaction through 
sonication.  A fresh sample of both batches of CNC-PEI along with a standard batch (0.1 
wt. equiv. of TEMPO) were suspended in water and subjected to sonication for thirty 
minutes. The solution was then filtered to collect the solid CNC-PEI, which was then 
allowed to dry. The dried, sonicated material was then tested in the GC headspace 
experiment and the percent remediation was determined. For the sample that used no 
TEMPO in the synthesis, the percent remediation dropped dramatically after sonication 
from above 90% to roughly 25%. The sample that used half the original amount of 
TEMPO, this decrease (roughly 40% remediation) was not as significant but was still 
observed.  Surprisingly, the sample that used the standard amount of TEMPO also saw a 
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slight decrease of remediation at approximately 50% reduction after sonication. These 
results support the hypothesis that there is an electrostatic interaction that occurs between 
the CNC and PEI which is sufficient enough to allow for successful remediation of the 
hexanal. Furthermore, it implies that the developed CNC-PEI material is modified in two 
different manners: portions of the PEI compound are added to the CNC core through the 
formation of new chemical bonds while other portions of the PEI compound are adhered 
to the CNC surface through an electrostatic interaction. These data suggests that both 
types of modification are required for the superior CNC-PEI material to be generated that 
results in 100% remediation of hexanal. The PEI optimization results were also 
informative, allowing us to reduce the wt. equiv. from 8.3 to 2.0 for the coupling 
reaction. All three materials generated using the different amounts of PEI (2.0, 4.0, and 






























of hexanal. The standard 8.3 wt. equiv. and the lowest 2.0 wt. equiv. both gave greater 
than 90% reduction of the hexanal vapor. Again, the sonication experiment was 
performed and the resulting material were tested in the GC headspace experiments to 
examine the differences. The sonicated, dried CNC-PEI samples gave roughly the same 
percent remediation at slightly greater than 50%. These results also corroborate the above 
statements about the nature of the CNC-PEI. Although the standard CNC-PEI uses four 
times as much PEI, it still performed the same before and after sonication when 
compared to the batch of CNC-PEI that used the 2.0 wt. equiv. of PEI. Therefore, it is 
reasoned that only a certain amount of PEI can be chemically added and electrostatically 
attached to the CNC material. Additionally, 8.3 wt. equiv. of PEI is excessive and the 
newly optimized synthetic protocol that uses the 2.0 wt. equiv. can generate CNC-PEI 
with the same effectiveness in the targeted application.  
The TGA and FTIR of the CNC-PEI materials produced during the optimization 
efforts support the above claims. For example, if one compares the TGA curves of the 
sample of CNC-PEI prepared with no TEMPO after sonication it looks very similar to the 
TGA profile of commercial CNC (Figure 4.11). This is due to the sonication treatment 
washing away most of the PEI that was electrostatically bound to the CNC  
resulting in a material that resembles commercial CNC. As one would except, the major 
difference between the CNC-PEI materials that were generated using difference wt. 
equiv. of PEI is the weight loss seen in the degradation profile (Figure 4.12). The material 
that used 8.3 wt. equiv. of PEI had the greatest weight loss while the one that used 2.0 wt. 




very similar TGA curves. Again, this supports the claim that there is a limit to the amount 
of PEI that can be added to CNC core either by means of covalent modification or 
electrostatic coating. This ideal amount of PEI was determined to be 2.0 wt. equiv. in the 











































Figure 4.10. TGA analysis of CNC-PEI materials synthesized 
in TEMPO optimization as well as commercial CNC and PEI. 
Equiv.= weight equivalences with respect to the CNC slurry. 






















Figure 4.11. TGA analysis of CNC-PEI material synthesized 
using 0.0 wt. equiv. of TEMPO. CNC-PEI sample was 











































Figure 4.12. TGA analysis of CNC-PEI materials synthesized 
in PEI optimization as well as commercial CNC and PEI. 
Equiv.= weight equivalences with respect to the CNC slurry. 




















Figure 4.13. TGA analysis of CNC-PEI material synthesized 
using 2.0 wt. equiv. of PEI. CNC-PEI sample was subject to 











































Figure 4.14. TGA analysis of standard CNC-PEI material 
synthesized using 8.3 wt. equiv. of PEI. CNC-PEI sample was 

















































Figure 4.15. Infrared spectra of CNC-PEI materials 
synthesized in TEMPO optimization as well as commercial 


























Figure 4.16. Infrared spectra of CNC-PEI materials 
synthesized in PEI optimization as well as commercial CNC 
and PEI. Equiv.= weight equivalences with respect to the CNC 
slurry. Standard CNC-PEI used 8.3 wt. equiv. of PEI.
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4.6   IN-HOUSE CNC SYNTHESIS 
 
 The most demanding and relatively expensive reagent in the synthesis of CNC-
PEI was the commercial CNC slurry, especially when considering scaling up to an 
industrial scale. Thus, we sought to explore the potential of synthesizing CNC from 
commercially available cotton in-house. The most reported protocol for generating CNC 
in the literature is the acidic hydrolysis of a cellulose source.80-81 The hydrogen ions from 
the acid can easily invade the loose amorphous regions of the cellulose to break 1,4-β-
glycoside bonds resulting in the hydrolysis of these regions. The crystalline regions of the 
cellulose are retained due to the inherent compact structure that prevents permeation of 
the acid. Although this method does require harsh conditions, it is considered the most 
efficient and reliable strategy.80-81 Thus, we chose to develop a working procedure 
utilizing cotton balls as the cellulose source and aqueous sulfuric acid as the hydrolyzing 
agent. After multiple trials and experimentation, we were able to produce CNC with a 
particle size ranging from 50 to 100 nm in approximately 50-60% yield by reacting 0.5 L 
of a 50% aqueous H2SO4 solution per 10 grams of mechanically processed cotton balls. 
The synthesis is extremely simple, the mechanically processed cotton balls and acidic 
solution are combined and stirred using an overhead stirrer. The hydrolysis reaction is 
monitored using dynamic light scattering (DLS) measurements and allowed to stir until 
the desired particle size is obtained. Once the reaction is complete, the reaction mixture is 
centrifuged and the solid is then re-suspended in water. Next, the suspension is filtered to 
remove any non-hydrolyzed pieces of cotton. Lastly, the filtrate is neutralized using 
 201 
sodium hydroxide and centrifuged to give the desired CNC product as an aqueous slurry. 
Some highlights of the procedure include pre-mixing the concentrated acid and water to 
prevent warming of the solution and/or degrading of the cotton as the 50% H2SO4 
solution is being added. Also, centrifuging immediately once the reaction is completed 
removed the majority of the acid making it easier to handle and neutralize. Neutralization 
was key to prevent conglomeration after the solid CNC is dried and re-suspended in 
water for further PEI modification. The in-house synthesis of CNC was completed on a 1, 
10, 100, and 500 gram scale. Additionally, the in-house CNC was successfully modified 
using the CNC-PEI protocol (i.e. oxidation and EDC coupling) and the resulting all-in-
house CNC-PEI showed the same effectiveness in both pesticide remediation and hexanal 
capturing. One gram of the commercial CNC from the manufacturer, Cellulose Lab, costs 
$3, whereas one gram of in-house CNC costs roughly $0.30. While the developed 
protocol for synthesizing CNC is not novel, it allows us to access the same quality CNC 
at a much cheaper cost.   
 As mentioned previously, the developed CNC-PEI material has the potential to be 
utilized on an industrial scale for environmental remediation. Thus, we also wanted to 
demonstrate that the optimized CNC-PEI protocol (i.e. TEMPO oxidation/carbodiimide 
coupling) could be scaled up effectively using the in-house CNC. The optimized protocol 
for oxidation and carbodiimide coupling described above was conducted starting with 1, 
10, and 100 grams of the in-house CNC. Each resulting batch of CNC-PEI was compared 
to CNC-PEI synthesized using the commercial CNC-slurry and 8.3 wt. equiv. of PEI 
which was ran on a 10 gram scale. The optimized protocol on a 100 gram scale returned 
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CNC-PEI with the same effectiveness (100% remediation of hexanal) and yield 
compared to the CNC-PEI generated using the old procedure. Additionally, all batches of 
CNC-PEI had very similar TGA profiles and FTIR specra. One thing to note is by using 
the optimized protocol on the 100 gram scale, the cost of the procedure dramatically 
decreased compared to what it would of cost using the first generation procedure. For 
example, using in-house CNC for the starting material cost 30 dollars where as if the 
commercial CNC was used it would have been 300 dollars, a 10-fold increase. The 
difference of PEI used in the coupling step was 375 mL (2.0 wt. equiv.) versus the 1.5 L 
of PEI that would of be used in the first generation procedure (8.3 wt. equiv.).  
 
 
4.7  CONCLUSIONS AND FUTURE WORKS 
 
 The above efforts have resulted in the successful synthesis and characterization of 
amine-functionalized CNC materials for applications in environmental research. The 
solid CNC was modified with poly(ethylenimine) (PEI), ethylendiamine (EDA), and 
tris(2-aminoethyl)amine (TRIS) to form materials that have the ability to capture VOCs 








Table 4.5. Comparative analysis of in-house 
CNC-PEI vs. commercial CNC-PEI for 
hexanal capturing via GC analysis.
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effective remediation agent for both applications. The synthetic protocol was optimized 
including the use of in-house CNC and the utilization of the ideal amount of PEI in the 
coupling reaction. Additionally, the entire synthesis of CNC-PEI was scaled up to 
demonstrate that this novel material has the potential to be employed on an industrial 
scale. 
 Future works include investigating the use of CNC-PEI in an aqueous spray 
application for remediation of VOCs. Initial results suggest that a suspension of CNC-
PEI in water has the ability to remediate vapors of hexanal via spray application (Figure 
4.17). Briefly, an Aeroqual VOC probe was placed in a closed chamber that was charged 
with a sample of hexanal. The probe detected the amount of hexanal (ppm) in the 
chamber before and after the CNC-PEI aqueous solution was sprayed. For the untreated 








Figure 4.17. Hexanl remediation study via spray application of CNC-PEI. Two 
different concentration of CNC-PEI in water were used. Water= solution with 
























Two different concentrations of CNC-PEI solution were tested along with a solution that 
contained only water. While the solution of water was able to reduce the hexanal vapors 
by 34%, the two solutions of CNC-PEI were both able to reduce the vapors by greater 
than 90%. The untreated sample confirms that a significant amount of the hexanal 
reduction is due to the CNC-PEI spray and not other variables. Additional future studies 
include further modification of the CNC-PEI material in hopes that it may be active 
against different bacterial strains. Halogenation of the CNC-PEI is on-going including the 
bromination, chlorination, and iodination. If successful, these results will add to the 















4.8   EXPERIMENTAL  
 
4.8.1  GENERAL INFORMATION 
 
 All reagents and chemicals were obtained from Sigma-Aldrich and used without 
further purification unless stated otherwise. The cellulose nanocrystal slurry (12.1 wt.% in 
H2O) which has a greater than 70% crystalline index was purchased from Cellulose Lab in 
Canada. Pesticide remediation gas chromatography (GC) analyses were carried out using 
an Agilent 7890A Gas Chromatograph equipped with an Agilent G4513A autosampler and 
a Flame Ionization Detector (FID). The GC utilized a Zebron ZB-MultiResidue-1 capillary 
GC column (30 m x 0.25 mm x 0.25 µm) which was installed for specific pesticide 
detection. The specific parameters for pesticide detection were as follows: inlet 
temperature: 170.0 ˚C; splitless injection at 15 mL min-1; column flow: 2.0143 mL min-1, 
constant pressure; carrier gas: helium; FID temperature: 340 ˚C; temperature program: 100 
˚C for 0.5 min, ramp to 180 ˚C at 20 ˚C min-1, hold for 4.5 min., final ramp to 240 ˚C at 6 
˚C min-1, hold for 14.5 min. Hexanal remediation gas chromatography analyses were 
conducted on a Shimadzu GC-2014 Gas Chromatograph, equipped with a Shimadzu AOC-
20i Auto-Injector and a Flame Ionization Detector (FID). The GC analyses used a 30 m x 
0.25 mm x 0.25 µm Zebron ZB-WAX Plus capillary GC column for the detection of 
common aldehydes. The specific parameters for hexanal detection were as follows: inlet 
temperature: 250.0 ˚C; splitless injection at 30.9 mL min-1; injector sampling depth: 10 
mm; column flow: 1.33 mL min-1, constant pressure; carrier gas: helium; FID temperature: 
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225 ˚C; temperature program: 40 ˚C for 5 min, 50 ˚C min-1 ramp to 200 ˚C, hold for 5 min. 
Both GC studies used standard Agilent Technologies Gas Chromatography 1.5 mL volume 
vials with septum screw-caps. Thermal gravimetric analysis (TGA) was conducted on a 
TA Instrument Hi-Res TGA 2950 analyzer. TGA curves were collected using a a 10 ˚C 
min-1 gradient from 25 to 1000 ˚C under nitrogen. Fourier Transform Infrared (FTIR) 
analysis was completed using a Nicolet Magna 500 with NicPlan FT-IR Microscope and 
Mapping Stage.  
 
4.8.2  SYNTHESIS OF AMINE-MODIFIED CNC 
 
 All weight equivalences (wt. equiv.) are with respect to the amount of solid CNC 
suspended in the CNC-slurry. For example, a 100 gram sample of the CNC-slurry delivers 
12.2 grams of solid cellulose nanocrystals. A 20 gram sample of the commercially available 
CNC slurry (12.2 wt.% in H2O) was suspended in a beaker charged with a solution of 0.20 
grams of TEMPO (0.1 wt. equiv.) and 0.025 grams of NaBr (0.0125 wt. equiv.) in water. 
Once the TEMPO and sodium bromide are solubilized, 4.77 grams of 12% aqueous NaClO 
solution (0.3 wt. equiv.) is added to the beaker to initiate the TEMPO-mediated oxidation 
of the cellulose suspension. The reaction was allowed to stir for 5 h at room temperature 
while the pH of solution was maintained at 10 via addition of a 0.5M aqueous NaOH 
solution. After 5 h, the pH of the suspension is adjusted to 2.5 using 0.1M HCl in order to 
neutralize the C-6 sodium carboxylates that resulted from the oxidation. To this acidified 
solution, EDC (2.68 grams, 1.1 wt. equiv.) and the amine derivatizing agent (8.3 wt. equiv.) 
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is added to the suspension. For the three amine-modified CNC-materials, ethylenediamine 
(30.6 mL), tris(2-aminoethyl)amine (68.1 mL), or poly(ethyleneimine) solution 50% wt. in 
H2O (30.6 mL) were added and allowed to stir for 6 h at room temperature. The resulting 
modified CNC materials were washed with ample amounts of water using dialysis to 
remove unreacted reagents and impurities. Finally, the purified suspension was freeze-
dried and stored at −20 ˚C prior to full characterization and testing for pesticide 
remediation. 
 
4.8.3             GAS CHROMATOGRAPHIC PESTICIDE REMEDIATION ASSAY 
 
 For the pesticide remediation experiments, the specific GC parameters used are 
listed above. The general methodology to assess the effectiveness of the amine-modified 
CNC material was to compare the area of the pesticide in treated samples to the area of the 
pesticide in the untreated samples. These two areas are then used to determine the percent 
reduction reported throughout the chapter. Control samples were also analyzed to ensure 
that reduction of the pesticide area was not a result of different variables including solvent 
interactions, agitation, or time. First, the standard pesticide area was determined prior to 
treatment with the modified CNC material. A 165 ppm solution of malathion in DCM was 
prepared and the solution was added in 1 mL portions to 1.5 mL glass screw top GC vials. 
These vials were subjected to GC analysis to the determine the peak area of the untreated 
pesticide sample at t = 0 h. Additionally, the same set of vials were prepared and agitated 
for 24 h then subjected to GC analysis acting as the control samples. Finally, a 1 mL aliquot 
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of the 165 ppm solution of malathion in DCM and 50 mg of the amine-modified CNC 
material were added to a new set of vials. The treated vials were capped, sealed with Teflon 
and Parafilm, and placed on the agitator plate for 24 h. Note, sealing of the vials was critical 
to avoid evaporation of the volatile DCM solvent. After agitation for 24 h, the treated vials 
were analyzed by GC to determine malathion peak after interaction with CNC-material. 
All experiments were conducted in triplicates.  
 
4.8.4             LOADING AND AGITATION EXPERIMENT 
 
 Both experiments used the above protocol for determining the percent reduction of 
malathion using CNC-PEI as the remediation agent. For the loading experiment, seven sets 
of vials were prepared with differing amounts of CNC-PEI material added to the vial 
containing 1 mL of a 165 ppm malathion solution in DCM. Amounts tested were: 10, 20, 
30, 40, 50 ,60, and 70 mg of CNC-PEI. The optimal loading of CNC-PEI for effective 
malathion remediation was determined to be 50 mg. For the agitation experiment, two sets 
of vials were prepared using 50 mg of CNC-PEI and 1 mL of a 165 ppm malathion solution 
in DCM. The experiment followed the standard protocol, the only difference being that one 
set of vials were set on the benchtop for 24 h with no agitation. Comparative analysis of 
the two experiments revealed that agitation is required for optimal and complete pesticide 
degradation to occur. All experiments were conducted in triplicates. 
 
4.8.5  CNC-PEI REMEDIATION OF PESTICIDES IN AQUEOUS SYSTEMS  
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 The three different pesticide formulations were purchased from a local hardware 
store or over the internet. The pesticide solutions were either used directly from the bottle 
as instructed or prepared following the directions indicated on their respective labels. The 
malathion solution was prepared using Southern AG® malathion commercial pesticide 
which contains 50% emulsifiable concentrate formulation. To make the the malathion 
solution utilized in the GC experiments, 2 tsp of the purchased formulation was solubilized 
into 1 gallon of water. Both deltamethrin (Eliminator® Ant, Flea, and Tick Killer) and 
permethrin (Eliminator® Home Insect Killer) were purchased as ready-to-use 
formulations, so no additional steps were required.  
Analytical standards of malathion, deltamethrin, and permethrin were purchased 
and solutions were prepared by adding 10 mg of the pure pesticide and 1 mL of water into 
a GC vial. These vials were subject to GC analysis to determine the retention times of the 
pure pesticide which then could be used in the analysis of the formulations that contain the 
active ingredient along with a number of different additives. The GC remediation 
experiments were conducted using the standard protocol where treated samples contained 
1 mL of the aqueous pesticide solution and 50 mg of the CNC-PEI and untreated samples 
contained only 1 mL of the aqueous pesticide solution. All experiments were conducted in 
triplicate.  
 
4.8.6  GC-MS METHOD FOR MALATHION DEGRADATION  
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Degradation by-products were evaluated using a Shimadzu GC-2010 Plus with a 
AOC-20i auto injector, coupled to a QP2010 SE mass spectrometer. A Shimadzu GC SH-
Rxi-5ms capillary column (15 m x 0.25 mm x 0.25 µm) and a Shimadzu SH-RXI-5SIL MS 
column (30 m x 0.25 mm x 0.25 µm) were installed for product detection. The specific 
parameters for degradation by-product detection were as follows: inlet temperature: 50.0 
˚C; split injection (4 µL) at 14.1 mL min-1; column flow: 1.0 mL min-1, constant pressure; 
carrier gas: helium; temperature program: 40 ˚C for 3 min.; ramp to 320 ˚C at 20 ˚C min-1, 
hold for 10 min. MS analyses were conducted as follows: ion source temperature: 200 ˚C; 
interface temperature: 100 ˚C; solvent cut time: 3 min. 
 
MALATHION DEGRADATION EXPERIMENT  
 
A standard remediation experiment was set up using 1 mL of the 165 ppm 
solution of malathion in deionized water and 50 mg of CNC-PEI. Following the 24 h 
agitation, the sample was filtered instead of subjecting it to GC analysis. The filtrate was 
then analyzed via GC-MS to determine the mass of all present compounds in the sample. 
All experiments were conducted in triplicate. 
 
4.8.7  SYNTHESIS OF IN-HOUSE CNC 
 
Prior to the synthesis, commercially available cotton balls were processed by 
adding several cotton balls to a blender and blending them until cotton strands were 
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produced. To 100 grams of mechanically processed cotton in a large glass vessel, a pre-
mixed 5 L solution of 50% H2SO4  in water is added slowly.  During the addition, the 
solution of cotton is stirred via an overhead stirrer equipped with a glass stir-rod and 
Teflon propellers. The solution is allowed to stir until the desired particle size (50-100 
nm) is reached. The acidic hydrolysis is monitored via DLS measurements of aliquots 
removed from the reaction mixture. Once the desired particle size is reached, the reaction 
mixture is centrifuged at room temperature with 7500 rpms to remove the majority of the 
acidic solution. Centrifugation vessels (500 mL) are filled with 75% of the reaction 
mixture and 25% of DI water. The solid is then re-suspended in water and vacuum 
filtered through a medium pore size frit to remove unhydrolyzed portions of the cotton. 
After filtration, the pH of the solution is monitored via pH probe and neutralized through 
the addition of 6M NaOH. Lastly, the neutralized solution is centrifuged and the resulting 
slurry is freeze dried to return the desired CNC solid.  
 
4.8.8  CNC-PEI HEXANAL CAPTURING EXPERIMENT 
  
For hexanal capturing experiments, the specific GC parameters used are listed 
above. The general methodology to assess the effectiveness of the CNC-PEI material was 
to compare the area of hexanal in treated samples to the area of hexanal in untreated 
samples. These two areas are then used to determine the percent reduction reported 
throughout the chapter. Control samples were also conducted to ensure that reduction of 
the hexanal area was not a result of different variables including evaporation, agitation, or 
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time. First, the opening of 1.5 mL GC vial was with covered with a 5 x 5 cm of Kimwipe 
tissue paper. This tissue paper was then pressed down using a glass stir rod to make a 
small sample well where 10 mg of the CNC-PEI be placed in the treated samples. The 
vial cap is then secured onto the vial and a 1 µL injection of hexanal is introduced by 
passing the microsyringe needle through the vial cap and Kimwipe barrier. The sample is 
allowed to sit for a 30 min vaporization equilibrium time followed by GC analysis to 
determine the peak area of hexanal. The same experimental conditions and amount of 
hexanal were used for all three sets of vials: untreated, control, and treated. The untreated 
samples contained no CNC-PEI and were tested a t = 0 min, while the control samples 
also contained no CNC-PEI but were tested at t =3 0 min. Lastly, the treated samples 
contained the remediation agent CNC-PEI and were tested a t = 30 mins. All experiments 























































Figure 4.18. GC trace of a malathion solution after 24 h treatment with CNC-
PEI. (A) Full GC chromatogram. (B) Zoomed GC chromatogram to highlight 
peaks at RT= 8.70 and 8.75 min. Note: peaks seen in (A) before 3 min can be 
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Figure 4.19. Identification of malathion degradation by-products via CNC-PEI. 
Mass spectrum of O,O- dimethyl phosphorodithioic acid (DMTP) (IV-2) 
(m/z=158), RT= 8.70 min.
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Figure 4.20. Identification of malathion degradation by-products via CNC-PEI. 
Mass spectrum of diethyl fumarate (IV-3) (m/z=172), RT= 8.75 min.
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IODOARENE-CONTAINING BIODEGRADABLE  
POLYESTERS FOR BIOMEDICAL IMAGING   
 
5.1   GENERAL REMARKS 
 
 Biomedical imaging agents and their corresponding techniques are essential to a 
number of different modern medical practices used every day in hospitals. Biomedical 
imaging is typically a noninvasive or minimally invasive in vivo technique which allows 
visualization and characterization of complex living organisms without perturbing them. 
The major applications of biomedical imaging include cell marking, early-stage diagnosis 
of diseases, guided stem cell therapies, drug delivery, pathogen detection, gene therapy, 
post-surgical medical devices, among many other clinically relevant procedures, 
diagnostics, and therapies.1-5 Many of these applications utilize contrast or imaging 
agents to achieve a signal that is sufficient enough for the specific clinical purpose. 
Contrast agents enhance the visualization of the targeted area by increasing the signal to 
noise ratio relative to the surrounding area in order to provide a clearer discrimination 
between the normal and pathological regions in the target area.1-5 The most commonly 
used imaging techniques include magnetic resonance imaging (MRI), optical imaging 
(bioluminescence and fluorescence), positron emission tomography or single photon 
emission tomography (PET/SPECT), ultrasound (US), and X-ray radiography/computed 
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tomography (CT). These tools span from enabling whole-organism anatomical imaging 
(MRI) to others that offer subcellular resolution (optical fluorescence).1-5  
 
5.2   X-RAY IMAGING  
 
X-rays have been used for non-invasive medical imaging since their discovery by 
Roentgen in 1895. X-ray computed tomography was developed in the early 1970s to 
produce cross-sectional images of the body. X-rays are absorbed with distinct degrees of 
attenuation as they pass through tissues with differing electron density.6 This difference 
in absorption allows for high contrast images of anatomical structures that provide 
contrast between bone, fat, air, and water. There are two main types of X-ray imaging 
techniques that are based on X-ray attenuation: X-ray projection imaging and X-ray 
computed tomography. Projection X-ray imaging generates two-dimensional images that 
highlight changes in electron density of the tissue. X-ray computed tomography 
determines the three-dimensional spatial attenuation within a sample using multiple X-
ray images acquired at different angles. Advantages of X-ray imaging include fast scan 
time, portability and direct imaging, resolutions as high as 10 µm and immediate image 
review. The major disadvantage is that X-ray images can have poor resolution between 
low contrast samples. Another disadvantage is the health concern of exposing the patient 
to ionizing radiation. The conventional way to address these concerns of low contrast and 
exposure to ionization radiation is through the use of contrasting agents.6-8 Contrast 
agents increase the attenuation of external X-rays which in turn reduces the dose of 
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radiation needed and increases the difference in the absolute X-ray attenuation between 
the target and surrounding area in the body.  
 
5.3   CONTRAST ENHANCING X-RAY IMAGING AGENTS  
 
Imaging agents have the capability to enhance the contrast between the area of the 
interest and surrounding areas which ultimately results in higher quality images in a 
shorter amount of time. Additionally, contrast agents can highlight vasculature before and 
after intravenous injection of the agent. Contrast agents can also be chemically modified 
with aptamers, antibodies, and other molecular recognition elements to target molecules 
expressed on the surface of specific cells and tissues.6  Traditional contrast agents are 
typically classified as low molecular weight imaging agents such as gold nanoparticles, 
heavy metal powders, inorganic salts of heavy elements (e.g. barium sulfate, bismuth 
sulfide), or organic compounds containing iodine (Table 5.1).6 The most routinely used  
 
Contrast Agent Application
Iohexol Cardiac angiography, liver imaging
Silver iodide Retrograde pyelography, liver imaging
Cesium chloride Bronchography
Barium sulfate Gastrointestinal tract
Gold nanoparticle Vascular casting, tumor
Silver nanoparticle Vascular casting
Gadolinium oxide Hepatobilary
Calcium tungstate Bronchography
Table 5.1. Examples of X-ray contrast agents and their applications.
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contrast agents are ones that contain iodine and barium due to their high contrast with 
respect to soft tissue. These agents provide high contrast due to the high electron density 
and large atomic number of barium and iodine, while also having a favorable location of 
the K-absorption edge relative to the typical X-ray source energy spectrum. While these 
imaging agents are often used, they do suffer from several limitations. These limitations 
include rapid clearance from blood vessels into the interstitial space, toxicity, and low 
sensitivity. Furthermore, they are known to induce recurrent problems like acute renal 
toxicity or adverse allergic and pseudo-allergic reactions.4-6  
 As mentioned above, one of the major applications of biomedical imaging is for 
the use of post-medical surgical devices. X-ray imaging is routinely used for monitoring 
the response, degradation, and defects of biomedical devices used post-surgery. 
Biomedical devices can include cardiovascular implants, prostheses, orthopedic implants, 
and to be able to visualize these inside the body is highly desirable.9 Concerns over these 
devices being permanent or having long-term stability has led to the development of 
polyester-based materials. Unlike traditional metals, polyester-based materials are 
biocompatible, biodegradabable, while also having an easily modified and facile 
synthesis. Polyester implants have begun to replace traditional devices and are now 
available on the market or many are in clinical trials. Applications of polyester-based 
materials include dental implants, cranio-maxillofacial implants, soft tissue sutures and 
staples, abdominal wall repair, tendon and ligament reconstruction, fracture fixation 
devices, and coronary drug eluting stents.9-14 The major advantage of these polyester-
based devices are their ability to be degraded and excreted from the body, preventing the 
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need for excision.  While these commercially available polyester devices have significant 
utility in the biomedical field, their in vivo performance can still be very difficult to 
predict, track, and monitor due to the complex biological environment associated with 
tissues. Thus, X-ray imaging is a critical technique for monitoring their performance and 
fate in the body in real time. However, the major shortcoming of polyester devices is that 
they lack inherent contrast imaging properties making it difficult to visualize them and 
the surrounding area of interest with X-ray imaging techniques. As mentioned above, 
without the sufficient intensity and contrast, distinguishing the target area or device from 
the surrounding area becomes problematic. This problem becomes more apparent when 
attempting to image materials through deep tissue or monitor minor defects in 
biomaterials. The common way to address this critical problem is through the 
incorporation of improved contrast agents into the polyester to allow for maximum 
visualization.9-14  
 The optimal polyester-based imaging agents should exhibit the following 
characteristics: (1) the biocompatibility, biodegradability, and biodistribution of the 
imaging agent should be well studied and understood, (2) the material should provide 
high contrast and stability, (3) adverse side effects should be mitigated even if high 
concentrations of the imaging agent are required for adequate imaging, and lastly (4) the 
imaging agent should be affordable and arise from a concise and economical synthesis.9 
With this in mind, our group set out to develop a series of novel iodine-containing 
polyesters in hopes to fulfill the above requirements and improve the state of current 
contrast imaging agents in the biomedical field. Previous collaborative work reported the 
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synthesis of degradable iodine-bearing polyester through two different strategies, 
conjugation15 and oxime “Click” ligation reactions.16 A post-polymerization modification 
reaction between poly(ε-caprolactones) and iodinated hydroxylamines was also 
investigated.17 The modified poly(ε-caprolactones) exhibited an increase in X-ray 
contrast properties when compared to previously reported monoiodinated materials.17  
Encouraged by these results, we set out to develop a protocol that allowed easy access to 
iodine-containing polyesters without the need for post-polymerization modifications. We 
sought to utilize a ring-opening polymerization of a unique set of synthesized mono-
iodinated monomers.18 This in turn furnishes an irreversible incorporation of the iodine-
containing motif throughout the polymer backbone. This chapter reports the design, 
synthesis, and characterization of iodine-containing monomers for the development of 
biocompatible polyesters as X-ray contrast imaging agents.18   
 
5.4   RESULTS AND DISCUSSION 
 
The initial goal of this study was to devise a synthetic strategy that allowed access 
to easily tailored monomers that could be utilized to generate biodegradable polyester 
contrast agents. Four different iodine-containing monomers were designed and targeted, 
each bearing a 4-iodobenzyl moiety to impart X-ray opacity to the resulting polymeric 
materials. The critical part of the design was developing monomers that maintained high 
reactivity in the tin-catalyzed polymerization reaction while also incorporating the aryl-
iodo motif through a stable, non-reversible carbon-carbon bond. The synthesis of 
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monomers (V-3, V-5, V-7) all commenced with the commercially available 4-
iodophenylalanine (V-1). The lactide, V-3, was synthesized in two steps, a diazotization 
and subsequent acylation. 4-Iodophenylalanine undergoes diazotization/hydrolysis using 
a solution of sulfuric acid and sodium nitrite in water to afford α-hydroxy carboxylic 
acid, V-2. Next, acylation of V-2 with 2-bromopropionyl chloride followed by 
cyclocondensation results in the 4-iodo-benzyl lactide, V-3, in 43% over the two steps. 
The methyl-substituted morpholinedione V-5 (48% over two steps) and non-substituted 
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Scheme 5.1. The Synthesis of Aryl-Iodinated Biodegradable Monomers. (A) Synthesis of lactide monomer (V-3). (B) Synthesis of 
methyl-substituted morpholinedione monomer (V-5). (C) Synthesis of non-substituted morpholinedione monomer (V-7). (D) 


















induced cyclization sequence employing 2-bromopropionyl chloride and chloroacetyl 
chloride as the electrophile in the acylation, respectively. Lastly, the 4-iodo-benzyl-
caprolactone (V-11) was constructed in three straightforward steps. First, pyrrolidine and 
cyclohexanone were refluxed in toluene to afford the enamine, V-9. Next, the critical 
aryl-iodo motif was incorporated via enamine alkylation with 4-iodo-benzylbromide to 
give the substituted ketone, V-10. The final step was a Baeyer-Villiger oxidation using 3-
chloroperbenzoic acid which provided the desired 4-iodobenzyl caprolactone, V-11, in 
45% over the three steps.   
Having the four targeted monomers in hand, the corresponding polyesters were 
synthesized using a conventional, thermal ring-opening polymerization with lactic acid as 














Scheme 5.2. Conventional thermal ring-opening polymerization with lactic acid 
as the initiator and tin(II) 2-ethylhexanoate as the catalyst.
Iodinated Lactide (iLA) Iodinated Polylactide (iPLA)
Monomer Polymer
V-3 = iLA iPLA
V-5 = iMMD iPMMD
V-7 = iMD iPMD
V-11 = iCL iPCL
Table 5.2. Abbreviations for the synthesized monomers and 
their corresponding polymers. i= aryl-iodo, LA= lactide, M= 
methyl, MD= morpholinedione, CL= caprolactone, P= polymer.
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final polymeric products were carried out through precipitation in cold methanol 
followed by centrifugation at –10 oC for complete separation of the desired polymer. The 
resulting iodinated polyesters were then characterized by 1H NMR and FTIR 
spectroscopy to ensure successful polymerization and that the important iodine moiety 
remained intact. In Figure 5.1, one can see illustrative 1H NMR spectra comparing the 











downfield resonances at 7.2 and 7.7 ppm in the 1H NMR spectrum of the monomeric 
aryl-iodo lactide (iLA) correspond to the aromatic protons at the ortho and para position.  
These same resonances can be found in the polymerized product (iPLA) indicating the 
presence and stability of the critical 4-iodobenzyl moiety. Successful polymerization was 
also confirmed through the signature downfield shift of the alpha proton in the PLA 



























Figure 5.1. 1H NMR spectral overlay of (A) aryl-iodo poly(lactic) acid (iPLA), 
(B) poly(lactic) acid (PLA), (C) aryl-iodo lactide (iLA), (D) lactide (LA).
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further support displaying a peak at 1755 cm-1 which corresponds to C=O in the lactide 
structures. Furthermore, the sp2 C-H aromatic stretches for iLA and iPLA are present 
around 2955 cm-1 which is absent for the non-iodinated PLA.  After thorough 
characterization, it was confirmed that the targeted polymeric materials were indeed 
accessed through the ring-opening polymerization of the synthesized iodine-containing 
monomers.  
 
Next, the ability of these biodegradable polyesters to serve as contrast agents was 
explored through X-ray imaging methodology. The X-ray contrasting efficiencies 
(recorded in Hounsfield units) of the four synthesized polymers were compared to the 
non-iodinated lactic acid polymer (Figure 5.3 A). Additionally, co-polymers were 





















Figure 5.2. FTIR characterization of the aryl-iodo poly(lactic) acid (iPLA), 
poly(lactic) acid (PLA), and aryl-iodo lactide (iLA).
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analyzed as well (Figure 5.3 B). As expected, the polymers containing the aryl-iodo motif 
had an increased relative X-ray intensity when compared to the unmodified, iodine-free 
PLA (Figure 5.3 A). The significance of the substituents on the polymeric backbone can 
be seen by comparing the two morpholinedione polyesters. The polymer synthesized 
using the methyl-substituted morpholinedione (iPMMD) has a lower iodine-weight 
concentration compared to the polymer synthesized using the non-substituted 
morpholinedione (iPMD). The additional methyl-substituent of iPMMD should, in 
theory, cause the polymer to have a lower X-ray intensity than the iPMD. However, 
surprisingly this was not the case and iPMMD was able to absorb X-rays more efficiently 
than the non-methylated analogue. The last synthesized monomer, iCL, allowed access to 
a unique iodine-containing poly(ε-caprolactone) (iPCL). The advantage of utilizing 
caprolactone polymers (iPCL) is that they slowly degrade into less acidic, low molecular 












Figure 5.3. X-ray imaging methodology. (A) Relative X-ray intensity of aryl-iodo polymers compared 
to non-iodinated poly(lactic) acid (PLA). (B) Relative X-ray intensity of iPLA co-polymers 
synthesized with varying ratios of iodinated and non-iodinated lactide monomers.
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when using lactide polymers (iPLA). Although the relative X-ray intensity was slightly 
lower than the iPLA and iPMMD materials, we were excited to be able to access this 
class of bioresorbable X-ray enhancing polycaprolactones. polycaprolactones.  
The initial X-ray imaging methodology had shown the polymer (iPLA) 
synthesized using the 4-iodo-benzyl lactide (iLA) was superior in absorbing X-rays when 
compared to the other three polymers. Thus, iPLA was chosen for additional studies due 
to its strong X-ray contrasting properties along with its easy, economical synthesis. As 
seen in Figure 5.3 A, the co-polymer synthesized with equal ratios of iLA and LA had 
comparable intensities to the homo-polymer, iPLA.  We were encouraged that the co-
polymer performed equally as well in the X-ray imaging methodology despite 
presumably having 50% less of iodine in the polymer. The ability to reduce the amount of 
iodine and yet retain the X-ray contrasting property is highly significant. Lowering the 
amount of iodine can result in a less lipophilic, more water soluble contrast agent, and 
can therefore be less toxic to the human body. To further investigate the strategy of 
incorporating cheaper, non-iodinated monomers into contrasting co-polymers, we set out 
to synthesize a series of co-polymers with varying ratios of LA to iLA. As seen in Figure 
5.3 B, there was a direct correlation between the amount of iodinated monomer used to 
the X-ray intensity of the resulting co-polymer. There was a gradual increase seen in X-
ray intensity as the ratio of LA to iLA went from 100:0 to 25:75.  
During the co-polymerization study, we wanted to ensure that iLA was being 
successfully incorporated into the co-polymer during the polymerization. Thus, we 
completed a time study (Figure 5.4) where the X-ray intensity of the resulting co-polymer 
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 of LA and iLA was probed at 6, 12, and 24-hour time points. In Figure 5.4 A, one can 
see the increase in relative X-ray intensity over the 24-hour time period. This confirmed 
the effective incorporation of the iLA into the resulting co-polymer.  The polymeric 
pellets that were used in the co-polymerization time study can be seen in Figure 5.4 B. 
Along with the gradual increase in X-ray intensity, one can visually see the intensity 
difference in the polymeric pellets with the PLA pellet having essentially no contrasting 
properties.  
 One of the biggest obstacles faced when imaging biomedical devices in humans is 
the visualization of them through portions of deep tissue. We wanted to explore the 
potential of our developed iPLA material to address this challenging problem, thus in 












Figure 5.4. Time study of the co-polymerization of aryl-iodo lactide (iLA) and lactide (LA). (A) Relative X-
ray intensity of the resulting co-polymer at 6,12, and 24 h time points during the co-polymerization 
compared to poly(lactic acid) (PLA) and aryl-iodo polycaprolactone (iPCL). (B) Depiction of polymeric 
pellets (10 mg) of the resulting co-polymer at 6,12, and 24 h time points during the co-polymerization 
compared to poly(lactic acid) (PLA) and aryl-iodo polycaprolactone (iPCL).
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was performed (Figure 5.5). Effective visualization of the iPLA material was observed 
through both the 2 cm and 5 cm thick chicken tissue. This successful visualization 




 As mentioned earlier in this chapter, the biggest advantage of using polymeric-
based contrast agents is their ability to biodegrade. While it was suspected that the iPLA 
material would hold this property, we wanted to ensure that the aryl-iodo motif did not 






























Figure 5.5. In vitro imaging of aryl-iodo poly(lactic acid) (iPLA) 
powder through different depths of chicken tissue.
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phosphate-buffered saline (pH 7.4) at 37°C and the weight loss of iPLA material was 
monitored over an eight-day period, providing the degradation profile seen in Figure 5.6. 
The degradation rate profile of iPLA gradually decreased per day resulting in roughly a 
70% weight loss after the eight-day study. This overall weight loss confirms that the 
synthesized polymer – containing the critical aryl-iodo functionality – can still 













5.5  CONCLUSIONS AND FUTURE WORKS 
 
 In conclusion, a series of aryl-iodo containing monomers were designed and 


























! Figure 5.6. Degrdation profile of aryl-iodo poly(lactic acid) (iPLA) pellets over time (days). iPLA pellets were incubated into PBS 
(pH 7.4) at 37 °C.
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were then leveraged in a ring-opening polymerization to furnish polymeric materials with 
X-ray contrast properties. This work highlights the synthesis and utilization of iodine-
containing monomers to allow for maximum incorporation of the critical iodine atom into 
the polymer. This is in contrast to the traditional post-polymerization methodology which 
limits the iodine concentration within the polymer and in turn the X-ray intensity of the 
material. The four monomers and corresponding polymers were characterized via 1H 
NMR and FTIR while also being analyzed using X-ray imaging methodology. The iPLA 
material proved to be superior, exhibiting the highest contrast imaging properties among 
the polymers. Co-polymerization studies revealed the potential to use the iLA monomer 
in co-polymers with non-iodinated LA while still exhibiting significant X-ray intensity. 
Additionally, the iPLA material could be visualized through thick portions of chicken 
tissue, providing promise for deep tissue imaging applications. Lastly, the biodegradation 
profile of iPLA was investigated and revealed that the covalently bound iodine atom does 
not affect the biodegradation of the polymer.  The reported iodine-containing polymers 
add to a class of important polymeric X-ray contrast agents which have improved the 
biomedical imaging field. These polymeric materials are biocompatible, biodegradable, 
and therefore provide a less-toxic alternative to traditional metal contrasting agents. The 
presented work established a highly efficient, easily modified, and convenient strategy to 
access iodine-containing monomers, which can be used to generate biodegradable and 
biocompatible X-ray visible polymeric materials.  
 Future works include using the developed strategy to synthesize polymers for 
nanoparticle drug carriers. Many reports in the literature outline the ability of polyester-
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based nanoparticles to serve as vehicles for drug delivery.20-24 Advantages of using 
polyester nanoparticles as a drug delivery platform include the ability to supply the 
therapeutic agents in a controlled manner. They can biodegrade and be excreted from the 
body after the drug is released, and they represent a tunable scaffold. The modification 
capability of the polyester allows for the properties of the desired material to be tailored 
for specific applications.20-24 Thus, we can take the developed monomers and 
functionalize them with various drug conjugates, including chemotherapeutics and 
antimicrobial agents. For example, we can take our first monomer (iLA) and modify it 












































 Drug Delivery Platform
Figure 5.7. Proposed drug delivery platforms utilzing the developed aryl-iodo monomers.
 243 
for an amine drug to be appended to the side-chain of the polymer via a conventional 
amidation reaction. After the drug is attached, the monomer can be polymerized through 
the tin-mediated ring-opening polymerization. The resulting polymer would now act as a 
drug delivery platform for the targeted drug that was just attached. It is known that 
polyesters serve as excellent drug delivery vehicles due to the attractive properties 
(biocompatibility, biodegradability, etc.) polymeric materials possess which have been 
well highlighted in this chapter. These properties can reduce the toxicity and minimize 
adverse effects while also being able to increase the drug loading and therapeutic 
efficiency.20-24 Additionally, one could envision the co-polymerization of the modified-
LA loaded with a given drug and the aryl-iodo lactide monomer (iLA). The resulting co-
polymer could potentially serve as X-ray visible drug delivery platform that also allows 
the for visualization and monitoring of the treatment in real time. The facile synthesis and 
X-ray contrast properties of the reported polymers has inspired our group to explore this 










5.6  EXPERIMENTAL  
 
5.6.1  GENERAL INFORMATION 
 
All reagents and chemicals were obtained from commercial sources and used 
without further purification unless stated otherwise. Water was purified on a Millipore 
Direct-Q S Water Purification System. Acetonitrile was dried by refluxing over 
phosphorous pentoxide (P2O5) and distilled under nitrogen prior to use. The synthesized 
monomers, lactic acid, and sodium sulfate were all vacuum-dried overnight in the 
reaction vessel before use. Isolated products were purified via flash column 
chromatography using silica gel SDS 60 C.C. 40-63 µm. All known compounds and 
starting materials had 1H NMR and 13C NMR spectra consistent with previously reported 
literature accounts. 1H NMR and 13C NMR were recorded at ambient temperature on a 
500 MHz NMR spectrometer (Bruker). Proton and carbon chemical shifts were reported 
in parts per million (ppm) downfield from tetramethylsilane (TMS) with reference to the 
deuterated solvent as the internal standard (i.e., δ 7.26 ppm for 1H NMR, 77 ppm for 13C 
NMR in CDCl3). Data are presented as follows: chemical shift, integration, multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), and coupling 
constants (J, in Hertz). Infrared (IR) spectra, reported in cm-1, were collected using a 
Shimadzu IRAffinity-1S Fourier transform spectrophotometer. Bands are characterized 
as strong (s), medium (m), weak (w), and broad (br). Melting points were recorded on a 
DigiMelt MPA160 apparatus.A Tingle 325MVET X-ray machine was used to perform 
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the X-ray imaging (51 kVp, 300 mA, and 5 millisecond exposure time). PLA was chosen 
as the control due to its lack of radio-opaque properties and frequent use in biomedical 
applications. All X-ray images were processed, and image intensities quantified using 
ImageJ (NIH) normalized to an unmodified polymer.  
5.6.2  SYNTHESIS 
α-hydroxy-4-iodo-benzenepropionic acid (V-2): General Procedure25 
To a flame-dried round bottom flask equipped with a stir bar was added 4-Iodo-ʟ-
phenylalanine (17.2 mmol, 5.0 g, 1.0 equiv) and 0.5 M H2SO4 (34.4 mmol, 2.0 equiv). 
The reaction was stirred until the solution became homogenous (10 min). Once 
homogenous, the reaction mixture was cooled to 0 °C and a solution of sodium nitrite 
(7.1 g, 103 mmol, 6.0 equiv.) in water (50 mL) was added dropwise.  The resulting 
mixture was stirred at 0 °C for an additional 4 h, and then allowed to warm to room 
temperature. The reaction was stirred at room temperature for 24 h and monitored for 
completion by TLC. After completion, the reaction mixture was extracted with diethyl 
ether (3 x 50 mL), and the organic phases were combined, washed with sat. aq. brine (50 
mL), and dried over anhydrous sodium sulfate. The drying agent was filtered off and the 
filtrate was concentrated in vacuo. The crude product was recrystallized from diethyl 
ether-hexane to give α-hydroxy-4-iodo-benzenepropionic acid as an off-white solid 
(74%, 3.7 g).  
(3S)-3-(4-iodobenzyl)-6-methyl-1,4-dioxane-2,5-dione (V-3): General Procedure26 
To a flame-dried round bottom flask equipped with a stir bar was added α-hydroxy-4-
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iodo-benzenepropionic acid (5.1 mmol, 1.5 g, 1.0 equiv), triethylamine (0.79 mL, 5.6 
mmol, 1.1 equiv), and dry MeCN (25 mL) while under argon. This solution was cooled to 
0 °C followed by drop-wise addition of 2-bromopropionyl chloride (0.57 mL, 5.6 mmol, 
1.1 equiv.). The resulting mixture was stirred for 30 min at 0 °C. A second portion of 
triethylamine (0.79 mL, 5.6 mmol, 1.1 equiv) was added, followed by stirring the 
resulting reaction mixture for 3-5 h at 70 °C. The reaction was then cooled to room 
temperature and quenched with 1M aq. HCl solution (25 mL). After quenching, the 
mixture was extracted with ethyl acetate (3 x 25 mL), and the organic phases were 
combined, washed with water (25 mL), sat. aq. brine (25 mL), and dried over anhydrous 
sodium sulfate. The drying agent was filtered off and the filtrate was concentrated in 
vacuo. The crude product was purified by flash column chromatography using a 70:30 
hexanes:ethyl acetate gradient (Rf =0.26) . The pure yellow oil, (3S)-3-(4-iodobenzyl)-6-
methyl-1,4-dioxane-2,5-dione, solidified upon storage in the freezer (58%, 1.03 g).  
(S)-2-((R)-2-bromopropanamido)-3-(4-iodophenyl)propionic acid (V-4): General 
Procedure26-28 
To a flame-dried round bottom flask equipped with a stir bar was added 4-Iodo-ʟ-
phenylalanine (6.9 mmol, 2.0 g, 1.0 equiv) and 20 mL of a 1:1 solution of H2O and Et2O. 
To this mixture was added a 4M aq. NaOH solution (8 mL) and the resulting solution was 
stirred until it became homogenous. Next, the resulting reaction mixture was cooled to 0 
°C. In a separate flame-dried vial was added 2-bromopropionyl chloride (0.76 mL, 7.6 
mmol, 1.1 equiv) and a 4M aq. NaOH solution (8 mL). The resulting solution was then 
added dropwise to the round bottom flask while maintaining a temperature of 0 °C and 
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pH of 11 via the addition of 4M aq. NaOH solution (10-15 mL) after confirmed 
completion of the reaction via TLC, the solution was allowed to warm to room 
temperature, and the ether layer was separated in a separatory funnel. The resulting 
aqueous layer was acidified with concentrated HCl to achieve a pH of 1.  The reaction 
mixture was extracted with ethyl acetate (3 x 25 mL), and the organic phases were 
combined, washed with sat. aq. brine (50 mL), and dried over anhydrous sodium sulfate. 
The drying agent was filtered off and the filtrate was concentrated in vacuo. The crude, 
white, solid product was placed under high vacuum and used in the next step without 
further purification.  
(3S,6S)-3-(4-iodobenzyl)-6-methylmorpholine-2,5-dione (V-5): General Procedure27-30 
To a flame-dried round bottom flask equipped with a stir bar was added crude (S)-2-((R)- 
2-bromopropanamido)-3-(4-iodophenyl)propionic acid (V-4) (6.8 mmol, 2.9 g, 1 equiv) 
and DMF (25-30 mL). After stirring for several minutes, trimethylamine (1.04 mL, 7.5 
mmol, 1.1 equiv) was added to the solution. The resulting mixture was heated to 90 °C 
and stirred under N2 for 12 h. After confirmed completion of the reaction via TLC, the 
reaction mixture was allowed to cool to room temperature and allowed to stand overnight 
in the freezer. The crystallized salt and DMF/TEA were filtered, and the filtrate was 
concentrated in vacuo. Residual DMF was removed by adding toluene to the sample, 
followed by rotary evaporation (repeated 4 times). The isolated product was 
recrystallized from chloroform-cold diethyl ether to give (3S,6S)-3-(4-iodobenzyl)-6-
methylmorpholine-2,5-dione as a white solid (1.12 g, 48% over 2 steps).  
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(S)-2-(2-chloroacetamido)-3-(4-iodophenyl)propionic acid (V-6): 
Following the general procedure26-28 for the synthesis of V-4, with the use of chloroacetyl 
chloride in place of 2-bromopropionyl chloride, the crude, yellow solid product was 
placed under high vacuum and used in the next step without further purification.  
(S)-3-(4-iodobenzyl)morpholine-2,5-dione (V-7):  
Following the general procedure27-30 of V-5, with the use of (V-6) as the starting material 
in place of V-4, the final product, (S)-3-(4-iodobenzyl)morpholine-2,5-dione, was 
obtained as an off-white solid (1.12 g, 41% over 2 steps).  
1-Cyclohexenylpyrrolidine (V-9): General Procedure31
To a flame-dried round bottom flask equipped with a stir bar and Dean-Stark trap (with 
activated 4 Å molecular sieves) was added cyclohexanone (4.22 mL, 40.8 mmol, 1 
equiv), pyrrolidine (6.02 mL, 73.4 mmol, 1.8 equiv) and dry toluene (20 mL) while under 
nitrogen. The resulting mixture was refluxed for 5-7 hours and monitored via TLC. After 
completion, toluene and excess pyrrolidine were removed in vacuo. The crude, colorless 
product (5.8 g, 94%) was placed under high vacuum and used in the next step without 
further purification. 
2-(4-iodobenzyl)cyclohexan-1-one (V-10): General Procedure31 
To a flame-dried round bottom flask equipped with a stir bar was added 4-iodobenzyl 
bromide (4.9 g, 16.5 mmol, 1 equiv) and dry toluene (30 mL) while under nitrogen. The 
solution was stirred until it became homogenous, then 1-cyclohexenylpyrrolidine (2.5 g, 
16.5 mmol , 1 equiv) (V-9) was added. The resulting mixture was refluxed under nitrogen 
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for 18 hour. Then, H2O (30 mL) was added and the solution was heated for an additional 
hour. The solvent was evaporated under vacuum, and the resulting residue was extracted 
with diethyl ether (3 x 25 mL). The ether phase was then washed consecutively with an 
aq. 5% HCl solution, an aq.  5% NaHCO3 solution, and water. The washed ether phase 
was dried over anhydrous sodium sulfate. The drying agent was filtered off and the 
filtrate was concentrated in vacuo. The crude product was purified by flash column 
chromatography using a 90:10 hexanes:ethyl acetate gradient providing 2-(4-
iodobenzyl)cyclohexan-1-one as a white solid (3.7 g, 71 %).  
7-(4-iodobenzyl)oxepan-2-one (V-11): General Procedure20 
To a flame-dried round bottom flask equipped with a stir bar was added 2-(4-
iodobenzyl)cyclohexan-1-one (V-10) (1.5 g, 4.8 mmol, 1 equiv.) and CHCl3 (50 mL). 
The resulting solution was cooled to 0 °C followed by addition of mCPBA (77% reagent) 
(14.3 mmol, 3 equiv). The reaction mixture was stirred for several days (2-3) and 
monitored via TLC. After completion, the mixture was quenched with a sat. aq. Na2S2O3 
solution. Once quenched, the reaction mixture was extracted with chloroform (3 x 25 
mL), and the organic phases were combined and then washed with sat. aq. NaHCO3 and 
brine (50 mL). The organic layer was dried over anhydrous sodium sulfate. The drying 
agent was filtered off and the filtrate was concentrated in vacuo. The crude product was 
purified by flash column chromatography using a 20:80 hexanes:ethyl acetate gradient 
(Rf =0.69) providing 7-(4-iodobenzyl)oxepan-2-one as a colorless oil (1.07 g, 68%). 
General Procedure for Conventional Ring-Opening Polymerization:  
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The polymers were synthesized using a conventional ring-opening polymerization with 
lactic acid as the initiator and tin(II) 2-ethylhexanoate as the catalyst. As mentioned 
above, the monomer, lactic acid, sodium sulfate, and the stir bar were all vacuum-dried in 
the reaction vessel prior to the polymerization. To the reaction vessel equipped with a 
reflux condenser, anhydrous toluene was added while under nitrogen. Once the resulting 
mixture became homogenous, the reaction was heated to 120 °C followed by addition 
tin(II) 2-ethylhexanoate. The reaction was refluxed for 24 h. The resulting polymer was 
partitioned between chloroform and water. The combined organic phases were then dried 
over MgSO4. The drying agent was filtered off and cold methanol was added to the 
filtrate to precipitate the desired polymer. 
5.6.3  X-RAY IMAGING METHODOLGY EXPERIMENTS 
Aryl-iodo poly(lactic acid) (iPLA) was fabricated into pellets (25 mg) by heating 
and molding the polyester into the desired shape. Polymeric pellets were then placed into 
plastic tubes filled with PBS (pH = 7.4), and incubated at 37 °C and 5% CO2. Each 
following day after being placed in the PBS solution, the plates were imaged using X-ray 
imaging methodology. Note: after being removed from the PBS, the pellets were replaced 
each day. Controls for this study was a disc made from poly(lactic acid) (PLA) which is 
known to have no imaging properties. All experiments were conducted in triplicate. 
Statistical analyses were performed using a two-tailed t-test and statistical significance 
was set at p < 0.05. Statistical significance is denoted by ‘*’.  
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In vitro X-ray Imaging of Polymeric Discs through Tissue:  
Aryl-iodo poly(lactic) acid (iPLA) was fabricated into dry powder. Chicken breast 
muscle tissue used and was sectioned into slices of known thickness (2 and 5 cm). The 
chicken sections were placed on top of the iPLA powder to simulate increases in tissue 
depth inside the human body and imaged using X-ray imaging methodology.  
5.6.4 1H AND 13C NMR DATA FOR ISOLATED PRODUCTS. FTIR DATA 
FOR FINAL PRODUCTS 
α-hydroxy-4-iodo-benzenepropionic acid (V-2): 
1H NMR (500MHz, DMSO-d6): δ 2.75 (dd, 1H, 1J=13.92, 2J=4.32Hz), 2.93 (dd, 1H, 
1J=13.7, 2J=8.3Hz), 4.16 (dd, 1H, 1J=7.9, 2J=4.4Hz),7.06 (d, 2H, 1J=7.8Hz), 7.62 (d, 2H, 
1J=7.8Hz) ppm. 13C NMR (125 MHz, DMSO-d6): δ 64.9, 70.6, 91.9, 131.9, 136.7, 137.9, 
174.9 ppm.  
(3S)-3-(4-iodobenzyl)-6-methyl-1,4-dioxane-2,5-dione (V-3): 
1H NMR (500MHz, CDCl3): δ 1.60 (d, 3H, 1J=6.7Hz), 3.19 (dd, 1H, 1J=14.8, 2J=7.5Hz), 
3.40 (dd, 1H, 1J=14.9, 2J=4.0Hz) 4.96 (q, 1H 1J=6.7Hz), 5.06 (dd, 1H, 1J=3.9, 2J=7.7Hz), 
7.08 (d, 1J=8.3Hz), 7.66 (d, 1J = 8.3 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 15.9, 35.7, 
72.5, 76.1, 93.1, 131.9, 134.2, 137.8, 166.0, 166.7 ppm. IR (neat): 2995 (w), 2932 (w), 
1769 (s), 1738 (s), 1485 (w), 1250 (s) cm−1.  
(3S,6S)-3-(4-iodobenzyl)-6-methylmorpholine-2,5-dione (V-5): 
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1H NMR (500MHz, DMSO-d6): δ 1.13 (d, 3H, 1J=6.9Hz), 3.02 (d, 2H, 1J=5.1Hz), 4.67 
(t, 1H, 1J=5.0Hz), 4.99 (q, 1H, 1J=6.8Hz), 7.09 (d, 2H, 1J=8.1Hz), 7.68 (d, 2H, 1J=8.2Hz) 
ppm. 13C NMR (125 MHz, CDCl3): δ 16.8, 36.1, 54.2, 74.6, 93.3, 132.7, 136.5, 137.4, 
168.5, 168.6 ppm. IR (neat): 3202 (br), 1747 (s), 1694 (s), 1483 (w), 1375 (m), 1315 (m) 
cm−1.  
(S)-3-(4-iodobenzyl)morpholine-2,5-dione (V-7):  
1H NMR (500 MHz, CDCl3): δ 3.17–3.19 (dd, 2 H, 1J = 2.32 Hz), 4.00–4.06 (d, 1 H, 1J = 
16.54 Hz), 4.46–4.50 (dd, 1 H, 1J = 3.60 Hz), 4.52–4.58 (d, 1 H, 1J = 16.54 Hz), 6.99–
7.01 (d, 2 H, 1J = 8.19 Hz), 7.11 (br, 1 H), 7.69–7.72 (d, 2 H, 1J = 8.16 Hz) ppm. 13C 
NMR (125 MHz, CDCl3): δ 39.2, 54.4, 67.0, 93.8, 131.6, 133.7, 138.4, 165.8, 165.9 ppm. 
IR (neat): 3205 (br), 2922 (m), 1755 (s), 1678 (s), 1485 (m), 1337 (m) cm−1.  
1-Cyclohexenylpyrrolidine (V-9): 
1H NMR (500 MHz, CDCl3): δ 1.38–1.43 (m, 2 H), 1.52–1.55 (m, 2 H), 1.66–1.68 (m, 4 
H), 1.95–1.96 (m, 2 H), 2.02–2.03 (m, 2 H), 2.84–2.85 (m, 4 H), 4.10–4.16 (m, 1 H) ppm. 
13C NMR (125 MHz, CDCl3): δ 22.9, 23.3, 24.5, 26.9, 27.4, 47.2, 93.3, 142.9 ppm.  
2-(4-iodobenzyl)cyclohexan-1-one (V-10): 
1H NMR (500 MHz, CDCl3): δ 1.15–3.02 (m, 11 H), 6.79 (d, 2 H, 1J = 8.3 Hz), 7.42 (d, 2 
H, 1J = 8.3 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 25.1, 27.9, 33.5, 35.1, 42.1, 52.0, 
91.2, 131.4, 137.2, 140.1, 211.4 ppm.  
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7-(4-iodobenzyl)oxepan-2-one (V-11): 
1H NMR (500 MHz, CDCl3): δ 1.33–2.78 (m, 10 H), 4.28–4.3 (m, 1 H), 6.85 (d, 2 H, 1J = 
8.1 Hz), 7.40 (d, 2 H, 1J = 8.2 Hz) ppm. 13C NMR (125 MHz, CDCl3): δ 22.9, 28.3, 33.8, 
34.9, 42.1, 80.7, 92.2, 131.7, 136.9, 137.6, 175.2 ppm. IR (neat): 2924 (w), 2857 (w), 
1726 (s), 1483 (w), 1173 (m), 1007 (w) cm−1.  
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5.6.5 1H NMR AND 13C NMR SPECTRA FOR ISOLATED PRODUCTS 
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 Figure 5.9. 1H NMR (top) and 13C NMR (bottom) spectra for V-3.






















































































































































































































































 Figure 5.10. 
1H NMR (top) and 13C NMR (bottom) spectra for V-5.
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 Figure 5.11. 
1H NMR (top) and 13C NMR (bottom) spectra for V-7.






















































































































































































 Figure 5.12. 1H NMR (top) and 13C NMR (bottom) spectra for V-9.












































































































































































































































 Figure 5.13. 
1H NMR (top) and 13C NMR (bottom) spectra for V-10.
























































































































































































































































































 Figure 5.14. 
1H NMR (top) and 13C NMR (bottom) spectra for V-11.
























































































































































































































































































5.7  REFERENCES 
 
1.! Tempany, C.M.; McNeil, B.J. Advances in Biomedical Imaging. J. Am. Med. 
Assoc. 2001, 285, 562-567.  
2.! Alikacem, N.; Stroman, P. W.; Marois, Y.; Jakubiec, B.; Roy, R.; Guidoin, R., 
Noninvasive follow-up of tissue encapsulation of foreign materials - Are magnetic 
resonance imaging and spectroscopy breakthroughs? Asaio Journal 1995, 41, 
617-624.  
3.! Kherlopian, A.R.; Song, T.; Duan, Q.; Neimark, M.A.; Po, M.J.; Gohagan, J.K.; 
Laine, A.F. A review of imaging techniques for systems biology. BMC Syst. Biol. 
2008, 74, 1-18.  
4.! Ehlerding, E. B.; Grodzinski, P.; Cai, W. B.; Liu, C. H., Big Potential from Small 
Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 
2018, 12, 2106-2121. 
5.! Hahn, M.A.; Singh, A.K.; Sharma, P.; Brown, S.C.; Moudgil, B.M.; 
Nanoparticles as contrast agents for in-vivo bioimaging: current status and future 
perspectives. Anal. Bioanal. Chem. 2011, 399, 3-27.  
6.! Chen, H.; Rogalski, M.M.; Anker, J.N. Advances in functional X-ray imaging 
techniques and contrast agents. Phys. Chem. Chem. Phys. 2012, 14, 13469-13486.  
7.! Wu, X.; Liu, H. Clinical implementation of x-ray phase-contrast imaging: 
Theoretical foundations and design considerations. Am. Assoc. Phys. Med. 2003, 
30, 2169-2179.  
 262 
8.! Hemonnot, C. Y. J.; Koster, S., Imaging of Biological Materials and Cells by X- 
ray Scattering and Diffraction. ACS Nano 2017, 11, 8542-8559.  
9.! Attia, M. F.; Brummel, B. R.; Lex, T. R.; Van Horn, B. A.; Whitehead, D. C.; 
Alexis, F., Recent Advances in Polyesters for Biomedical Imaging. Adv. Healthc. 
Mater. 2018, 7. 
10.!Nottelet, B.; Darcos, V.; Coudane, J., Aliphatic polyesters for medical imaging 
and theranostic applications. Eur. J. Pharm. Biopharm. 2015, 97, 350-370.  
11.!El Habnouni, S.; Darcos, V.; Coudane, J., Synthesis and Ring Opening 
Polymerization of a New Functional Lactone, alpha-Iodo-epsilon-caprolactone: A 
Novel Route to Functionalized Aliphatic Polyesters. Macromol. Rapid Commun. 
2009, 30, 165- 169. 
12.!Benabdillah, K. M.; Coudane, J.; Boustta, M.; Engel, R.; Vert, M., Synthesis and 
characterization of novel degradable polyesters derived from D-gluconic and 
glycolic acids. Macromolecules 1999, 32, 8774-8780. 
13.!Samuel, R.; Girard, E.; Chagnon, G.; Dejean, S.; Favier, D.; Coudane, J.; Nottelet, 
B., Radiopaque poly(epsilon-caprolactone) as additive for X-ray imaging of 
temporary implantable medical devices. RSC Adv. 2015, 5, 84125-84133. 
14.!Boase, N. R. B.; Blakey, I.; Thurecht, K. J., Molecular imaging with polymers. 




15.!Olsen, T. R.; Davis, L. L.; Nicolau, S. E.; Duncan, C. C.; Whitehead, D. C.; Horn, 
B. A.; Alexis, F., Non-invasive deep tissue imaging of iodine modified 
poly(caprolactone-co-1-4-oxepan-1,5-dione) using X-ray. Acta Biomaterialia 
2015, 20, 94-103.  
16.!Nicolau, S. E.; Davis, L. L.; Duncan, C. C.; Olsen, T. R.; Alexis, F.; Whitehead, 
D. C.; Van Horn, B. A., Oxime functionalization strategy for iodinated 
poly(epsilon- caprolactone) X-ray opaque materials. J. Polym. Sci. A 2015, 53, 
2421-2430. 
17.!Van Horn, B. A.; Davis, L. L.; Nicolau, S. E.; Burry, E. E.; Bailey, V. O.; Guerra, 
F. D.; Alexis, F.; Whitehead, D. C., Synthesis and conjugation of a 
triiodohydroxylamine for the preparation of highly X-ray opaque poly(epsilon-
caprolactone) materials. J. Polym. Sci. A 2017, 55, 787-793.  
18.!Lex, T.R.; Brummel, B.R.; Attia, M.F.; Giambalvo, L.N.; Lee, K.G.; Van Horn, 
B.A.; Whitehead, D.C.; Alexis, F. Iodinated Polyesters with Enhanced X-ray 
Constrast Properties for Biomedical Imaging. Sci. Rep. 2020, 10, 1508-1517.  
19.!Dechy-Cabaret, O.; Martin-Vaca, B.; Bourissou, D., Controlled ring-opening 
polymerization of lactide and glycolide. Chem. Rev. 2004, 104, 6147-6176. 
20.!Benoit, M. A.; Baras, B.; Gillard, J., Preparation and characterization of protein- 
loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery. Int. J. 
Pharm. 1999, 184, 73-84.  
21.!Janib, S. M.; Moses, A. S.; MacKay, J. A., Imaging and drug delivery using 
theranostic nanoparticles. Adv. Drug Delivery Rev. 2010, 62, 1052-1063. 
 264 
22.!Bikiaris, D.; Karavelidis, V.; Karavas, E., Novel Biodegradable Polyesters. 
Synthesis and Application as Drug Carriers for the Preparation of Raloxifene HCl 
Loaded Nanoparticles. Molecules 2009, 14, 2410-2430 
23.!Shalgunov, V.; Zaytseva-Zotova, D.; Zintchenko, A.; Levada, T.; Shilov, Y.; 
Andreyev, D.; Dzhumashev, D.; Metelkin, E.; Urusova, A.; Demin, O.; 
McDonnell, K.; Troiano, G.; Zale, S.; Safarova, E., Comprehensive study of the 
drug delivery properties of poly(L-lactide)-poly (ethylene glycol) nanoparticles in 
rats and tumor-bearing mice. J Control Release. 2017, 261, 31-42. 
24.!Washington, K. E.; Kularatne, R. N.; Karmegam, V.; Biewer, M. C.; Stefan, M. 
C., Recent advances in aliphatic polyesters for drug delivery applications. Wiley 
Interdiscip. Rev. Nanomed. Nanobiotechnol. 2017, 9.  
25.!Barrera, D. A., Zylstra, E., Lansbury, P. T. & Langer, R. Copolymerization and 
degradation of poly (lactic acid-co-lysine). Macromolecules 1995, 25, 425–432.  
26.!Barrera, D. A., Zylstra, E., Lansbury, P. T. Jr. & Langer, R. Synthesis and RGD 
peptide modification of a new biodegradable copolymer: poly (lactic acid-co-
lysine). J. Am. Chem. Soc. 1993, 115, 11010–11011.  





28.!Ye, L., Lo, K.-Y., Gu, Q. & Yang, D. Pd-Catalyzed Intramolecular 
Aminoalkylation of Unactivated Alkenes: Access to Diverse N-Heterocycles. 
Org. Lett. 2017, 19, 308–311. 
29.!Harvey, R. G., Pataki, J., Cortez, C., Di Raddo, P. & Yang, C. X. A new general 
synthesis of polycyclic aromatic compounds based on enamine chemistry. J. Org. 
Chem. 1992, 56, 1210–1217.  
30.!Jeyaraj, D. A., Kapoor, K. K., Yadav, V. K., Gauniyal, H. M. & Parvez, M. DBU-
catalyzed deconjugation of 7-substituted 3,4-didehydro-2-oxepanones. 
Deuterium incorporation, significance of the imine double bond, and application 
to the synthesis of a key pharmacophore. J. Org. Chem. 1998, 63, 287–294.  
31.!Matsumoto, Y. & Yonaga, M. One-pot sequential 1, 4-and 1, 2-reductions of α, β-
unsaturated δ-lactones to the corresponding δ-lactols with CuCl and NaBH4 in 









GUANIDINIUM SULFATE SALTS:  
DIRECTORS OF ACENTRIC STRUCTURES 
 
 
6.1  GENERAL REMARKS 
 
 
Hydrogen bonding is a powerful tool for organizing and controlling the structures 
of molecular aggregates or crystals. Often in literature, acentric materials are targeted and 
desired due to the unique and exciting properties they frequently possess. These include, 
but are not limited to, ferroelectricity, polarity, magnetism, and second-order nonlinear 
optical behavior.  To be able to access crystals with these important properties, a non-
centrosymmetric arrangement or lack of symmetry in the crystalline state is required. 
Thus, acentricity of a single crystal strongly depends on the relative orientations of 
molecular and crystallographic axes.1-4 This in turn makes the development of synthetic 
strategies that ensure the self-assembly of molecules into acentric arrays of high 
importance.  
 A common way to exert control over the topology of a given crystalline lattice is 
through hydrogen bonding. It has been demonstrated throughout the literature that 
hydrogen-bonding interactions in organic compounds can be used to direct the formation 
of aggregate structures with predictable connectivity patterns.5-9 Such regulation over the 
crystalline form will render control over crucial physical properties like optical activity, 
thermal stability, solubility, color, conductivity, external shape, and mechanical strength. 
Therefore, it is critical to be able to understand, predict, and achieve important hydrogen 
bonding interactions in organic solid-state materials.   
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 While the definition of a hydrogen bond is in a constant state of flux, most 
crystallographers agree that a hydrogen bond is a weak interaction between X-H and A 
that contains a directional force. The functional group X-H is considered the donor where 
X is generally an electronegative atom and A is the acceptor which typically has a lone 
pair to interact with the hydrogen. Definitions for a general hydrogen bond have been on-
going since Latimer and Rodebush reported theirs in 1920.8-9 Many definitions are 
empirical, while others may be restrictive as new hydrogen bonds donor and acceptors 
continue to be reported. Often, the definition of a hydrogen bond gets boiled down to: a 
hydrogen bond exists where there is evidence that it exists.5-9  
 Hydrogen bonds can occur between atoms, molecules, or ions (positive or 
negative) in the gas, liquid, or supercritical phases. There are examples of extremely 
simple hydrogen bonds (involving only one donor and one acceptor) along with more 
complex examples such a bifurcated (three-center) or trifucated (four-center) hydrogen 
bonds. Depending on the strength and complexity of the hydrogen bond, the hydrogen 
bond angle and distance will vary. The average hydrogen bond length is 1.5 to 2.5 Å, 
while there are hardly any viable hydrogen bonds in which the distance is greater than 3.0 
Å. As one would expect, the strength of the hydrogen is highly dependent on length and 
the nature of the structure. The thermodynamic strength of a hydrogen bond in a neutral 
molecule lies in the range of 10-65 kJ mol-1which is greater than what is found for a van 
der Waals interactions (<8 kJ mol-1). However, when one component of the hydrogen 
bond is ionic, the bond strength rises to 40-190 kJ mol-1.8-9 While it is clear that hydrogen 
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bonds are fairly weak interactions, their impact on molecular packing in a crystal lattice 
and the resulting symmetry of the material is monumental.  
 
6.2 GUANIDINIUM SULFATION CRYSTALLIZATION: STRATEGY 
FOR ENANTIOMERIC IDENTIFCATION  
 
The developed absolute stereochemical identification methodology presented in 
Chapter Two of this thesis relied heavily on a strong network of hydrogen bonds for 
successful chiral identification.10 The strategy is able to successfully convert liquid chiral 
alcohols into highly crystalline guanidinium sulfate salts which can be utilized in an X-
ray diffraction experiment (Scheme 6.1). Briefly, the sulfate is attached to the chiral 
alcohol via sulfur trioxide pyridine. After the sulfation, guanidinium chloride is added to 
the sulfate pyridinium complex along with a common alcohol solvent to solubilize the 
components of the mixture. Slow evaporation of this solution results in large, single 
crystals of the organosulfate guanidinium salt. The single crystals can then be used in an 
X-ray diffraction experiment from which the crystal structure can be solved and the 
absolute stereochemistry of the starting alcohol can be assigned. The two-step, one-pot 
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ABSTRACT: A novel technique for the absolute stereochemical
determination of alcohols has been developed that uses
crystallization of guanidinium salts of organosulfates. The simple
one-pot, two-step process leverages facile formation of guandinium
organosulfate single crystals for the straightforward determination
of the absolute stereochemistry of enantiopure alcohols by means
of X-ray crystallography. The strong hydrogen bonding network
drives the stability of the crystal lattice and allows for a diverse range of organic alcohol substrates to be analyzed.
The identity of the absolute stereochemistry of acompound is essential to a number of different discip ines
in organic chemistry including synthetic, pharmaceutical, and
biological processes. The task of assigning the absolute
stereochemistry of a small organic molecule, as opposed to
measuring the enantiomeric excess (ee) or enantiomeric ratio
(e.r.) of a scalemic sample, often can be very difficult.1
Resolution techniques, such as chiral high-performance liquid
chromatography (HPLC), have allowed for the evaluation of
the enantiomeric purity (ee or e.r.) of a sample to be
completed with relative ease. Nonetheless, determining with
certainty which enantiomer has been generated or isolated
remains a daunting challenge.
Indeed, the critical importance of chiral identification has led
to the development of a range of techniques for the assignment
of absolute stereochemistry.2−6 The most popular practices
include chiroptical spectroscopy, stereoselective reactions,
NMR spectroscopy, and X-ray crystallography. Advances in
circular dichroism (CD) by a Nakanishi,2a Harada,2a Berova,2b
and Stephens,2c among others has made it a promising tool for
the determination of the absolute configuration of target
molecules.2 Circular dichroism can be coupled with electronic
transitions, electronic CD (ECD), to examine chiral substrates
containing electronic chromophores capable of absorbing
visible light.2a−c If the chiral molecule lacks an electronic
chromophore, circular dichroism can be coupled with
vibrational transitions (VCD) or Raman scattering known as
vibrational Raman optical activity (VROA).2d−f The major
disadvantage of these chiroptical methods is that they cannot
directly assign the absolute configuration of chiral molecules.
Theoretical methods must be used to predict the chiroptical
properties of the targeted molecule followed by comparative
analysis of the experimental and predicted chiroptical spectra
to then infer the absolute stereochemistry. More recently,
Borhan and co-workers have developed a series of metalated
bis-porphyrin tweezers that are capable of binding chiral
substrates.3 The induced helicity of the tweezer-substrate
complex is measured using exciton coupled circular dichroism
(ECCD) which then can be used to empirically predict the
absolute stereochemistry of the chiral substrate. A variety of
chiral organic compounds including carboxylic acids,3a−e 1,2-
diols, 1,2-diamines, 1,2-aminoalcohols,3f epoxy alcohols,3g 1,n-
glycols,3h amines,3i−j cyanohydrins,3k and sulfoxides3l have
been successfully identified using this method. Despite the
wide range of chiral substrat s tolerat d under this approach,
the strategy requires the nontrivial synthesis of the porphyrin
tweezer probes, and each different chiral functional group
demands different tweezers for analysis. The approach also
involves the use of specialized analytical equipment (circular
dichroism) which may not be universally available and is often
complicated by the need for derivatizations of the analyte
samples.
Another strategy for absolute stereochemical determination
is the competing enantioselective conversion (CEC) method.4
In this technique, both enantiomers of a kinetic resolution
reagent are reacted with the target enantiopure compound.
The conversion of this reaction is measured, and the faster
reacting substrate-reagent pair is then determined via NMR,
TLC, or GC analysis. The absolute stereochemical assignment
is deduced by comparing the kinetic resolution results to an
empirical mnemonic. Although this method has successfully
identified amines,4a−c oxazolidinones, lactams,4d and chiral
alcohols,4e−h each class of substrates requires its own unique
suitable catalyst or reagent capable of kinetic resolution.
Another common method for chiral identification is the
advanced Mosher ester analysis or the use of other chiral
derivatizing agents (CDAs) in order to solve the absolute
stereochemistry via NMR spectroscopy. Methods that utilize
NMR spectroscopy require a transformation of the chiral
molecule to two different species which can be differentiated
by their NMR spectra. The differences in chemical shifts (Δδ)
of the two species (diastereomers or conformers) along with
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large, high quality 
crystals
Scheme 6.1. One-pot guanidinium sulfation crystallization of (S)-1-phenylethanol.
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chiral alcohols that would otherwise prove to be recalcitrant. The key feature of this 
strategy was the highly abundant hydrogen bonding network that takes place between the 
sulfate and guanidinium moieties. This highly directing hydrogen bonding network 
provides a favorable lattice for the formation of high quality crystals from small organic 
compounds.10  
Previous work done by Ward and co-workers demonstrated the high versatility of 
a guanidinium cation in organic sulfonate (R-SO3–) chemistry.12-17 The trigonal 
guanidinium cation is ideally configured to hydrogen bond with the sulfonate 
functionality which has lead to a rich variety of complex structures including framework, 
pore-, pillar-, and channel-based architectures. Ward was able to access hundreds of these 
compounds through the utilization of this unique sulfonate guanidinium network.12-17 We 
adapted this approach employing a guanidinium sulfate (R-OSO3–) network for the 
absolute stereochemical identification of small organic compounds.10 During our efforts 
in the enantiomeric identification of chiral alcohols, we serendipitously generated seven 
unique guanidinium sulfate salts. These structures are excellent examples of the highly 
favorable hydrogen bonding network that forms between guanidinium and sulfate 
moieties. Furthermore, all seven structures crystallized in the highly desired non-
centrosymmetric space group, and in many cases they crystallize in a polar or chiral 
space group. Herein, we report and examine the hydrogen bonding frameworks of seven 
guanidinium sulfate salts and their assembly incorporating additional hydrogen bonded 
organic cations and solvent molecules. 
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6.3  RESULTS AND DISCUSSION  
 
During the development of the synthetic methodology presented in Chapter Two, 
we observed several instances where the sulfur trioxide pyridine reagent would react 
directly with the guanidinium chloride instead of the chiral alcohol. Reaction of the 
SO3·pryidine complex with the guanidinium chloride resulted in the formation of these 
untargeted guanidinium sulfates, or other sulfate salts with mixed organic cation families. 
This typically occurred when attempting the sulfation of a highly functionalized 
secondary alcohol or stubborn tertiary alcohols. The reluctance of these type of alcohol 
substrates to undergo sulfation results in an abundance of the SO3·pyridine complex in 
solution leading to a number of different side reactions. Additionally, bases such as 
triethylamine were added to try increase the rate of the sulfation reaction. In such 
instances, the resulting triethylammonium cation was paired with the guanidinium cation 
and sulfate anion.  
First, the parent structure of guanidinium sulfate, (C(NH2)3)2(SO4) (VI-1), shows 
the formation of the three-dimensional hydrogen bonding network (Figure 6.1) comprised 
of only guanidinium cations and sulfate anions. Although the room temperature structure 
of (VI-1) was previously reported in the literature, an improved refinement (R1=0.1026) 
based on a low temperature data collection is provided in the current study. In this 
structure, there are two unique sulfate anions and each oxygen atom of the sulfate 
molecules supports hydrogen bonds to three different guanidinium molecules. 
Additionally, each guanidinium cation is hydrogen bonded to three sulfate anions. These 
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N-H!!!O interactions result in each sulfate anion being hydrogen bonded to six 
guanidinium cations, so that each guanidinium chelates one edge of the sulfate 
tetrahedron (Figure 6.1). This highly complex framework results in distorted six-  
membered rings of three guanidinium cations and three sulfate anions (Figure 6.2). 
During the formation of these distorted six-membered guanidinium sulfate rings, 
distorted eight-membered rings can also be formed. It is important to note that these six-
membered and eight-membered guanidinium sulfate rings are key components of all the 
structures reported in this chapter. 
 Next, we uncovered a family of four structures that all have some type of mixed 
pyridinium and guanidinium cation system with the isolated sulfate compounds as the 
anions. In all four structures, the pyridinium ion is the minor component of the cationic 
mixture, existing in the structures as 3:1 and 11:1 ratios of guanidinium:pyridinium. It is 










Figure 6.1. (A) Hydrogen bonding interactions between the guanidinium cations and sulfate anions for 
(C(NH2)3)2(SO4) (VI-1). (B) Packing diagram for (C(NH2)3)2(SO4) (VI-1). Hydrogen atoms are omitted 
for clarity, and green dashed lines represent the N-H!!!O hydrogen bonds. The color scheme for the 
atoms in the diagram is: Carbon atoms are gray, nitrogen atoms are blue, oxygen atoms are red, and 
sulfur atoms are yellow.
272 
SO3•pyridine being filtered off after the 24 hour reaction and before the guanidinium 
crystallization step. Therefore, the 1 equivalence of guanidinium chloride added to the 
sulfate pyridinium complex is always in stoichiometric excess relative to the 
SO3•pyridine reagent. The compounds crystallizing in the 3:1 cation ratio were as 
follows: the solvent-free ((C(NH2)3)3(C5H6N)(SO4)2 (VI-2) and solvated 
(C(NH2)3)3(C5H6N)(SO4)2!H2O (VI-3) and (C(NH2)3)3(C5H6N)(SO4)2!CH3OH (VI-4). 
While the compound with the 11:1 cation ratio was obtained as the ethanol solvate, 
(C(NH2)3)11(C5H6N)(SO4)6!2.5C2H5OH (VI-5). 
 The guanidinium pyridinium sulfate salt, VI-2, crystallizes in one of the higher 
symmetry space groups seen in the study, R32. Each tetrahedral sulfate group is 
surrounded by six guanidinium and three pyridinium cations. Additionally, each sulfate 
























Figure 6.2. Guanidinium sulfate netowrk in (C(NH2)3)2(SO4) (VI-1). 
Connections drawn between the center of the guanidinium cations 
(gray) and sulfate anions (yellow) represent N-H!!!O hydrogen 
bonds forming the framework.
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All six of the hydrogen atoms of the guanidinium cations are participating in hydrogen 
bonding with the sulfate anions. The nitrogen atom in the pyridinium cation is disordered 
over the six resulting positions on the pyridine ring. This in turn causes each position to 
have a weaker N/C-H···O hydrogen bonding interaction with a sulfate oxygen acceptor 
compared to the N-H···O interaction from the guanidinium nitrogen atoms. The standard 
three dimensional framework seen in VI-1 is only strengthened by the additional 
pyridinium contributions. As can be seen in Figure 6.4 A, the structures have a distinct 
layered nature along the c-axis with alternating layers of the guanidinium and pyridinium 
sulfate ions.  
 The mixed cation water solvate, (C(NH2)3)3(C5H6N)(SO4)2·H2O (VI-3), 
crystallizes in the C2 space group and has slightly different structural features including 
the sulfate group being coordinated by six guanidinium cations and one water molecule 
via hydrogen bonding. The pyridinium cation is well ordered and participates in N-H···O 
hydrogen bonding with the water molecule opposite of the O-H···O hydrogen bonding 
from the water molecule to the sulfate. Interestingly, the immediate coordination of 
guanidinium cations about the sulfate group is identical to that in the anhydrous VI-2 
resulting in similar guanidinium sulfate frameworks though distorted from the ideal 
three-fold symmetry of VI-2 (Figure 6.3 B). Honeycomb-like nets form in the bc plane 
while eight-membered rings formed in the ac plane to craft a framework with hexagonal 
channels (Figure 6.4 B). The slight distortion of the channel structure of VI-3 compared 
to VI-2 helps accommodate the water molecule channels of VI-3. This also enables the 
associated O- H···O interactions with the sulfate groups to occur in the lattice of VI-3. 
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The polar nature of this structure can easily be seen in the cooperative alignment of the 
C1- N1 bonds of the guanidinium cations, the N6 atoms of the pyridinium cations, and 
the orientation of the water molecules along the b-axis. Of course, the sulfate group are 
also co-aligned, with the S1-O4 bond most closely corresponding to the polar b-axis. 
Similarly, to structure VI-2, there is a layered nature of the guanidinium cations 
alternating with layers containing both of the pyridinium cations and sulfate anions, 
except here the layers are orientated diagonally in the ac plane.  
 For the mixed guanidinium/pyridinium sulfate salts with a cation ratio of 3:1, the 
last structure is the methanol solvate, (C(NH2)3)3(C5H6N)(SO4)2!CH3OH (VI-4), which 
crystallized in the P21 space group (Figure 6.3 C). The connectivity in this structure is 








(A) VI-2 (B) VI-3 (C) VI-4
Figure 6.3. Hydrogen bonding interactions between guanidinium cations, pyridinium cations, solvent molecules and sulfate anions 
(top row) and packing diagrams (bottom row) for the 3:1 guanidinium to pyridinium cation family. (A) (C(NH2)3)3(C5H6N)(SO4)2  (VI-
2). (B) (C(NH2)3)3(C5H6N)(SO4)2・H2O (VI-3). (C) (C(NH2)3)3(C5H6N)(SO4)2・CH3OH (VI-4). Hydrogen atoms attached to carbon 
and nitrogen atoms are omitted for clarity and green dashed lines represent the N-H!!!O hydrogen bonds that occur. The color 
scheme for the atoms in the diagram is: carbon atoms are gray, nitrogen atoms are blue, oxygen atoms are red, and sulfur atoms 
are yellow. Disordered C/N sites of the pyridinium cation in VI-2 are shown in black.
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coordinated by five guanidinium cations and each cation chelated one edge of the 
tetrahedron. Additionally, the S2 sulfate anion participates in hydrogen bonding with four 
guanidinium molecules, the pyridinium cation, and the methanol solvent molecule. 
Again, we see that the guanidinium cations are chelating toward the edges of the sulfate 
tetrahedron. The pyridinium and methanol molecules have hydrogen bonding interactions 
to single oxygen atoms of the sulfate. The three-dimensional framework formed by the 
guanidinium and sulfate anions is much different in VI-4 compared to that in VI-2 or VI-
3. In VI-4, the framework is built of six- and eight-membered rings of the ions’ central 
atoms (Figure 6.4 C) where the pyridinium cations are then aligned in channels in the 
resulting framework. 
 As we expected, the structure of C(NH2)3)11(C5H6N)(SO4)6!2.5C2H5OH (VI-5) 
with a 11:1 guandinium to pyridinium ratio was the most complex. Along with the 11 
unique guanidinium cations, the structure consisted of six unique sulfate groups, one 




(A) VI-2 (B) VI-3 (C) VI-4
Figure 6.4. Guanidinium sulfate frameworks of VI-2, VI-3, and VI-4 visualized by connections between the 
central carbon and sulfur atoms of the guanidinium cations and sulfate anions, including the positions of the 
pyridinium cations and solvent molecules. In VI-2, the nitrogen atom of the pyridinium cation is disordered 
evenly over all sites in that molecule.
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molecule, one half-occupied ethanol solvent molecule, and one ethanol solvent molecule 
disordered over the same two areas of the pyridinium cation, giving the balance of that 
occupancy. As seen in Figure 6.5, each unique sulfate group has a different pattern of 
coordination through hydrogen bonding. The S1 sulfation anion is coordinated to six 
guanidinium cations, five of which have chelate edges. The S2 sulfate group is 
coordinated by six guanidinium cations and one ethanol molecule (i.e. the fully occupied 
EtOH). Further, the S3 and S4 sulfate groups are both coordinated by five guanidinium 
cations. For the S3 and S4 sulfates, all the guanidinium cations are the chelating edges of 
the tetrahedron with one of the sulfate edges being doubly-chelated. The S5 sulfate anion 
is also coordinated by five edge-chelating guanidinium cations, however none of them 

















Figure 6.5. (A) Hydrogen bonding interactions between guanidinium cations, pyridinium cations, ethanol 
solvent molecules and sulfate anions and (B) packing diagram for the 11:1 guanidinium to pyridinium 
sulfate, C(NH2)3)11(C5H6N)(SO4)6・2.5 C2H5OH (VI-5). Hydrogen atoms attached to carbon and nitrogen 
atoms are omitted for clarity and green dashed lines represent the N-H!!!O hydrogen bonds that occur. 
Only one of the disordered arrangements for the pyridinium, ethanol, and sulfate disorder is shown.
Figure 6.5. (A) Hydrogen bonding interactions between guanidinium cations, pyridinium cations, ethanol 
solvent molecules and sulfate anions and (B) packing diagram for the 11:1 guanidinium to pyridinium 
sulfate, C(NH2)3)11(C5H6N)(SO4)6・2.5 C2H5OH (VI-5). Hydrogen atoms attached to carbon and nitrogen 
atoms are omitted for clarity and green dashed lines represent the N-H!!!O hydrogen bonds that occur. 
Only one of the disordered arrangements for the pyridinium, ethanol, and sulfate disorder is shown. The 
color scheme is the same as in the previous figures.
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involved. The pyridinium cation participates in a N-H!!!O hydrogen bond to the ethanol 
oxygen atom, which then acts as the hydrogen bond donor for the O-H!!!O interaction to 
the sulfate group. The final sulfate anion, S6, is coordinated by six guanidinium cations, 
four of which chelate edges of the tetrahedron. Additionally, one can see that two of the 
four chelate edges form bifurcated coordination at the oxygen corners. These complex 
interactions result in a framework of distorted six- and eight-membered rings of 
guanidinium cations and sulfate anions (Figure 6.6). As was seen in the framework of the 
parent guanidinium sulfate (VI-1), the six-membered rings exhibit varying conformations 
and degrees of distortion. One of the highlights of structure VI-5 is the honeycomb-type 
layers found in the bc plane, which are similar to what was observed in the structures of 
VI-2 and VI-3. In this honeycomb, the pyridinium cations and ethanol molecules occupy 
























Figure 6.6. Guanidinium sulfate framework of VI-5 visualized by connections 
between the central carbon and sulfur atoms of the guanidinium cations and 
sulfate anions, including the positions of the pyridinium cations and solvent 
molecules.
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As stated previously, in certain sulfation attempts trimethylamine was added to 
the reaction followed by the standard crystallization using guanidinium chloride. Again, 
the base was added in hopes of increasing the rate of sulfation when employing stubborn 
alcohol substrates. During these attempts, the crystallization led to to the formation of the 
mixed cation sulfate salt of (C(NH2)3)3(C6H16N)(SO4)2 (VI-6). This structure had a 3:1 
ratio of guanidinium to triethylammonium cations, and consisted of two unique sulfate 
anions. The first sulfate anion, S1, is coordinated by four guanidinium cations that chelate 
the edges of the sulfate tetrahedron. The second sulfate group, S2, is coordinated by five 
guanidinium atoms; four of the five chelate the edges of the sulfate tetrahedron. The fifth 
non-chelating guanidinium cation is positioned such that one of the hydrogen atoms is 
bifurcated, creating both a chelated sulfate edge and bifurcated oxygen corner. The 




Figure 6.7. (A) Hydrogen bonding interactions between guanidinium cations, triethylammonium 
cations, and sulfate anions and (B) packing diagram for the 3:1 guanidinium to triethylammonium 
sulfate, C(NH2)3)3(C6H16N)(SO4)2 (VI-6). Hydrogen atoms attached to carbon and nitrogen atoms 
are omitted for clarity and green dashed lines represent the N-H!!!O hydrogen bonds that occur. 
The color scheme is the same as in the previous figures.
(A) (B)
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in a three-dimensional guanidinium sulfate framework comprised of distorted six-
membered rings (Figure 6.7). In this framework, there are two unique six-membered 
rings which exhibit similar conformations with differing degrees of distortion. One can 
see the triethylammonium cations reside in the small channels of the framework 
extending along the a- and b-axes. Finally, the polar nature of the crystal structure in 
space group P41 is evident in the cooperative alignment along the c-axis of the N-H 
bonds of the triethylammonium cation. 
 Lastly, in a reaction where the target substrate (i.e. quinidine) did not undergo 
sulfation, instead we saw the formation of a mixed cation guanidinium-quinidinium 
sulfate, (C(NH2)3)2(C20H26N2O2)(SO4)2 (VI-7). In this structure, the protonation of both 
available nitrogen atoms forms the quinidinium dication species. Both of the protonated 
sites are then available to participate in hydrogen bonding to sulfate anions which makes 




















Figure 6.8. Guanidinium sulfate framework of VI-6 visualized by 
connections between the central carbon and sulfur atoms of the 
guanidinium cations and sulfate anions, including the positions 
of the triethylammonium cations.
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(VI-2 – VI-6) with pyridinium and triethylammonium cations only having one available 
N-H donor site unlike the traditional guanidinium cation. The ability to have multiple 
hydrogen donor sites, including an O-H donor site, allows the quinidinium cations to 
participate in the extended long range hydrogen bonding network as seen in the parent 
guanidinium sulfate (Figure 6.9). The three dimensional framework found in VI-7 
consisted of guanidinium sulfate sheets in the ab plane, connected by quinidinium cations 
along the c-axis. Hydrogen bonding of the guanidinium cations to the three available 
oxygen atoms of the sulfate tetrahedron enable the formation of guanidinium sulfate 
sheets (Figure 6.10). This is very similar to what occurs in the organosulfate guanidinium 
 salts, where the three free oxygen atoms act as hydrogen bond acceptors and the fourth 
oxygen atom connects to the organic backbone.10 In VI-7, there are two unique sulfate 
anions and two unique guanidinium cations. Each sulfate tetrahedron is coordinated by 
 
 
Figure 6.9. (A) Hydrogen bonding interactions between guanidinium cations, quinidinium cations, 
and sulfate anions and (B) packing diagram for C(NH2)3)2(C20H26NO2)(SO4)2 (VI-7). Hydrogen 
atoms attached to carbon and nitrogen atoms are omitted for clarity and green dashed lines 




three guanidinium cations through chelated edges, resulting in two unique corrugated 
honeycomb-like layers of guanidinium and sulfate ions. Additionally, each sulfate group 
also participates in hydrogen bonding to the quinidinium cations. The S1 sulfate group 
has one such interaction while the S2 sulfate group has two hydrogen bonding 
interactions with two neighboring quinidinium cations. In this way, any individual 
quinidinium cation in the structure provides hydrogen bond donor sites to three sulfate 
anions, providing pillared connections between the guanidinium sulfate sheets.  
 
 
Although the above seven structures were synthesized by chance, this work helps 
expand the structural characterization of the general class of guanidinium salts with 
isolated [SO4]2– tetrahedra as the anionic species. The work also reveals that guanidinium 
sulfate salts including sulfate salts with a mixed cation system readily crystallize in non-
















Figure 6.10. Guanidinium sulfate framework of VI-7 visualized by connections 
between the central carbon and sulfur atoms of the guanidinium cations and 
sulfate anions, including the positions of the quinidinium cations.
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to belong to the highly desired non-centrosymmetric space groups. We believe this arises 
due to the highly directing hydrogen bonding network that forms between the 
guanidinium and sulfate ions, both of which themselves lack a center of symmetry. In 
addition, there is a broad sense of favorability towards frameworks consisting of six-
membered rings of three guanidinium cations and three sulfate anions (Figure 6.11). As 
discussed previously, sometimes these frameworks can distort slightly to allow for the 
assembly of eight-membered rings as well.  
Many of these unique hydrogen bonding networks also have a defined polarity or 
chirality. Six of the seven presented structures crystallized in polar space groups, while 
five of the seven crystallize in chiral space groups. This high percentage of chiral and 
polar structures shows the apparent tendency toward co-alignment of the sulfate 
tetrehedra and trigonal planar guanidinium ions. The edge lengths of the sulfate 
tetrahedra closely match the span of the  hydrogen atoms on the guanidinium ion which 
allows the oxygen edges of the sulfate units to be chelated by hydrogen bonds from the 
guanidinium units. This in turn, permits the building blocks of the crystal lattice, the 
guanidinium and sulfate ions, to adopt a non-centrosymmetric, often polar sense. 
Additionally, the edge-chelation of the tetrahedral may lead to the screw sense apparent 
in all the structures, and thus the high frequency of chiral space groups. Besides the 
quinidinium dication structure (VI-7), none of the other structures were comprised of 
chiral molecules. Therefore, the chirality found in the five different crystals is a 
characteristic of the resulting crystalline framework.  
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For all seven reported guanidinium sulfate salts, the non-guanidinium cations and 
solvent molecules generally occupied voids in the larger guanidinium sulfate networks. 
These minor components of the structure are then connected to the main network through 








Figure 6.11. Six-membered guanidinium sulfate motifs comprising the hydrogen bonded 
frameworks of VI-1 to VI-7.
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IV-5) and triethylammonium (IV-6) structures, the relatively small size and singular 
hydrogen bonding capability of the cations allows them to reside in gaps or channels in 
the guanidinium sulfate network, essentially acting as decorations. While these non-
guanidinium cations are not responsible for the continuation of the framework, their 
presence influences or templates the surrounding guanidinium sulfate network. Lastly, for 
the quinidinium dication structure we observe a slightly different behavior. This is largely 
due to the ability of the dication to have two available N-H hydrogen bond donors. In this 
structure, the extra cation does play an additional role in connecting two-dimensional 
guanidinium sulfate sheets into a three-dimensional framework. The retention of the 
parent quinidine moiety in the structure allows for easy determination of the absolute 
stereochemistry of the antiarrhythmic drug, with the carbon stereocenters C11, C12, C14, 
and C15 identified as S, R, S, and R, respectively. 
 
6.4   CONCLUSIONS 
 
In conclusion, the structure of seven compounds based on guanidinium cations, 
isolated sulfation anions, and additional organic cations and solvent molecules are 
reported. All seven compounds, (C(NH2)3)2(SO4) (VI-1), (C(NH2)3)3(C5H6N)(SO4)2 (VI-
2),  (C(NH2)3)3(C5H6N)(SO4)2·H2O (VI-3), (C(NH2)3)3(C5H6N)(SO4)2·CH3OH (VI-4), 
(C(NH2)3)11(C5H6N)(SO4)6·2.5C2H5OH (VI-5), (C(NH2)3)3(C6H16N)(SO4)2 (VI-6), and 
(C(NH2)3)2(C20H26N2O2)(SO4)2 (VI-7) were obtained serendipitously from reactions 
targeting guanidinium organosulfate salts. Remarkably, the seven structures reported all 
 285 
crystallized without a center of symmetry, and a high percentage of them are either chiral 
(6 of the 7) or polar (5 of the 7). Additional features of the structures that are worth 
noting include the three-dimensional hydrogen bonding framework which is built of 
related motifs of six-membered rings of three guanidinium cations and three sulfate 
anions. These six-membered rings are then connected into extended sheets and 
frameworks through an extensive hydrogen bonding network. Additionally, the presence 
of additional cations and solvent molecules in varying ratios modify the original 
guanidinium sulfate framework leading to crystals with a large structural diversity. This 
study demonstrates the high frequency for which these guanidinium sulfate frameworks 
crystallize in desired noncentrosymmetric, polar, and/or chiral space groups. Thus, this 
framework provides a potential pathway for the use of hydrogen bonding interactions to 












6.5  EXPERIMENTAL  
 
6.5.1  GENERAL SYNTHESIS  
 
Crystals in the present study were all obtained serendipitously from one-pot 
reactions targeting organosulfate salts of guanidinium.  In this process, an organic alcohol 
(1 mmol) was treated with 1.3 equivalence of technical grade (≥45% SO3 basis) sulfur 
trioxide•pyridine in 5 mL of dry dichloromethane (DCM) to afford the organosulfate 
pyridinium complex in solution. After the suspension has stirred for 24 h under N2, the 
mixture is filtered and concentrated in vacuo or directly used in the subsequent 
guanidinium crystallization. To the sulfate pyridinium complex, guanidinium chloride is 
added and an alcohol solvent is added dropwise until the solution becomes homogenous. 
Slow evaporation or solvent diffusion of the solution will give the guanidinium 
organosulfate salt.  In general, when sulfation of the organic substrate is unsuccessful or 
the rate of the reaction is slow, at the end of the 24 h reaction there remains a significant 
amount of the unreacted SO3•pyridine in solution that is available to react directly with 
the guanidinium chloride once it is added.  These circumstances led to the formation of 
the compounds in the present study.  Since the primary interest in these specific 
compounds at this time is solely structural in nature, no efforts have been made to 
optimize their synthesis or gauge their purity.  All reagents and chemicals were obtained 
from commercial sources and used without further purification unless stated otherwise. 
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Dichloromethane (DCM) was dried by refluxing over phosphorous pentoxide (P2O5) and 
distilling under nitrogen prior to use 
 
6.5.2  SYNTHESIS OF CRYSTALS 
 
(C(NH2)3)2(SO4) (VI-1): 
To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv) and dry DCM (5 mL) 
was added. The suspension was stirred under N2 and (–)-carveol was added dropwise (1 
mmol, 1 equiv). The resulting solution was stirred for 24 h, and after completion the 
unreacted SO3·Pyr was filtered off. The filtrate was then concentrated in vacuo and 
guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 equiv) was added. Iso-propyl alcohol 
(IPA) was added until the solution became homogenous. Solvent diffusion with hexanes 
produced crystals.  
 
(C(NH2)3)3(C5H6N)(SO4)2 (VI-2): 
To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv) and dry DCM (5 mL) 
was added. The suspension was stirred under N2 and 1,3-butanediol was added dropwise 
(0.5 mmol, 1 equiv). The resulting solution was stirred for 24 h, and after completion the 
unreacted SO3·Pyr was filtered off. Guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 
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equiv) was added directly to filtrate and methanol (MeOH) was added until the solution 
became homogenous. Slow evaporation of the solution produced crystals.  
 
(C(NH2)3)3(C5H6N)(SO4)2·H2O (VI-3): 
To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv) and dry DCM (5 mL) 
was added. The suspension was stirred under N2 and (–)-Corey lactone benzoate was added 
dropwise (1.0 mmol, 1 equiv). The resulting solution was stirred for 24 h, and after 
completion the unreacted SO3·Pyr was filtered off. Guanidinium chloride (1.0 mmol, 0.095 
grams, 1.0 equiv) was added directly to filtrate and MeOH was added until the solution 
became homogenous. Slow evaporation of the solution produced crystals.  
 
 (C(NH2)3)3(C5H6N)(SO4)2·CH3OH (VI-4): 
To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv) and dry DCM (5 mL) 
was added. The suspension was stirred under N2 and (–)-linalool was added dropwise (1.0 
mmol, 1 equiv). The resulting solution was stirred for 24 h, and after completion the 
unreacted SO3·Pyr was filtered off. Guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 
equiv) was added directly to filtrate and MeOH was added until the solution became 




To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv) and dry DCM (5 mL) 
was added. The suspension was stirred under N2 and (–)-carveol was added dropwise (1 
mmol, 1 equiv). The resulting solution was stirred for 24 h, and after completion the 
unreacted SO3·Pyr was filtered off. The filtrate was then concentrated in vacuo and 
guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 equiv) was added. Ethanol (EtOH) was 




To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv), trimethylamine (1.0 
mmol, 0.101 grams, 1.0 equiv), and dry DCM (5 mL) was added. The suspension was 
stirred under N2 and D-phenylalanine was added dropwise (1.0 mmol, 1 equiv). The 
resulting solution was stirred for 24 h, and after completion the unreacted SO3·Pyr was 
filtered off. Guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 equiv) was added directly 
to filtrate and MeOH was added until the solution became homogenous. Slow evaporation 
of the solution produced crystals.  
 
(C(NH2)3)2(C20H26N2O2)(SO4)2 (VI-7): 
To a flame dried 10 mL round bottom with a stir bar, technical grade (≥45% SO3 basis) 
sulfur trioxide·pyridine complex (1.3 mmol, 0.207 grams, 1.3 equiv) and dry DCM (5 mL) 
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was added. The suspension was stirred under N2 and (+)-quinidine was added dropwise (1 
mmol, 1 equiv). The resulting solution was stirred for 24 h, and after completion the 
unreacted SO3·Pyr was filtered off. The filtrate was then concentrated in vacuo and 
guanidinium chloride (1.0 mmol, 0.095 grams, 1.0 equiv) was added. MeOH was added 
until the solution became homogenous. Slow evaporation of the solution produced crystals. 
 
6.5.3   GENERAL PROCEDURE FOR X-RAY DIFFRACTION 
 
Single crystal X-ray diffraction data were collected using a Bruker D8 Venture 
diffractometer with a Photon 100 detector and a Mo Kα (λ = 0.71073 Å) microfocus 
source.  Crystals were mounted on low-background loops and quenched in a cold 
nitrogen stream.  Data were collected using phi and omega scans with a width of 0.5°. 
Data collection and processing was performed through the Apex 3 software suite (SAINT 
and SADABS).18 Space group determinations based on the systematic absences were 
made using the XPREP module of SHELXTL.  Structure solution was achieved using 
intrinsic phasing (SHELXT) with subsequent refinement by full matrix least squares on 
F2 (SHELXL).19  
All non-hydrogen atoms were refined anisotropically.  All hydrogen atoms bound 
to carbon atoms were placed in geometrically-optimized positions and refined using 
appropriate riding models.  Hydrogen atoms attached to nitrogen and oxygen atoms were 
first identified from the difference electron density map, and their positions and thermal 
parameters fully refined. In some circumstances, more reasonable hydrogen atom 
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positions were obtained by incorporating distance fixing restraints into the model.  When 
the parent atom was on a special position or the hydrogen bonding arrangement subject to 
disorder, geometrically-optimized positions were found to be preferable, and these 
positions remained consistent with residual electron density in the difference map.  All of 
the structures in the present study were refined in noncentrosymmetric space groups with 
acceptable Flack parameters indicating the proper absolute structure (given the presence 
of sulfur in all the structures to enhance anomalous dispersion).  All bond lengths were 
found to be within the typical ranges.  Crystallographic data are given in Tables 6.1 and 
6.2. Further details may be obtained in CIF form from the Cambridge Crystallographic 
Data Centre, upon quoting deposition numbers. 
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6.5.4 CRYSTALLOGRAPHIC DATA FOR GUANIDNIUM SULFATES 
 
 
 VI-1 VI-2 VI-3 VI-4 
Formula C2H16N6O4S C8H24N10O8S2 C8H26N10O9S2 C9H28N10O9S2 
Space group P4332 (no. 212) R32 (no 155) C2 (no. 5) P21 (no. 4) 
a (Å) 17.8273(6) 10.0469(10) 12.3826(9) 7.4737(6) 
b (Å) 17.8273(6) 10.0469(10) 11.1225(7) 11.8491(11) 
c (Å) 17.8273(6) 17.3180(17) 7.7723(5) 13.0179(13) 
α (°) 90 90 90 90 
β (°) 90 90 102.385(2) 93.723(3) 
γ (°) 90 120 90 90 
Cell volume (Å3) 5665.7(6) 1513.9(3) 1045.53(12) 1150.39(18) 
Z 20 3 2 2 
Formula weight 216.24 452.49 470.51 484.53 
Density (calc, Mg/m3) 1.268 1.489 1.495 1.399 
Temp (K) 100 100 100 140 
Size (mm) 0.2 x 0.12 x 0.1 0.3 x 0.3 x 0.04 0.2 x 0.2 x 0.14 0.2 x 0.11 x 0.07 
Abs. coeff. (mm-1) 0.286 0.322 0.318 0.291 
Θ range (deg.) 3.23-26.41 2.62-27.47 2.49-28.50 2.33-25.50 
Reflections 131432 11748 11289 25166 
Unique reflections 1952 774 2640 4270 
Rint 0.0616 0.0373 0.0277 0.0578 
No. of parameters 131 54 179 352 
R1, wR2 (all data) 0.0371, 0.1163 0.0257, 0.0629 0.0216, 0.0550 0.0297, 0.0680 
R1, wR2 (obs. data) 0.0384, 0.1178 0.0265, 0.0632 0.0223, 0.0554 0.0340, 0.0701 
Goodness of fit on F2 1.200 1.092 1.076 1.056 
Flack param. 0.013(14) 0.01(3) -0.018(18) 0.07(3) 
Larg. diff. peak (e/Å3) 0.738 0.195 0.169 0.379 
Larg. diff. hole (e/Å3) -0.283 -0.337 -0.333 -0.250 
CCDC deposition no.     
 




Table 6.2. Crystallographic data for VI-5 to VI-7.
 
 VI-5 VI-6 VI-7 
Formula C21H87N34O26.5S6 C9H34N10O8S2 C22H38N8O10S2 
Space group Pna21 (no 33) P41 (no. 76) P21 (no. 4) 
a (Å) 26.0251(8) 10.8776(4) 7.1728(4) 
b (Å) 22.0693(6) 10.8776(4) 11.1002(7) 
c (Å) 12.5545(4) 20.4184(7) 19.3610(12) 
α (°) 90 90 90 
β (°) 90 90 100.265(2) 
γ (°) 90 90 90 
Cell volume (Å3) 7210.7(4) 2415.9(2) 1516.84(16) 
Z 4 4 2 
Formula weight 1432.60 474.58 638.72 
Density (calc, Mg/m3) 1.320 1.305 1.398 
Temp (K) 140 100 140 
Size (mm) 0.17 x 0.15 x 0.14 0.44 x 0.40 x 0.35 0.38 x 0.10 x 0.10 
Abs. coeff. (mm-1) 0.278 0.272 0.240 
Θ range (deg.) 2.02-26.00 2.65-26.50 2.12-26.50 
Reflections 59324 22103 46918 
Unique reflections 13979 4984 6243 
Rint 0.0558 0.0264 0.0527 
No. of parameters 945 341 440 
R1, wR2 (all data) 
 
0.0482, 0.1309 0.0254, 0.0620 0.0336, 0.0762 
R1, wR2 (obs. data) 
 
0.0642, 0.1420 0.0268, 0.0628 0.0390, 0.0785 
Goodness of fit on F2 1.095 1.090 1.025 
Flack param. 0.07(2) 0.000(14) -0.007(17) 
Larg. diff. peak (e/Å3) 0.680 0.168 0.388 
Larg. diff. hole (e/Å3) -0.541 -0.282 -0.277 
CCDC deposition no.    
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